,baseMean,log2FoldChange,lfcSE,stat,pvalue,padj,ofav_gene,contrast,contrast_gene,name,description,contrast_id
657,4.115552389,-42.99346931,2.810664675,-15.29654878,8.06E-53,1.28E-48,LOC110063428,3,3_LOC110063428,LOC110063428,uncharacterized LOC110063428, C_PE_D_D_EE_D
659,2.364015573,-39.71379081,3.531191481,-11.24656961,2.41E-29,1.28E-25,LOC110063825,3,3_LOC110063825,LOC110063825,cytochrome P450 3A19-like, C_PE_D_D_EE_D
663,1.26322746,-25.94995512,3.54139249,-7.327613416,2.34E-13,5.32E-10,LOC110046365,3,3_LOC110046365,LOC110046365,"potassium channel subfamily K member 9-like, transcript variant X2", C_PE_D_D_EE_D
660,25.75827594,-25.60439212,2.549916046,-10.04126868,1.00E-23,3.99E-20,LOC110069565,3,3_LOC110069565,LOC110069565,"uncharacterized LOC110069565, transcript variant X1", C_PE_D_D_EE_D
16,36.04349222,-23.87214578,3.352371521,-7.120972611,1.07E-12,1.00E-09,LOC110047027,1,1_LOC110047027,LOC110047027,uncharacterized LOC110047027, C_EE_H_D_EE_H
409,16.97349575,-23.62987444,7.23743222,-3.264952778,0.001094823,0.042537498,LOC110047843,1,1_LOC110047843,LOC110047843,testis-expressed protein 10-like, C_EE_H_D_EE_H
428,12.40394884,-23.61636553,7.724267958,-3.057424426,0.002232479,0.082888617,LOC110050129,1,1_LOC110050129,LOC110050129,"hydroxyacyl-coenzyme A dehydrogenase, mitochondrial-like", C_EE_H_D_EE_H
6,27.23000385,-23.5928003,2.761910441,-8.542203233,1.32E-17,3.49E-14,LOC110045720,1,1_LOC110045720,LOC110045720,"myoferlin-like, transcript variant X1", C_EE_H_D_EE_H
300,10.36837764,-23.53724614,5.87510406,-4.006268808,6.17E-05,0.003267478,LOC110066386,1,1_LOC110066386,LOC110066386,uncharacterized LOC110066386, C_EE_H_D_EE_H
48,21.45628148,-23.42425684,3.763297797,-6.224396288,4.83E-10,1.60E-07,LOC110053631,1,1_LOC110053631,LOC110053631,C2 domain-containing protein 3-like, C_EE_H_D_EE_H
608,8.895019662,-23.2479699,5.095885041,-4.562106428,5.06E-06,0.000459867,LOC110069668,2,2_LOC110069668,LOC110069668,FH protein interacting protein FIP2-like, D_EE_D_D_EE_H
83,15.17119865,-23.18869214,3.980631813,-5.825379797,5.70E-09,1.09E-06,LOC110044544,1,1_LOC110044544,LOC110044544,uncharacterized LOC110044544, C_EE_H_D_EE_H
349,10.4313104,-23.12073229,6.295670519,-3.672481306,0.000240207,0.010937321,LOC110064592,1,1_LOC110064592,LOC110064592,uncharacterized LOC110064592, C_EE_H_D_EE_H
392,8.19675064,-23.11282467,6.837181396,-3.380460944,0.000723644,0.029186346,LOC110054377,1,1_LOC110054377,LOC110054377,twist-related protein-like, C_EE_H_D_EE_H
118,18.185449,-23.05469805,4.285479557,-5.379724193,7.46E-08,9.90E-06,LOC110052681,1,1_LOC110052681,LOC110052681,uncharacterized LOC110052681, C_EE_H_D_EE_H
314,11.51928097,-23.02466579,5.848843593,-3.936618482,8.26E-05,0.004182158,LOC110039915,1,1_LOC110039915,LOC110039915,"putative adenosylhomocysteinase 3, transcript variant X2", C_EE_H_D_EE_H
19,38.98174562,-23.00735593,3.268760963,-7.038555647,1.94E-12,1.62E-09,LOC110059082,1,1_LOC110059082,LOC110059082,cytosolic carboxypeptidase 2-like, C_EE_H_D_EE_H
183,11.39655721,-22.96027534,4.733745928,-4.850339602,1.23E-06,0.000106444,LOC110047676,1,1_LOC110047676,LOC110047676,neuromedin-U receptor 2-like, C_EE_H_D_EE_H
89,16.21273541,-22.80299854,3.975934929,-5.735254461,9.74E-09,1.74E-06,LOC110050828,1,1_LOC110050828,LOC110050828,uncharacterized LOC110050828, C_EE_H_D_EE_H
12,46.49452675,-22.79289046,3.039829195,-7.498082623,6.48E-14,8.58E-11,LOC110047374,1,1_LOC110047374,LOC110047374,collagen triple helix repeat-containing protein 1-like, C_EE_H_D_EE_H
60,131.1652588,-22.72426348,3.723175982,-6.103462095,1.04E-09,2.75E-07,LOC110040175,1,1_LOC110040175,LOC110040175,uncharacterized LOC110040175, C_EE_H_D_EE_H
739,15.29580865,-22.65762714,2.738724417,-8.273058436,1.31E-16,3.40E-14,LOC110069143,4,4_LOC110069143,LOC110069143,"tensin-3-like, transcript variant X1", C_PE_H_C_EE_H
149,15.21174516,-22.62798618,4.431366625,-5.106322292,3.28E-07,3.50E-05,LOC110043028,1,1_LOC110043028,LOC110043028,"uncharacterized LOC110043028, transcript variant X3", C_EE_H_D_EE_H
797,12.44458191,-22.57415079,3.095094058,-7.293526584,3.02E-13,4.03E-11,LOC110055775,4,4_LOC110055775,LOC110055775,uncharacterized LOC110055775, C_PE_H_C_EE_H
707,29.70030396,-22.53650909,2.484128244,-9.072200333,1.17E-19,6.39E-17,LOC110050490,4,4_LOC110050490,LOC110050490,sodium-coupled monocarboxylate transporter 1-like, C_PE_H_C_EE_H
84,24.17473323,-22.51751605,3.884740495,-5.796401607,6.78E-09,1.28E-06,LOC110062326,1,1_LOC110062326,LOC110062326,uncharacterized LOC110062326, C_EE_H_D_EE_H
780,21.79876206,-22.51712204,2.95838948,-7.611277079,2.71E-14,4.23E-12,LOC110048539,4,4_LOC110048539,LOC110048539,uncharacterized LOC110048539, C_PE_H_C_EE_H
694,36.12983085,-22.50863433,2.330359194,-9.658869067,4.51E-22,4.48E-19,LOC110054205,4,4_LOC110054205,LOC110054205,uncharacterized LOC110054205, C_PE_H_C_EE_H
50,32.80436493,-22.4891644,3.644678078,-6.170411739,6.81E-10,2.07E-07,LOC110057496,1,1_LOC110057496,LOC110057496,uncharacterized LOC110057496, C_EE_H_D_EE_H
70,21.18367373,-22.45549653,3.714769677,-6.044922964,1.49E-09,3.39E-07,LOC110068534,1,1_LOC110068534,LOC110068534,histone H2A, C_EE_H_D_EE_H
701,36.10334154,-22.44455153,2.426236122,-9.250769671,2.23E-20,1.54E-17,LOC110039872,4,4_LOC110039872,LOC110039872,anion exchange protein 3-like, C_PE_H_C_EE_H
704,23.82108009,-22.43218799,2.447649008,-9.164789524,4.96E-20,3.03E-17,LOC110045499,4,4_LOC110045499,LOC110045499,lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog, C_PE_H_C_EE_H
81,21.02369953,-22.40267458,3.802993415,-5.890800254,3.84E-09,7.52E-07,LOC110059770,1,1_LOC110059770,LOC110059770,"NACHT, LRR and PYD domains-containing protein 12-like, transcript variant X1", C_EE_H_D_EE_H
344,4.817511735,-22.39945025,6.073925936,-3.687804311,0.000226197,0.010449141,LOC110040700,1,1_LOC110040700,LOC110040700,"beta-1,4-N-acetylgalactosaminyltransferase 3-like", C_EE_H_D_EE_H
750,19.33495207,-22.37701563,2.783775079,-8.038370556,9.10E-16,2.01E-13,LOC110062257,4,4_LOC110062257,LOC110062257,uncharacterized LOC110062257, C_PE_H_C_EE_H
686,35.19885966,-22.29348642,2.101950475,-10.606095,2.79E-26,5.55E-23,LOC110053599,4,4_LOC110053599,LOC110053599,uncharacterized LOC110053599, C_PE_H_C_EE_H
29,18.03375438,-22.28929855,3.394177606,-6.566921694,5.14E-11,2.74E-08,LOC110048560,1,1_LOC110048560,LOC110048560,"metalloendopeptidase OMA1, mitochondrial-like", C_EE_H_D_EE_H
423,4.68689956,-22.28703404,7.176152972,-3.10570777,0.001898242,0.071311975,LOC110047450,1,1_LOC110047450,LOC110047450,interstitial collagenase-like, C_EE_H_D_EE_H
128,17.25987139,-22.25824179,4.182076286,-5.322294542,1.02E-07,1.27E-05,LOC110047159,1,1_LOC110047159,LOC110047159,"RNA polymerase-associated protein LEO1-like, transcript variant X2", C_EE_H_D_EE_H
45,21.2831231,-22.23776889,3.547686595,-6.268245036,3.65E-10,1.29E-07,LOC110050375,1,1_LOC110050375,LOC110050375,uncharacterized LOC110050375, C_EE_H_D_EE_H
97,20.31730805,-22.23590362,3.934142519,-5.65203307,1.59E-08,2.60E-06,LOC110045768,1,1_LOC110045768,LOC110045768,ankyrin repeat and BTB/POZ domain-containing protein BTBD11-like, C_EE_H_D_EE_H
62,18.14695616,-22.21060135,3.64812743,-6.088219715,1.14E-09,2.93E-07,LOC110051129,1,1_LOC110051129,LOC110051129,"uncharacterized LOC110051129, transcript variant X2", C_EE_H_D_EE_H
955,20.45242045,-22.20902132,4.037705833,-5.500405984,3.79E-08,2.17E-06,LOC110064737,4,4_LOC110064737,LOC110064737,uncharacterized LOC110064737, C_PE_H_C_EE_H
267,10.63862775,-22.1943471,5.251674547,-4.226146709,2.38E-05,0.001414877,LOC110068563,1,1_LOC110068563,LOC110068563,uncharacterized LOC110068563, C_EE_H_D_EE_H
291,7.451608309,-22.12852495,5.432958396,-4.07301572,4.64E-05,0.002538049,LOC110063383,1,1_LOC110063383,LOC110063383,uncharacterized LOC110063383, C_EE_H_D_EE_H
653,4.353835066,-22.11882457,6.623197215,-3.339599268,0.000838994,0.060602033,LOC110065008,2,2_LOC110065008,LOC110065008,"D(3) dopamine receptor-like, transcript variant X1", D_EE_D_D_EE_H
710,21.2831231,-22.08059498,2.462570018,-8.966484126,3.06E-19,1.52E-16,LOC110050375,4,4_LOC110050375,LOC110050375,uncharacterized LOC110050375, C_PE_H_C_EE_H
77,30.14853123,-22.06432858,3.718155826,-5.934212985,2.95E-09,6.09E-07,LOC110064066,1,1_LOC110064066,LOC110064066,tyrosine-protein kinase FRK-like, C_EE_H_D_EE_H
53,15.08641006,-22.05148096,3.574788354,-6.168611613,6.89E-10,2.07E-07,LOC110068247,1,1_LOC110068247,LOC110068247,forkhead box protein Q1-like, C_EE_H_D_EE_H
699,18.03375438,-22.03946734,2.360033019,-9.338626689,9.76E-21,7.38E-18,LOC110048560,4,4_LOC110048560,LOC110048560,"metalloendopeptidase OMA1, mitochondrial-like", C_PE_H_C_EE_H
689,40.65909261,-22.0021102,2.120584751,-10.37549204,3.21E-25,4.63E-22,LOC110055994,4,4_LOC110055994,LOC110055994,ZP domain-containing protein-like, C_PE_H_C_EE_H
690,46.49452675,-21.99542492,2.124291284,-10.35424148,4.00E-25,5.30E-22,LOC110047374,4,4_LOC110047374,LOC110047374,collagen triple helix repeat-containing protein 1-like, C_PE_H_C_EE_H
120,18.4495957,-21.97232251,4.084344399,-5.3796449,7.46E-08,9.90E-06,LOC110069503,1,1_LOC110069503,LOC110069503,uncharacterized LOC110069503, C_EE_H_D_EE_H
382,7.116240392,-21.96521967,6.366231067,-3.450270566,0.000560025,0.023296745,LOC110063864,1,1_LOC110063864,LOC110063864,pyroglutamylated RFamide peptide receptor-like, C_EE_H_D_EE_H
153,14.44288459,-21.96430799,4.309139991,-5.097144217,3.45E-07,3.58E-05,LOC110055837,1,1_LOC110055837,LOC110055837,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3-like, C_EE_H_D_EE_H
685,21.68498461,-21.96145695,2.063237622,-10.6441724,1.86E-26,4.21E-23,LOC110057236,4,4_LOC110057236,LOC110057236,"centrosomal protein POC5-like, transcript variant X1", C_PE_H_C_EE_H
715,18.11739116,-21.94736422,2.497349762,-8.788262083,1.52E-18,6.52E-16,LOC110069663,4,4_LOC110069663,LOC110069663,"uncharacterized LOC110069663, transcript variant X2", C_PE_H_C_EE_H
855,8.611637324,-21.93393567,3.336518698,-6.573898622,4.90E-11,4.38E-09,LOC110058730,4,4_LOC110058730,LOC110058730,protein decapentaplegic-like, C_PE_H_C_EE_H
801,9.813666225,-21.93134503,3.033465678,-7.22979831,4.84E-13,6.25E-11,LOC110062663,4,4_LOC110062663,LOC110062663,sodium- and chloride-dependent taurine transporter-like, C_PE_H_C_EE_H
727,15.85395136,-21.9184527,2.589477156,-8.464431768,2.57E-17,8.35E-15,LOC110058152,4,4_LOC110058152,LOC110058152,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A-like", C_PE_H_C_EE_H
723,21.18367373,-21.9184025,2.574608363,-8.513295775,1.69E-17,5.97E-15,LOC110068534,4,4_LOC110068534,LOC110068534,histone H2A, C_PE_H_C_EE_H
23,25.223293,-21.91637037,3.26408784,-6.714393559,1.89E-11,1.30E-08,LOC110061179,1,1_LOC110061179,LOC110061179,uncharacterized LOC110061179, C_EE_H_D_EE_H
835,15.56345351,-21.9036533,3.231200052,-6.778798264,1.21E-11,1.23E-09,LOC110049641,4,4_LOC110049641,LOC110049641,"histone acetyltransferase KAT7-like, transcript variant X3", C_PE_H_C_EE_H
254,10.25903085,-21.89675748,5.107290408,-4.287353123,1.81E-05,0.001131231,LOC110040308,1,1_LOC110040308,LOC110040308,probable E3 ubiquitin-protein ligase ARI11, C_EE_H_D_EE_H
679,49.56764317,-21.89659771,1.791561465,-12.22207451,2.37E-34,3.77E-30,LOC110066850,4,4_LOC110066850,LOC110066850,uncharacterized LOC110066850, C_PE_H_C_EE_H
751,10.96513886,-21.88990367,2.732340909,-8.011410141,1.13E-15,2.47E-13,LOC110047414,4,4_LOC110047414,LOC110047414,protein CIP2A homolog, C_PE_H_C_EE_H
656,4.390519646,-21.87952274,6.823455703,-3.206516419,0.001343526,0.09573981,LOC110067499,2,2_LOC110067499,LOC110067499,uncharacterized LOC110067499, D_EE_D_D_EE_H
698,39.5607303,-21.87699526,2.331427325,-9.383520143,6.38E-21,5.07E-18,LOC110052514,4,4_LOC110052514,LOC110052514,two pore potassium channel protein sup-9-like, C_PE_H_C_EE_H
726,16.00430886,-21.8615108,2.577070119,-8.483087301,2.19E-17,7.26E-15,LOC110053046,4,4_LOC110053046,LOC110053046,maltase 1-like, C_PE_H_C_EE_H
85,25.38680759,-21.84793568,3.776860546,-5.784681593,7.26E-09,1.34E-06,LOC110052731,1,1_LOC110052731,LOC110052731,glycogen synthase kinase-3 beta-like, C_EE_H_D_EE_H
910,7.512101115,-21.80114255,3.694667249,-5.900705283,3.62E-09,2.48E-07,LOC110053460,4,4_LOC110053460,LOC110053460,uncharacterized LOC110053460, C_PE_H_C_EE_H
877,12.74835016,-21.78581785,3.435401894,-6.34156309,2.27E-10,1.82E-08,LOC110043323,4,4_LOC110043323,LOC110043323,coiled-coil domain-containing protein 15-like, C_PE_H_C_EE_H
66,23.61564826,-21.77515155,3.58603796,-6.072203305,1.26E-09,3.04E-07,LOC110044586,1,1_LOC110044586,LOC110044586,uncharacterized LOC110044586, C_EE_H_D_EE_H
15,40.65909261,-21.77218013,3.035411658,-7.172727322,7.35E-13,7.79E-10,LOC110055994,1,1_LOC110055994,LOC110055994,ZP domain-containing protein-like, C_EE_H_D_EE_H
729,8.681886301,-21.76621354,2.573415116,-8.45810433,2.72E-17,8.47E-15,LOC110058416,4,4_LOC110058416,LOC110058416,"phosphoglycolate phosphatase-like, transcript variant X1", C_PE_H_C_EE_H
752,17.40039705,-21.74863407,2.725394553,-7.979994694,1.46E-15,3.14E-13,LOC110063495,4,4_LOC110063495,LOC110063495,uncharacterized LOC110063495, C_PE_H_C_EE_H
145,14.65722099,-21.73040036,4.235597201,-5.130421834,2.89E-07,3.17E-05,LOC110054165,1,1_LOC110054165,LOC110054165,vacuolar protein sorting-associated protein 72 homolog, C_EE_H_D_EE_H
162,17.4845792,-21.71118635,4.322880932,-5.022388239,5.10E-07,5.01E-05,LOC110050011,1,1_LOC110050011,LOC110050011,protein DBF4 homolog B-like, C_EE_H_D_EE_H
10,35.95108468,-21.67798562,2.776857236,-7.806661912,5.87E-15,9.33E-12,LOC110063950,1,1_LOC110063950,LOC110063950,transient receptor potential cation channel subfamily A member 1 homolog, C_EE_H_D_EE_H
766,11.42279308,-21.65141335,2.766235621,-7.827031502,5.00E-15,9.02E-13,LOC110069527,4,4_LOC110069527,LOC110069527,"uncharacterized protein C15orf41 homolog, transcript variant X2", C_PE_H_C_EE_H
189,13.26979478,-21.64029447,4.500037833,-4.808913896,1.52E-06,0.000127593,LOC110065762,1,1_LOC110065762,LOC110065762,EGF-like repeat and discoidin I-like domain-containing protein 3, C_EE_H_D_EE_H
21,17.83992755,-21.63742149,3.208990065,-6.742751162,1.55E-11,1.15E-08,LOC110062674,1,1_LOC110062674,LOC110062674,tetratricopeptide repeat protein 28-like, C_EE_H_D_EE_H
778,18.34832084,-21.62989362,2.825176168,-7.656122073,1.92E-14,3.05E-12,LOC110052533,4,4_LOC110052533,LOC110052533,uncharacterized skeletal organic matrix protein 5-like, C_PE_H_C_EE_H
9,66.66491864,-21.6267732,2.671974691,-8.093928911,5.78E-16,1.02E-12,LOC110054542,1,1_LOC110054542,LOC110054542,uncharacterized LOC110054542, C_EE_H_D_EE_H
892,9.272207476,-21.62554734,3.50139925,-6.176258631,6.56E-10,4.87E-08,LOC110069718,4,4_LOC110069718,LOC110069718,DNA polymerase delta subunit 2-like, C_PE_H_C_EE_H
757,19.54120028,-21.6075551,2.735074522,-7.900170514,2.79E-15,5.59E-13,LOC110046618,4,4_LOC110046618,LOC110046618,mitochondrial carnitine/acylcarnitine carrier protein-like, C_PE_H_C_EE_H
287,13.30897963,-21.60226246,5.282301431,-4.089555043,4.32E-05,0.002386568,LOC110042054,1,1_LOC110042054,LOC110042054,FUN14 domain-containing protein 1-like, C_EE_H_D_EE_H
94,20.12088212,-21.59595504,3.801317015,-5.681177065,1.34E-08,2.26E-06,LOC110062317,1,1_LOC110062317,LOC110062317,angiogenic factor with G patch and FHA domains 1-like, C_EE_H_D_EE_H
792,14.82885086,-21.57985352,2.944639378,-7.328521679,2.33E-13,3.24E-11,LOC110051143,4,4_LOC110051143,LOC110051143,"tolloid-like protein 2, transcript variant X1", C_PE_H_C_EE_H
705,28.25669217,-21.5771306,2.360787219,-9.139803209,6.26E-20,3.55E-17,LOC110041256,4,4_LOC110041256,LOC110041256,von Hippel-Lindau tumor suppressor homolog, C_PE_H_C_EE_H
817,13.26979478,-21.55949233,3.101806618,-6.95062426,3.64E-12,4.16E-10,LOC110065762,4,4_LOC110065762,LOC110065762,EGF-like repeat and discoidin I-like domain-containing protein 3, C_PE_H_C_EE_H
806,11.91791726,-21.53961931,3.045907005,-7.071660191,1.53E-12,1.90E-10,LOC110055594,4,4_LOC110055594,LOC110055594,dehydrogenase/reductase SDR family member on chromosome X-like, C_PE_H_C_EE_H
788,11.12371178,-21.53718351,2.897992749,-7.431758939,1.07E-13,1.55E-11,LOC110067164,4,4_LOC110067164,LOC110067164,uncharacterized LOC110067164, C_PE_H_C_EE_H
861,8.777416147,-21.53122421,3.302611466,-6.519454204,7.06E-11,6.12E-09,LOC110042472,4,4_LOC110042472,LOC110042472,uncharacterized LOC110042472, C_PE_H_C_EE_H
744,20.12088212,-21.52563707,2.632122358,-8.178053352,2.88E-16,6.95E-14,LOC110062317,4,4_LOC110062317,LOC110062317,angiogenic factor with G patch and FHA domains 1-like, C_PE_H_C_EE_H
195,18.83549534,-21.51128114,4.518084892,-4.761150279,1.92E-06,0.000157057,LOC110056474,1,1_LOC110056474,LOC110056474,sterol regulatory element-binding protein 1-like, C_EE_H_D_EE_H
749,16.50115776,-21.50965523,2.669932994,-8.056252829,7.87E-16,1.76E-13,LOC110059284,4,4_LOC110059284,LOC110059284,"paramyosin-like, transcript variant X2", C_PE_H_C_EE_H
733,14.56710071,-21.50934766,2.555644576,-8.416408082,3.88E-17,1.12E-14,LOC110042096,4,4_LOC110042096,LOC110042096,potassium channel subfamily K member 15-like, C_PE_H_C_EE_H
958,8.068358084,-21.50310762,3.930157697,-5.471309113,4.47E-08,2.54E-06,LOC110052143,4,4_LOC110052143,LOC110052143,uncharacterized LOC110052143, C_PE_H_C_EE_H
711,26.34680769,-21.4992054,2.41238535,-8.912011259,5.01E-19,2.41E-16,LOC110054683,4,4_LOC110054683,LOC110054683,nudix hydrolase 8-like, C_PE_H_C_EE_H
730,17.36169121,-21.47551558,2.541552579,-8.449762464,2.92E-17,8.92E-15,LOC110066112,4,4_LOC110066112,LOC110066112,"arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2-like", C_PE_H_C_EE_H
772,14.14335469,-21.47523167,2.778973132,-7.727757934,1.09E-14,1.85E-12,LOC110055237,4,4_LOC110055237,LOC110055237,vesicle transport protein GOT1B-like, C_PE_H_C_EE_H
696,17.83992755,-21.47515567,2.236181452,-9.60349423,7.73E-22,6.82E-19,LOC110062674,4,4_LOC110062674,LOC110062674,tetratricopeptide repeat protein 28-like, C_PE_H_C_EE_H
725,12.42205274,-21.46565433,2.524068913,-8.50438521,1.83E-17,6.17E-15,LOC110048542,4,4_LOC110048542,LOC110048542,zinc phosphodiesterase ELAC protein 2-like, C_PE_H_C_EE_H
812,18.23614329,-21.46330827,3.054739641,-7.026231626,2.12E-12,2.52E-10,LOC110069515,4,4_LOC110069515,LOC110069515,glutathione-specific gamma-glutamylcyclotransferase 1-like, C_PE_H_C_EE_H
997,7.280149294,-21.43972374,4.374780308,-4.900754376,9.55E-07,4.76E-05,LOC110056074,4,4_LOC110056074,LOC110056074,"ATP synthase subunit s, mitochondrial-like", C_PE_H_C_EE_H
940,5.332188431,-21.43843253,3.781460253,-5.669352869,1.43E-08,8.69E-07,LOC110061555,4,4_LOC110061555,LOC110061555,"uncharacterized LOC110061555, transcript variant X1", C_PE_H_C_EE_H
781,18.4495957,-21.43016578,2.822453519,-7.59274356,3.13E-14,4.83E-12,LOC110069503,4,4_LOC110069503,LOC110069503,uncharacterized LOC110069503, C_PE_H_C_EE_H
901,10.34384614,-21.42872165,3.542615371,-6.048842284,1.46E-09,1.04E-07,LOC110039848,4,4_LOC110039848,LOC110039848,uncharacterized LOC110039848, C_PE_H_C_EE_H
697,28.1765426,-21.42630127,2.275186451,-9.417382588,4.62E-21,3.87E-18,LOC110067644,4,4_LOC110067644,LOC110067644,"neurocalcin homolog, transcript variant X1", C_PE_H_C_EE_H
702,18.13833569,-21.42504878,2.31915176,-9.238312536,2.50E-20,1.66E-17,LOC110055735,4,4_LOC110055735,LOC110055735,uncharacterized LOC110055735, C_PE_H_C_EE_H
1006,14.79010743,-21.42401348,4.529573446,-4.729808166,2.25E-06,0.000108879,LOC110069209,4,4_LOC110069209,LOC110069209,deleted in malignant brain tumors 1 protein-like, C_PE_H_C_EE_H
7,49.56764317,-21.42000356,2.538574382,-8.437808128,3.23E-17,7.34E-14,LOC110066850,1,1_LOC110066850,LOC110066850,uncharacterized LOC110066850, C_EE_H_D_EE_H
902,17.3917965,-21.41983542,3.559621819,-6.017446938,1.77E-09,1.26E-07,LOC110041899,4,4_LOC110041899,LOC110041899,E3 ubiquitin-protein ligase TRIM71-like, C_PE_H_C_EE_H
213,11.23704164,-21.41576705,4.602152957,-4.653423572,3.26E-06,0.000243564,LOC110040957,1,1_LOC110040957,LOC110040957,BLOC-1-related complex subunit 5-like, C_EE_H_D_EE_H
700,21.58455583,-21.40434725,2.310889576,-9.262384269,2.00E-20,1.44E-17,LOC110067912,4,4_LOC110067912,LOC110067912,"uncharacterized LOC110067912, transcript variant X2", C_PE_H_C_EE_H
59,36.10334154,-21.40075584,3.494437231,-6.1242353,9.11E-10,2.45E-07,LOC110039872,1,1_LOC110039872,LOC110039872,anion exchange protein 3-like, C_EE_H_D_EE_H
124,11.42279308,-21.39088802,4.00158507,-5.345603717,9.01E-08,1.15E-05,LOC110069527,1,1_LOC110069527,LOC110069527,"uncharacterized protein C15orf41 homolog, transcript variant X2", C_EE_H_D_EE_H
38,39.5607303,-21.37160988,3.35248036,-6.374865052,1.83E-10,7.66E-08,LOC110052514,1,1_LOC110052514,LOC110052514,two pore potassium channel protein sup-9-like, C_EE_H_D_EE_H
755,13.37077615,-21.34742035,2.687249225,-7.943967442,1.96E-15,4.08E-13,LOC110068266,4,4_LOC110068266,LOC110068266,serine/threonine-protein phosphatase 4 regulatory subunit 1-like, C_PE_H_C_EE_H
878,17.27914701,-21.34675216,3.372508413,-6.329636445,2.46E-10,1.95E-08,LOC110045604,4,4_LOC110045604,LOC110045604,uncharacterized LOC110045604, C_PE_H_C_EE_H
682,35.95108468,-21.34606182,1.949422463,-10.94994144,6.65E-28,2.64E-24,LOC110063950,4,4_LOC110063950,LOC110063950,transient receptor potential cation channel subfamily A member 1 homolog, C_PE_H_C_EE_H
234,7.320402136,-21.34503997,4.738021324,-4.505053589,6.64E-06,0.000450627,LOC110047416,1,1_LOC110047416,LOC110047416,uncharacterized LOC110047416, C_EE_H_D_EE_H
174,14.81624534,-21.34253721,4.332993414,-4.925587271,8.41E-07,7.68E-05,LOC110064890,1,1_LOC110064890,LOC110064890,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1-like", C_EE_H_D_EE_H
905,8.27947898,-21.32500621,3.563696472,-5.983956933,2.18E-09,1.52E-07,LOC110064941,4,4_LOC110064941,LOC110064941,uncharacterized LOC110064941, C_PE_H_C_EE_H
745,13.68292128,-21.32085508,2.616384992,-8.148974692,3.67E-16,8.71E-14,LOC110057383,4,4_LOC110057383,LOC110057383,adenosine receptor A3-like, C_PE_H_C_EE_H
768,14.65079506,-21.32010544,2.742510236,-7.773938327,7.61E-15,1.34E-12,LOC110045038,4,4_LOC110045038,LOC110045038,vacuolar protein sorting-associated protein 37A-like, C_PE_H_C_EE_H
928,6.624776761,-21.31787661,3.711460735,-5.743796885,9.26E-09,5.88E-07,LOC110059968,4,4_LOC110059968,LOC110059968,carbohydrate sulfotransferase 3-like, C_PE_H_C_EE_H
779,14.64740373,-21.31717868,2.794095498,-7.629366531,2.36E-14,3.71E-12,LOC110060233,4,4_LOC110060233,LOC110060233,beta-2 adrenergic receptor-like, C_PE_H_C_EE_H
135,12.15077083,-21.31568554,4.059175994,-5.251234628,1.51E-07,1.78E-05,LOC110041025,1,1_LOC110041025,LOC110041025,kelch-like protein 1, C_EE_H_D_EE_H
753,18.79934339,-21.29923979,2.680853993,-7.944945846,1.94E-15,4.08E-13,LOC110057336,4,4_LOC110057336,LOC110057336,atherin-like, C_PE_H_C_EE_H
106,16.50115776,-21.26826018,3.8582234,-5.512449118,3.54E-08,5.32E-06,LOC110059284,1,1_LOC110059284,LOC110059284,"paramyosin-like, transcript variant X2", C_EE_H_D_EE_H
301,8.781686532,-21.24487657,5.307715724,-4.002640245,6.26E-05,0.003306992,LOC110060670,1,1_LOC110060670,LOC110060670,putative beta-lactamase-like 1, C_EE_H_D_EE_H
185,12.57453693,-21.23962038,4.382875563,-4.846046865,1.26E-06,0.000108184,LOC110045444,1,1_LOC110045444,LOC110045444,SHC SH2 domain-binding protein 1 homolog B-like, C_EE_H_D_EE_H
681,66.66491864,-21.21939111,1.88016266,-11.28593369,1.54E-29,8.16E-26,LOC110054542,4,4_LOC110054542,LOC110054542,uncharacterized LOC110054542, C_PE_H_C_EE_H
771,15.13043523,-21.21842323,2.742069893,-7.738104444,1.01E-14,1.72E-12,LOC110041529,4,4_LOC110041529,LOC110041529,uncharacterized LOC110041529, C_PE_H_C_EE_H
767,14.36679424,-21.21692773,2.719220216,-7.802577961,6.07E-15,1.08E-12,LOC110068357,4,4_LOC110068357,LOC110068357,"alternative oxidase, mitochondrial-like", C_PE_H_C_EE_H
343,7.02457019,-21.21562472,5.74680126,-3.691727581,0.000222736,0.0103735,LOC110068112,1,1_LOC110068112,LOC110068112,"gamma-2-syntrophin-like, transcript variant X2", C_EE_H_D_EE_H
309,7.873200286,-21.20468869,5.363042113,-3.953854593,7.69E-05,0.003942104,LOC110043862,1,1_LOC110043862,LOC110043862,uncharacterized protein YxeI-like, C_EE_H_D_EE_H
820,15.80166519,-21.20428677,3.06657316,-6.914652175,4.69E-12,5.25E-10,LOC110057028,4,4_LOC110057028,LOC110057028,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2-like, C_PE_H_C_EE_H
932,9.153247807,-21.20214384,3.695737863,-5.736917667,9.64E-09,6.03E-07,LOC110054364,4,4_LOC110054364,LOC110054364,coadhesin-like, C_PE_H_C_EE_H
240,8.899897964,-21.20212722,4.820050798,-4.398735223,1.09E-05,0.000721584,LOC110067588,1,1_LOC110067588,LOC110067588,uncharacterized LOC110067588, C_EE_H_D_EE_H
818,10.26599665,-21.19103879,3.049612022,-6.948765493,3.68E-12,4.18E-10,LOC110059406,4,4_LOC110059406,LOC110059406,pre-mRNA-splicing factor cwc2-like, C_PE_H_C_EE_H
734,32.80436493,-21.17709544,2.528035242,-8.376898823,5.43E-17,1.54E-14,LOC110057496,4,4_LOC110057496,LOC110057496,uncharacterized LOC110057496, C_PE_H_C_EE_H
832,9.566083556,-21.16379155,3.116742129,-6.790356942,1.12E-11,1.15E-09,LOC110052700,4,4_LOC110052700,LOC110052700,uncharacterized LOC110052700, C_PE_H_C_EE_H
187,6.255005425,-21.16067707,4.380520755,-4.830630478,1.36E-06,0.000115657,LOC110058803,1,1_LOC110058803,LOC110058803,"hemicentin-1-like, transcript variant X2", C_EE_H_D_EE_H
25,18.18188695,-21.15867451,3.18276578,-6.64788928,2.97E-11,1.89E-08,LOC110053099,1,1_LOC110053099,LOC110053099,"cytosolic 5'-nucleotidase 3-like, transcript variant X2", C_EE_H_D_EE_H
970,11.51928097,-21.1561413,4.013449041,-5.271311801,1.35E-07,7.37E-06,LOC110039915,4,4_LOC110039915,LOC110039915,"putative adenosylhomocysteinase 3, transcript variant X2", C_PE_H_C_EE_H
791,18.77911264,-21.15515213,2.870668362,-7.369416966,1.71E-13,2.41E-11,LOC110046651,4,4_LOC110046651,LOC110046651,protein asunder homolog, C_PE_H_C_EE_H
862,42.34002475,-21.13625601,3.242380203,-6.518746936,7.09E-11,6.12E-09,LOC110048391,4,4_LOC110048391,LOC110048391,uncharacterized LOC110048391, C_PE_H_C_EE_H
693,15.59451563,-21.13471972,2.186038516,-9.668045448,4.12E-22,4.37E-19,LOC110047798,4,4_LOC110047798,LOC110047798,dimethylaniline monooxygenase [N-oxide-forming] 2-like, C_PE_H_C_EE_H
852,12.11812886,-21.13273009,3.206322931,-6.590954979,4.37E-11,3.99E-09,LOC110040778,4,4_LOC110040778,LOC110040778,probable E3 ubiquitin-protein ligase DTX2, C_PE_H_C_EE_H
894,8.953009132,-21.12020576,3.426507405,-6.163770646,7.10E-10,5.23E-08,LOC110046286,4,4_LOC110046286,LOC110046286,uncharacterized LOC110046286, C_PE_H_C_EE_H
773,16.24906596,-21.1172865,2.733280829,-7.725984931,1.11E-14,1.86E-12,LOC110045356,4,4_LOC110045356,LOC110045356,nephrocystin-1-like, C_PE_H_C_EE_H
123,17.40039705,-21.09182393,3.941308996,-5.35147687,8.72E-08,1.13E-05,LOC110063495,1,1_LOC110063495,LOC110063495,uncharacterized LOC110063495, C_EE_H_D_EE_H
871,15.93293761,-21.08700544,3.298954126,-6.392027484,1.64E-10,1.35E-08,LOC110043480,4,4_LOC110043480,LOC110043480,tumor necrosis factor receptor superfamily member 27-like, C_PE_H_C_EE_H
716,16.76579232,-21.08389896,2.406932625,-8.759654815,1.96E-18,8.19E-16,LOC110062629,4,4_LOC110062629,LOC110062629,uncharacterized LOC110062629, C_PE_H_C_EE_H
1017,4.78455994,-21.0741581,4.668610904,-4.514010385,6.36E-06,0.000298193,LOC110039926,4,4_LOC110039926,LOC110039926,"zinc finger CCCH domain-containing protein 3-like, transcript variant X3", C_PE_H_C_EE_H
151,15.70415737,-21.07179877,4.130570653,-5.101425575,3.37E-07,3.54E-05,LOC110048425,1,1_LOC110048425,LOC110048425,14-3-3 protein 2-like, C_EE_H_D_EE_H
839,6.727683723,-21.04519124,3.117835839,-6.749935635,1.48E-11,1.46E-09,LOC110066624,4,4_LOC110066624,LOC110066624,uncharacterized LOC110066624, C_PE_H_C_EE_H
68,26.34680769,-21.03514706,3.47417032,-6.054725336,1.41E-09,3.29E-07,LOC110054683,1,1_LOC110054683,LOC110054683,nudix hydrolase 8-like, C_EE_H_D_EE_H
825,22.55665089,-21.03369496,3.072249512,-6.846349841,7.58E-12,8.19E-10,LOC110056376,4,4_LOC110056376,LOC110056376,uncharacterized LOC110056376, C_PE_H_C_EE_H
11,36.81138718,-21.0284814,2.782278012,-7.558008693,4.09E-14,5.91E-11,LOC110050929,1,1_LOC110050929,LOC110050929,uncharacterized LOC110050929, C_EE_H_D_EE_H
204,13.96730665,-21.02740806,4.488802932,-4.684413278,2.81E-06,0.000218706,LOC110069487,1,1_LOC110069487,LOC110069487,"collagen triple helix repeat-containing protein 1-like, transcript variant X2", C_EE_H_D_EE_H
914,9.733453567,-21.01936015,3.593459662,-5.849338,4.94E-09,3.32E-07,LOC110052970,4,4_LOC110052970,LOC110052970,neural cell adhesion molecule 2-like, C_PE_H_C_EE_H
41,18.13833569,-21.0032964,3.334645883,-6.298508789,3.01E-10,1.16E-07,LOC110055735,1,1_LOC110055735,LOC110055735,uncharacterized LOC110055735, C_EE_H_D_EE_H
148,13.91643357,-21.00273835,4.111819671,-5.107893835,3.26E-07,3.50E-05,LOC110057786,1,1_LOC110057786,LOC110057786,homeobox protein ceh-19-like, C_EE_H_D_EE_H
131,19.89658491,-20.99587543,3.970733549,-5.287656592,1.24E-07,1.50E-05,LOC110055643,1,1_LOC110055643,LOC110055643,T-cell acute lymphocytic leukemia protein 1-like, C_EE_H_D_EE_H
156,18.77911264,-20.99567243,4.157299867,-5.050314653,4.41E-07,4.46E-05,LOC110046651,1,1_LOC110046651,LOC110046651,protein asunder homolog, C_EE_H_D_EE_H
987,8.643826804,-20.97434781,4.179793908,-5.018033967,5.22E-07,2.68E-05,LOC110068152,4,4_LOC110068152,LOC110068152,hemicentin-2-like, C_PE_H_C_EE_H
429,2.399259415,-20.97007248,6.876831256,-3.049380115,0.002293141,0.084942446,LOC110064549,1,1_LOC110064549,LOC110064549,tctex1 domain-containing protein 2-like, C_EE_H_D_EE_H
277,10.81119995,-20.96809632,5.031125022,-4.167675466,3.08E-05,0.001765345,LOC110069042,1,1_LOC110069042,LOC110069042,carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1-like, C_EE_H_D_EE_H
738,18.14695616,-20.95322838,2.530331438,-8.280823636,1.22E-16,3.24E-14,LOC110051129,4,4_LOC110051129,LOC110051129,"uncharacterized LOC110051129, transcript variant X2", C_PE_H_C_EE_H
90,19.33840243,-20.95176562,3.657168835,-5.728957717,1.01E-08,1.78E-06,LOC110048084,1,1_LOC110048084,LOC110048084,serine protease 23-like, C_EE_H_D_EE_H
831,13.25500393,-20.94354033,3.081388941,-6.796785712,1.07E-11,1.11E-09,LOC110053132,4,4_LOC110053132,LOC110053132,"uncharacterized LOC110053132, transcript variant X2", C_PE_H_C_EE_H
684,27.23000385,-20.93988711,1.941144144,-10.78739422,3.95E-27,1.05E-23,LOC110045720,4,4_LOC110045720,LOC110045720,"myoferlin-like, transcript variant X1", C_PE_H_C_EE_H
867,8.532301412,-20.93520639,3.247564356,-6.446433108,1.15E-10,9.63E-09,LOC110069436,4,4_LOC110069436,LOC110069436,"perlucin-like protein, transcript variant X2", C_PE_H_C_EE_H
747,131.1652588,-20.93089124,2.580820581,-8.110169064,5.05E-16,1.18E-13,LOC110040175,4,4_LOC110040175,LOC110040175,uncharacterized LOC110040175, C_PE_H_C_EE_H
963,6.561833955,-20.92555913,3.898444163,-5.36766932,7.98E-08,4.45E-06,LOC110066836,4,4_LOC110066836,LOC110066836,"uncharacterized LOC110066836, transcript variant X1", C_PE_H_C_EE_H
722,18.39736395,-20.920681,2.456746456,-8.515604431,1.66E-17,5.97E-15,LOC110062773,4,4_LOC110062773,LOC110062773,uncharacterized LOC110062773, C_PE_H_C_EE_H
361,4.962080715,-20.91967345,5.844885641,-3.579141619,0.000344725,0.01513265,LOC110057808,1,1_LOC110057808,LOC110057808,uncharacterized protein YwnB-like, C_EE_H_D_EE_H
899,11.10946331,-20.90788912,3.448354716,-6.063149194,1.33E-09,9.60E-08,LOC110046089,4,4_LOC110046089,LOC110046089,"uncharacterized LOC110046089, transcript variant X1", C_PE_H_C_EE_H
953,6.910456338,-20.90154177,3.791678635,-5.512477133,3.54E-08,2.04E-06,LOC110066517,4,4_LOC110066517,LOC110066517,uncharacterized LOC110066517, C_PE_H_C_EE_H
113,24.06848071,-20.89703367,3.841994104,-5.439111333,5.35E-08,7.53E-06,LOC110050139,1,1_LOC110050139,LOC110050139,"HEAT repeat-containing protein 4-like, transcript variant X1", C_EE_H_D_EE_H
824,8.893675594,-20.88686547,3.041136549,-6.868111685,6.51E-12,7.08E-10,LOC110061326,4,4_LOC110061326,LOC110061326,matrix metalloproteinase-16-like, C_PE_H_C_EE_H
837,11.86698384,-20.87643443,3.085674212,-6.765599021,1.33E-11,1.33E-09,LOC110043035,4,4_LOC110043035,LOC110043035,acetylserotonin O-methyltransferase-like, C_PE_H_C_EE_H
904,6.983002979,-20.87588221,3.484674102,-5.990770326,2.09E-09,1.47E-07,LOC110043637,4,4_LOC110043637,LOC110043637,gamma-tubulin complex component 2-like, C_PE_H_C_EE_H
843,18.83549534,-20.87041906,3.114203612,-6.701687385,2.06E-11,1.98E-09,LOC110056474,4,4_LOC110056474,LOC110056474,sterol regulatory element-binding protein 1-like, C_PE_H_C_EE_H
951,5.708759375,-20.86626628,3.779189548,-5.521360073,3.36E-08,1.96E-06,LOC110061335,4,4_LOC110061335,LOC110061335,fez family zinc finger protein 1-like, C_PE_H_C_EE_H
154,12.84604616,-20.86385466,4.096430898,-5.093178716,3.52E-07,3.63E-05,LOC110052922,1,1_LOC110052922,LOC110052922,8-oxo-dGDP phosphatase NUDT18-like, C_EE_H_D_EE_H
795,20.32764263,-20.86147866,2.858536278,-7.297958335,2.92E-13,3.94E-11,LOC110060414,4,4_LOC110060414,LOC110060414,"TNF receptor-associated factor 6-like, transcript variant X1", C_PE_H_C_EE_H
796,15.03594828,-20.85652221,2.857956153,-7.297705456,2.93E-13,3.94E-11,LOC110060934,4,4_LOC110060934,LOC110060934,"uncharacterized LOC110060934, transcript variant X4", C_PE_H_C_EE_H
125,13.6855018,-20.85535021,3.903071623,-5.343317321,9.13E-08,1.16E-05,LOC110053701,1,1_LOC110053701,LOC110053701,peroxisome assembly protein 26-like, C_EE_H_D_EE_H
859,13.95051494,-20.85238153,3.180286531,-6.556761893,5.50E-11,4.83E-09,LOC110040065,4,4_LOC110040065,LOC110040065,neuronal growth regulator 1-like, C_PE_H_C_EE_H
703,17.55248846,-20.85223422,2.268758631,-9.19103246,3.89E-20,2.47E-17,LOC110046631,4,4_LOC110046631,LOC110046631,"uncharacterized LOC110046631, transcript variant X1", C_PE_H_C_EE_H
347,9.751764372,-20.82521579,5.659784316,-3.67950696,0.000233685,0.010670958,LOC110058479,1,1_LOC110058479,LOC110058479,uncharacterized LOC110058479, C_EE_H_D_EE_H
732,20.4109407,-20.822927,2.471661492,-8.424667807,3.62E-17,1.06E-14,LOC110066455,4,4_LOC110066455,LOC110066455,serine/threonine-protein kinase 33-like, C_PE_H_C_EE_H
890,9.580204957,-20.82081405,3.351593772,-6.212212895,5.22E-10,3.92E-08,LOC110059684,4,4_LOC110059684,LOC110059684,uncharacterized LOC110059684, C_PE_H_C_EE_H
206,15.9945349,-20.81625696,4.450312983,-4.67748157,2.90E-06,0.000225003,LOC110049717,1,1_LOC110049717,LOC110049717,F-box/WD repeat-containing protein 7-like, C_EE_H_D_EE_H
188,15.04173147,-20.81310225,4.317708235,-4.820404973,1.43E-06,0.000121099,LOC110056831,1,1_LOC110056831,LOC110056831,uncharacterized LOC110056831, C_EE_H_D_EE_H
736,23.61564826,-20.81088903,2.488551265,-8.362652327,6.13E-17,1.68E-14,LOC110044586,4,4_LOC110044586,LOC110044586,uncharacterized LOC110044586, C_PE_H_C_EE_H
274,14.42420473,-20.80781276,4.965990024,-4.190063342,2.79E-05,0.001617382,LOC110055691,1,1_LOC110055691,LOC110055691,"general transcription factor 3C polypeptide 1-like, transcript variant X1", C_EE_H_D_EE_H
759,21.02369953,-20.80409126,2.634290066,-7.897418559,2.85E-15,5.59E-13,LOC110059770,4,4_LOC110059770,LOC110059770,"NACHT, LRR and PYD domains-containing protein 12-like, transcript variant X1", C_PE_H_C_EE_H
161,20.32764263,-20.799865,4.13941008,-5.024837984,5.04E-07,4.97E-05,LOC110060414,1,1_LOC110060414,LOC110060414,"TNF receptor-associated factor 6-like, transcript variant X1", C_EE_H_D_EE_H
1046,3.662025027,-20.76425832,5.322713394,-3.901066388,9.58E-05,0.004135541,LOC110064503,4,4_LOC110064503,LOC110064503,uncharacterized LOC110064503, C_PE_H_C_EE_H
735,15.08641006,-20.76409463,2.481290882,-8.368262982,5.85E-17,1.63E-14,LOC110068247,4,4_LOC110068247,LOC110068247,forkhead box protein Q1-like, C_PE_H_C_EE_H
167,13.52807743,-20.76193431,4.181315356,-4.965407424,6.86E-07,6.50E-05,LOC110054393,1,1_LOC110054393,LOC110054393,uncharacterized LOC110054393, C_EE_H_D_EE_H
930,10.63862775,-20.72332052,3.609637379,-5.741108689,9.41E-09,5.95E-07,LOC110068563,4,4_LOC110068563,LOC110068563,uncharacterized LOC110068563, C_PE_H_C_EE_H
829,9.357035268,-20.7120269,3.039660713,-6.813927231,9.50E-12,1.00E-09,LOC110066988,4,4_LOC110066988,LOC110066988,BTB/POZ domain-containing protein 6-B-like, C_PE_H_C_EE_H
936,4.774919322,-20.71128946,3.62884723,-5.70740187,1.15E-08,7.07E-07,LOC110056359,4,4_LOC110056359,LOC110056359,pterin-4-alpha-carbinolamine dehydratase-like, C_PE_H_C_EE_H
805,14.65722099,-20.70394372,2.924377008,-7.079779269,1.44E-12,1.81E-10,LOC110054165,4,4_LOC110054165,LOC110054165,vacuolar protein sorting-associated protein 72 homolog, C_PE_H_C_EE_H
719,21.04134717,-20.69637742,2.383743374,-8.682300975,3.88E-18,1.47E-15,LOC110048050,4,4_LOC110048050,LOC110048050,collagen alpha-1(XII) chain-like, C_PE_H_C_EE_H
763,25.52048844,-20.696361,2.633316168,-7.859428825,3.86E-15,7.21E-13,LOC110042988,4,4_LOC110042988,LOC110042988,"UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit-like, transcript variant X2", C_PE_H_C_EE_H
265,9.01594659,-20.6765993,4.887262945,-4.230711449,2.33E-05,0.001396929,LOC110041798,1,1_LOC110041798,LOC110041798,"mevalonate kinase-like, transcript variant X1", C_EE_H_D_EE_H
1044,4.119675906,-20.67210106,5.27322616,-3.920199976,8.85E-05,0.003841433,LOC110046335,4,4_LOC110046335,LOC110046335,uncharacterized LOC110046335, C_PE_H_C_EE_H
1004,7.432222707,-20.65083748,4.310156786,-4.791203315,1.66E-06,8.08E-05,LOC110049030,4,4_LOC110049030,LOC110049030,"transcription factor A, mitochondrial-like", C_PE_H_C_EE_H
833,17.10320846,-20.64824224,3.045144686,-6.780709744,1.20E-11,1.22E-09,LOC110054147,4,4_LOC110054147,LOC110054147,serine/threonine-protein kinase CTR1-like, C_PE_H_C_EE_H
172,11.41687605,-20.63501228,4.170573786,-4.947763387,7.51E-07,6.94E-05,LOC110043451,1,1_LOC110043451,LOC110043451,protein phosphatase 1 regulatory subunit 27-like, C_EE_H_D_EE_H
943,5.987536744,-20.63443379,3.689479787,-5.59277594,2.23E-08,1.34E-06,LOC110056647,4,4_LOC110056647,LOC110056647,uncharacterized LOC110056647, C_PE_H_C_EE_H
913,14.11813743,-20.63167811,3.507335504,-5.882436422,4.04E-09,2.73E-07,LOC110063098,4,4_LOC110063098,LOC110063098,"uncharacterized LOC110063098, transcript variant X2", C_PE_H_C_EE_H
881,6.150945463,-20.62719681,3.277190329,-6.294171146,3.09E-10,2.42E-08,LOC110056711,4,4_LOC110056711,LOC110056711,"uncharacterized LOC110056711, transcript variant X1", C_PE_H_C_EE_H
782,20.31730805,-20.62505533,2.722290563,-7.576360735,3.55E-14,5.43E-12,LOC110045768,4,4_LOC110045768,LOC110045768,ankyrin repeat and BTB/POZ domain-containing protein BTBD11-like, C_PE_H_C_EE_H
954,4.04688094,-20.62290199,3.741279412,-5.512259234,3.54E-08,2.04E-06,LOC110039709,4,4_LOC110039709,LOC110039709,"target of rapamycin complex 2 subunit MAPKAP1-like, transcript variant X1", C_PE_H_C_EE_H
803,17.25987139,-20.62168382,2.888810314,-7.13846933,9.44E-13,1.20E-10,LOC110047159,4,4_LOC110047159,LOC110047159,"RNA polymerase-associated protein LEO1-like, transcript variant X2", C_PE_H_C_EE_H
814,13.3037258,-20.6132911,2.936329732,-7.020087314,2.22E-12,2.59E-10,LOC110050547,4,4_LOC110050547,LOC110050547,deleted in malignant brain tumors 1 protein-like, C_PE_H_C_EE_H
863,19.11899392,-20.61177766,3.17361976,-6.494721869,8.32E-11,7.15E-09,LOC110044491,4,4_LOC110044491,LOC110044491,uncharacterized LOC110044491, C_PE_H_C_EE_H
691,21.83561907,-20.60921185,2.077501421,-9.920191455,3.40E-23,4.16E-20,LOC110046058,4,4_LOC110046058,LOC110046058,galanin receptor type 1-like, C_PE_H_C_EE_H
984,5.431177505,-20.60630821,4.05129963,-5.086345146,3.65E-07,1.90E-05,LOC110053083,4,4_LOC110053083,LOC110053083,uncharacterized LOC110053083, C_PE_H_C_EE_H
840,12.00407834,-20.60279614,3.055366385,-6.743150752,1.55E-11,1.52E-09,LOC110065054,4,4_LOC110065054,LOC110065054,mitochondrial ribonuclease P protein 3-like, C_PE_H_C_EE_H
816,13.86692027,-20.60057772,2.960337679,-6.958860764,3.43E-12,3.95E-10,LOC110066436,4,4_LOC110066436,LOC110066436,uncharacterized LOC110066436, C_PE_H_C_EE_H
874,12.7121887,-20.60005875,3.229155005,-6.379396071,1.78E-10,1.44E-08,LOC110068397,4,4_LOC110068397,LOC110068397,"uncharacterized LOC110068397, transcript variant X2", C_PE_H_C_EE_H
880,11.39655721,-20.59088261,3.260510866,-6.315232018,2.70E-10,2.12E-08,LOC110047676,4,4_LOC110047676,LOC110047676,neuromedin-U receptor 2-like, C_PE_H_C_EE_H
55,36.12983085,-20.58944503,3.353115232,-6.140392921,8.23E-10,2.34E-07,LOC110054205,1,1_LOC110054205,LOC110054205,uncharacterized LOC110054205, C_EE_H_D_EE_H
907,10.37596709,-20.58846346,3.458053428,-5.953772518,2.62E-09,1.82E-07,LOC110052521,4,4_LOC110052521,LOC110052521,ras-related and estrogen-regulated growth inhibitor-like, C_PE_H_C_EE_H
708,38.98174562,-20.57867556,2.277660166,-9.035007004,1.64E-19,8.69E-17,LOC110059082,4,4_LOC110059082,LOC110059082,cytosolic carboxypeptidase 2-like, C_PE_H_C_EE_H
851,12.48633781,-20.57327414,3.113983699,-6.606737905,3.93E-11,3.61E-09,LOC110068997,4,4_LOC110068997,LOC110068997,sec14 cytosolic factor-like, C_PE_H_C_EE_H
777,6.485786337,-20.57216755,2.679658578,-7.677159964,1.63E-14,2.61E-12,LOC110057547,4,4_LOC110057547,LOC110057547,uncharacterized LOC110057547, C_PE_H_C_EE_H
756,10.1639114,-20.56987096,2.595592327,-7.924923629,2.28E-15,4.65E-13,LOC110049889,4,4_LOC110049889,LOC110049889,uncharacterized LOC110049889, C_PE_H_C_EE_H
424,4.16884235,-20.56346345,6.70062252,-3.068888508,0.002148568,0.080388726,LOC110061135,1,1_LOC110061135,LOC110061135,Meckel syndrome type 1 protein-like, C_EE_H_D_EE_H
99,19.11888819,-20.55989224,3.671973557,-5.599139515,2.15E-08,3.46E-06,LOC110067194,1,1_LOC110067194,LOC110067194,"ral guanine nucleotide dissociation stimulator-like 1, transcript variant X1", C_EE_H_D_EE_H
216,18.23614329,-20.55427198,4.432035917,-4.637659162,3.52E-06,0.000259242,LOC110069515,1,1_LOC110069515,LOC110069515,glutathione-specific gamma-glutamylcyclotransferase 1-like, C_EE_H_D_EE_H
714,17.1497346,-20.54790638,2.315866062,-8.872666133,7.14E-19,3.15E-16,LOC110053692,4,4_LOC110053692,LOC110053692,putative exosome complex component rrp40, C_PE_H_C_EE_H
941,8.781686532,-20.53718041,3.646974745,-5.631292192,1.79E-08,1.08E-06,LOC110060670,4,4_LOC110060670,LOC110060670,putative beta-lactamase-like 1, C_PE_H_C_EE_H
923,7.407848966,-20.52820584,3.541552232,-5.796386582,6.78E-09,4.38E-07,LOC110051739,4,4_LOC110051739,LOC110051739,"UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2-like, transcript variant X2", C_PE_H_C_EE_H
227,12.48633781,-20.52555836,4.519326458,-4.541729515,5.58E-06,0.000390587,LOC110068997,1,1_LOC110068997,LOC110068997,sec14 cytosolic factor-like, C_EE_H_D_EE_H
386,6.696852863,-20.52016737,5.973577153,-3.435155661,0.000592214,0.024380481,LOC110043483,1,1_LOC110043483,LOC110043483,helicase with zinc finger domain 2-like, C_EE_H_D_EE_H
969,9.751764372,-20.51631394,3.884584806,-5.281468925,1.28E-07,7.00E-06,LOC110058479,4,4_LOC110058479,LOC110058479,uncharacterized LOC110058479, C_PE_H_C_EE_H
52,21.58455583,-20.51151357,3.323673591,-6.171338133,6.77E-10,2.07E-07,LOC110067912,1,1_LOC110067912,LOC110067912,"uncharacterized LOC110067912, transcript variant X2", C_EE_H_D_EE_H
939,9.320771589,-20.51054594,3.605746312,-5.68829423,1.28E-08,7.81E-07,LOC110044200,4,4_LOC110044200,LOC110044200,"uncharacterized LOC110044200, transcript variant X3", C_PE_H_C_EE_H
980,5.139103845,-20.51046378,3.996789845,-5.13173436,2.87E-07,1.51E-05,LOC110068201,4,4_LOC110068201,LOC110068201,uncharacterized LOC110068201, C_PE_H_C_EE_H
294,14.0969625,-20.50774831,5.074567538,-4.041280002,5.32E-05,0.002873365,LOC110068550,1,1_LOC110068550,LOC110068550,D-inositol 3-phosphate glycosyltransferase-like, C_EE_H_D_EE_H
731,14.73987629,-20.50759835,2.434044243,-8.425318646,3.60E-17,1.06E-14,LOC110058403,4,4_LOC110058403,LOC110058403,uncharacterized LOC110058403, C_PE_H_C_EE_H
42,17.55248846,-20.50103825,3.260094263,-6.288480208,3.21E-10,1.21E-07,LOC110046631,1,1_LOC110046631,LOC110046631,"uncharacterized LOC110046631, transcript variant X1", C_EE_H_D_EE_H
339,13.68546478,-20.49299887,5.540814184,-3.698553713,0.000216831,0.010164215,LOC110042692,1,1_LOC110042692,LOC110042692,dermatan-sulfate epimerase-like protein, C_EE_H_D_EE_H
1071,2.522286356,-20.48464291,5.705424191,-3.59038035,0.000330196,0.013351504,LOC110069478,4,4_LOC110069478,LOC110069478,"uncharacterized LOC110069478, transcript variant X1", C_PE_H_C_EE_H
64,20.74259272,-20.4743027,3.367832155,-6.079371465,1.21E-09,3.00E-07,LOC110063730,1,1_LOC110063730,LOC110063730,calmodulin-like, C_EE_H_D_EE_H
117,25.52048844,-20.47277248,3.80495772,-5.380551898,7.43E-08,9.90E-06,LOC110042988,1,1_LOC110042988,LOC110042988,"UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit-like, transcript variant X2", C_EE_H_D_EE_H
823,14.44288459,-20.46251081,2.97421257,-6.879975902,5.99E-12,6.56E-10,LOC110055837,4,4_LOC110055837,LOC110055837,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3-like, C_PE_H_C_EE_H
983,6.98771023,-20.43712197,4.004113113,-5.104032128,3.32E-07,1.73E-05,LOC110054069,4,4_LOC110054069,LOC110054069,cytidine deaminase-like, C_PE_H_C_EE_H
887,7.771327218,-20.43371672,3.271733219,-6.245532673,4.22E-10,3.21E-08,LOC110044341,4,4_LOC110044341,LOC110044341,UPF0573 protein C2orf70 homolog A-like, C_PE_H_C_EE_H
911,10.81119995,-20.4086258,3.459962507,-5.898510681,3.67E-09,2.50E-07,LOC110069042,4,4_LOC110069042,LOC110069042,carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1-like, C_PE_H_C_EE_H
57,17.1497346,-20.39919745,3.330610907,-6.124761499,9.08E-10,2.45E-07,LOC110053692,1,1_LOC110053692,LOC110053692,putative exosome complex component rrp40, C_EE_H_D_EE_H
924,11.55081215,-20.39545111,3.518717038,-5.796274859,6.78E-09,4.38E-07,LOC110063870,4,4_LOC110063870,LOC110063870,uncharacterized LOC110063870, C_PE_H_C_EE_H
1007,7.183966188,-20.38699057,4.328612068,-4.709821588,2.48E-06,0.000119754,LOC110065687,4,4_LOC110065687,LOC110065687,collagen alpha-1(I) chain-like, C_PE_H_C_EE_H
160,7.652599008,-20.38003439,4.051360428,-5.030417498,4.89E-07,4.86E-05,LOC110061154,1,1_LOC110061154,LOC110061154,uncharacterized LOC110061154, C_EE_H_D_EE_H
850,8.322761244,-20.37782029,3.077610393,-6.621312541,3.56E-11,3.29E-09,LOC110063531,4,4_LOC110063531,LOC110063531,uncharacterized LOC110063531, C_PE_H_C_EE_H
915,10.59121114,-20.37702818,3.48564087,-5.845991867,5.04E-09,3.38E-07,LOC110051192,4,4_LOC110051192,LOC110051192,major facilitator superfamily domain-containing protein 6-like, C_PE_H_C_EE_H
790,16.21273541,-20.37349392,2.750848379,-7.4062584,1.30E-13,1.84E-11,LOC110050828,4,4_LOC110050828,LOC110050828,uncharacterized LOC110050828, C_PE_H_C_EE_H
1018,4.115552389,-20.36437695,4.54855563,-4.477108473,7.57E-06,0.000353625,LOC110063428,4,4_LOC110063428,LOC110063428,uncharacterized LOC110063428, C_PE_H_C_EE_H
785,7.812380515,-20.35288777,2.733651174,-7.445312687,9.67E-14,1.44E-11,LOC110061296,4,4_LOC110061296,LOC110061296,uncharacterized LOC110061296, C_PE_H_C_EE_H
412,7.432222707,-20.35028131,6.289487913,-3.235602261,0.001213864,0.046819204,LOC110049030,1,1_LOC110049030,LOC110049030,"transcription factor A, mitochondrial-like", C_EE_H_D_EE_H
706,37.43951369,-20.34960045,2.226486725,-9.139780723,6.26E-20,3.55E-17,LOC110054576,4,4_LOC110054576,LOC110054576,uncharacterized LOC110054576, C_PE_H_C_EE_H
688,36.81138718,-20.33567332,1.953003798,-10.41251089,2.17E-25,3.45E-22,LOC110050929,4,4_LOC110050929,LOC110050929,uncharacterized LOC110050929, C_PE_H_C_EE_H
811,13.52807743,-20.32870274,2.887069191,-7.041293919,1.90E-12,2.28E-10,LOC110054393,4,4_LOC110054393,LOC110054393,uncharacterized LOC110054393, C_PE_H_C_EE_H
830,14.81624534,-20.32791819,2.989857198,-6.798959564,1.05E-11,1.10E-09,LOC110064890,4,4_LOC110064890,LOC110064890,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1-like", C_PE_H_C_EE_H
74,28.25669217,-20.32033015,3.399142017,-5.978076247,2.26E-09,4.85E-07,LOC110041256,1,1_LOC110041256,LOC110041256,von Hippel-Lindau tumor suppressor homolog, C_EE_H_D_EE_H
102,17.36169121,-20.31975162,3.669383369,-5.537647494,3.07E-08,4.78E-06,LOC110066112,1,1_LOC110066112,LOC110066112,"arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2-like", C_EE_H_D_EE_H
807,28.85657506,-20.30382501,2.872963738,-7.067205458,1.58E-12,1.95E-10,LOC110052232,4,4_LOC110052232,LOC110052232,uncharacterized LOC110052232, C_PE_H_C_EE_H
255,8.653726507,-20.30373778,4.757510802,-4.267722896,1.97E-05,0.001230639,LOC110043628,1,1_LOC110043628,LOC110043628,O-acetyl-ADP-ribose deacetylase 1-like, C_EE_H_D_EE_H
159,19.33495207,-20.30346694,4.030545868,-5.037398805,4.72E-07,4.72E-05,LOC110062257,1,1_LOC110062257,LOC110062257,uncharacterized LOC110062257, C_EE_H_D_EE_H
858,13.96730665,-20.29811106,3.094426258,-6.55957175,5.40E-11,4.76E-09,LOC110069487,4,4_LOC110069487,LOC110069487,"collagen triple helix repeat-containing protein 1-like, transcript variant X2", C_PE_H_C_EE_H
804,11.29211306,-20.27567717,2.857525693,-7.095536261,1.29E-12,1.63E-10,LOC110059142,4,4_LOC110059142,LOC110059142,UDP-glucuronosyltransferase 2B19-like, C_PE_H_C_EE_H
883,14.99790522,-20.2745214,3.230242509,-6.276470372,3.46E-10,2.68E-08,LOC110063175,4,4_LOC110063175,LOC110063175,voltage-dependent calcium channel subunit alpha-2/delta-2-like, C_PE_H_C_EE_H
279,29.551711,-20.25470824,4.869687616,-4.159344467,3.19E-05,0.001817852,LOC110055858,1,1_LOC110055858,LOC110055858,"uncharacterized LOC110055858, transcript variant X2", C_EE_H_D_EE_H
947,8.917943875,-20.25190278,3.642934606,-5.559227647,2.71E-08,1.60E-06,LOC110050700,4,4_LOC110050700,LOC110050700,UDP-glucuronosyltransferase 2B33-like, C_PE_H_C_EE_H
721,20.74259272,-20.24628293,2.341283157,-8.647515728,5.26E-18,1.95E-15,LOC110063730,4,4_LOC110063730,LOC110063730,calmodulin-like, C_PE_H_C_EE_H
836,17.4845792,-20.21012568,2.983503731,-6.773956898,1.25E-11,1.26E-09,LOC110050011,4,4_LOC110050011,LOC110050011,protein DBF4 homolog B-like, C_PE_H_C_EE_H
712,25.223293,-20.20800776,2.274323397,-8.885283327,6.38E-19,2.89E-16,LOC110061179,4,4_LOC110061179,LOC110061179,uncharacterized LOC110061179, C_PE_H_C_EE_H
1075,2.364015573,-20.19868082,5.705600121,-3.540150097,0.0003999,0.016007061,LOC110063825,4,4_LOC110063825,LOC110063825,cytochrome P450 3A19-like, C_PE_H_C_EE_H
898,9.984978681,-20.19080256,3.316187718,-6.088558393,1.14E-09,8.23E-08,LOC110063490,4,4_LOC110063490,LOC110063490,diphthine--ammonia ligase-like, C_PE_H_C_EE_H
93,31.02365786,-20.18775948,3.55214454,-5.683259578,1.32E-08,2.26E-06,LOC110060001,1,1_LOC110060001,LOC110060001,BTB/POZ domain-containing protein 6-like, C_EE_H_D_EE_H
957,7.679987272,-20.18746238,3.686193975,-5.476505717,4.34E-08,2.47E-06,LOC110040897,4,4_LOC110040897,LOC110040897,uncharacterized LOC110040897, C_PE_H_C_EE_H
746,14.49499471,-20.18414547,2.48923855,-8.108562141,5.12E-16,1.18E-13,LOC110059420,4,4_LOC110059420,LOC110059420,myosin-2 heavy chain-like, C_PE_H_C_EE_H
138,18.79934339,-20.18206724,3.877446348,-5.204989424,1.94E-07,2.23E-05,LOC110057336,1,1_LOC110057336,LOC110057336,atherin-like, C_EE_H_D_EE_H
381,6.98771023,-20.15662637,5.837886203,-3.452726838,0.000554951,0.023146249,LOC110054069,1,1_LOC110054069,LOC110054069,cytidine deaminase-like, C_EE_H_D_EE_H
100,18.11739116,-20.14864386,3.604317209,-5.590141681,2.27E-08,3.61E-06,LOC110069663,1,1_LOC110069663,LOC110069663,"uncharacterized LOC110069663, transcript variant X2", C_EE_H_D_EE_H
920,11.80520943,-20.14778073,3.470192045,-5.805955539,6.40E-09,4.20E-07,LOC110051193,4,4_LOC110051193,LOC110051193,major facilitator superfamily domain-containing protein 6-like, C_PE_H_C_EE_H
1012,4.279062042,-20.14239911,4.321568473,-4.660900142,3.15E-06,0.000149789,LOC110061589,4,4_LOC110061589,LOC110061589,L-cysteine desulfhydrase-like, C_PE_H_C_EE_H
912,14.42420473,-20.14146515,3.41603132,-5.896159392,3.72E-09,2.53E-07,LOC110055691,4,4_LOC110055691,LOC110055691,"general transcription factor 3C polypeptide 1-like, transcript variant X1", C_PE_H_C_EE_H
284,9.580204957,-20.12605004,4.873100806,-4.13002949,3.63E-05,0.002029553,LOC110059684,1,1_LOC110059684,LOC110059684,uncharacterized LOC110059684, C_EE_H_D_EE_H
1008,3.152450218,-20.10232326,4.271209226,-4.706471212,2.52E-06,0.000121369,LOC110043922,4,4_LOC110043922,LOC110043922,uncharacterized LOC110043922, C_PE_H_C_EE_H
1021,4.16884235,-20.09606585,4.589429865,-4.378771751,1.19E-05,0.000552942,LOC110061135,4,4_LOC110061135,LOC110061135,Meckel syndrome type 1 protein-like, C_PE_H_C_EE_H
783,24.06848071,-20.07995567,2.659705113,-7.549692474,4.36E-14,6.60E-12,LOC110050139,4,4_LOC110050139,LOC110050139,"HEAT repeat-containing protein 4-like, transcript variant X1", C_PE_H_C_EE_H
808,10.63872114,-20.07378933,2.849026977,-7.045840384,1.84E-12,2.25E-10,LOC110042671,4,4_LOC110042671,LOC110042671,protein lin-41-like, C_PE_H_C_EE_H
271,10.88480087,-20.07029561,4.771071983,-4.206663761,2.59E-05,0.001519721,LOC110049607,1,1_LOC110049607,LOC110049607,"adenylosuccinate lyase-like, transcript variant X2", C_EE_H_D_EE_H
98,20.4109407,-20.06577402,3.56533578,-5.628018021,1.82E-08,2.96E-06,LOC110066455,1,1_LOC110066455,LOC110066455,serine/threonine-protein kinase 33-like, C_EE_H_D_EE_H
303,10.37596709,-20.0636949,5.03070894,-3.98824403,6.66E-05,0.003490994,LOC110052521,1,1_LOC110052521,LOC110052521,ras-related and estrogen-regulated growth inhibitor-like, C_EE_H_D_EE_H
238,19.99326703,-20.05059438,4.557961355,-4.399026849,1.09E-05,0.000721584,LOC110042118,1,1_LOC110042118,LOC110042118,"cAMP-dependent protein kinase catalytic subunit-like, transcript variant X2", C_EE_H_D_EE_H
421,7.280149294,-20.0479541,6.38604492,-3.139338096,0.0016933,0.06391502,LOC110056074,1,1_LOC110056074,LOC110056074,"ATP synthase subunit s, mitochondrial-like", C_EE_H_D_EE_H
245,19.11899392,-20.04750714,4.609313952,-4.34934729,1.37E-05,0.000885637,LOC110044491,1,1_LOC110044491,LOC110044491,uncharacterized LOC110044491, C_EE_H_D_EE_H
761,19.11888819,-20.04325634,2.545144674,-7.875095095,3.40E-15,6.52E-13,LOC110067194,4,4_LOC110067194,LOC110067194,"ral guanine nucleotide dissociation stimulator-like 1, transcript variant X1", C_PE_H_C_EE_H
720,16.48774386,-20.04320713,2.308307632,-8.683074497,3.85E-18,1.47E-15,LOC110054499,4,4_LOC110054499,LOC110054499,gamma-butyrobetaine dioxygenase-like, C_PE_H_C_EE_H
181,12.91228449,-20.03933047,4.126664411,-4.856060119,1.20E-06,0.00010513,LOC110064527,1,1_LOC110064527,LOC110064527,transient receptor potential cation channel subfamily A member 1-like, C_EE_H_D_EE_H
789,13.6855018,-20.02644458,2.700637506,-7.415450807,1.21E-13,1.74E-11,LOC110053701,4,4_LOC110053701,LOC110053701,peroxisome assembly protein 26-like, C_PE_H_C_EE_H
760,19.33840243,-20.02058171,2.536000297,-7.894550223,2.91E-15,5.65E-13,LOC110048084,4,4_LOC110048084,LOC110048084,serine protease 23-like, C_PE_H_C_EE_H
310,9.331471995,-19.98300871,5.053183476,-3.954538521,7.67E-05,0.003942104,LOC110057534,1,1_LOC110057534,LOC110057534,sodium channel modifier 1-like, C_EE_H_D_EE_H
918,6.482459625,-19.9732108,3.428390825,-5.825826699,5.68E-09,3.76E-07,LOC110057904,4,4_LOC110057904,LOC110057904,uncharacterized LOC110057904, C_PE_H_C_EE_H
828,15.15242072,-19.97266263,2.931447135,-6.813243327,9.54E-12,1.00E-09,LOC110065626,4,4_LOC110065626,LOC110065626,tetratricopeptide repeat protein 28-like, C_PE_H_C_EE_H
228,9.813666225,-19.96749067,4.402882946,-4.535094599,5.76E-06,0.000401301,LOC110062663,1,1_LOC110062663,LOC110062663,sodium- and chloride-dependent taurine transporter-like, C_EE_H_D_EE_H
133,13.68292128,-19.95701791,3.782160709,-5.276618169,1.32E-07,1.57E-05,LOC110057383,1,1_LOC110057383,LOC110057383,adenosine receptor A3-like, C_EE_H_D_EE_H
838,10.61774758,-19.95571535,2.955957876,-6.751014792,1.47E-11,1.46E-09,LOC110064402,4,4_LOC110064402,LOC110064402,uncharacterized LOC110064402, C_PE_H_C_EE_H
849,15.42024078,-19.95030103,3.008028362,-6.632351372,3.30E-11,3.07E-09,LOC110066600,4,4_LOC110066600,LOC110066600,"inosine-5'-monophosphate dehydrogenase 1b-like, transcript variant X2", C_PE_H_C_EE_H
321,7.407848966,-19.933578,5.154752056,-3.867029448,0.000110169,0.005453887,LOC110051739,1,1_LOC110051739,LOC110051739,"UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2-like, transcript variant X2", C_EE_H_D_EE_H
810,12.84604616,-19.93065504,2.830632129,-7.041061548,1.91E-12,2.28E-10,LOC110052922,4,4_LOC110052922,LOC110052922,8-oxo-dGDP phosphatase NUDT18-like, C_PE_H_C_EE_H
876,10.27987411,-19.92879619,3.137022354,-6.352774684,2.11E-10,1.70E-08,LOC110062420,4,4_LOC110062420,LOC110062420,"potassium voltage-gated channel subfamily A member 2-like, transcript variant X2", C_PE_H_C_EE_H
96,14.73987629,-19.9249052,3.509422862,-5.677544709,1.37E-08,2.27E-06,LOC110058403,1,1_LOC110058403,LOC110058403,uncharacterized LOC110058403, C_EE_H_D_EE_H
399,9.386953467,-19.92090258,5.988059733,-3.326770852,0.000878586,0.0349915,LOC110051433,1,1_LOC110051433,LOC110051433,CUB and peptidase domain-containing protein 2-like, C_EE_H_D_EE_H
774,30.14853123,-19.90473035,2.57819756,-7.720405397,1.16E-14,1.92E-12,LOC110064066,4,4_LOC110064066,LOC110064066,tyrosine-protein kinase FRK-like, C_PE_H_C_EE_H
317,10.59121114,-19.89257955,5.07188027,-3.92213114,8.78E-05,0.004399812,LOC110051192,1,1_LOC110051192,LOC110051192,major facilitator superfamily domain-containing protein 6-like, C_EE_H_D_EE_H
295,6.617960423,-19.88120735,4.924263857,-4.037396843,5.40E-05,0.002911425,LOC110048821,1,1_LOC110048821,LOC110048821,uncharacterized LOC110048821, C_EE_H_D_EE_H
288,10.6867184,-19.87332895,4.859741958,-4.089379462,4.33E-05,0.002386568,LOC110067067,1,1_LOC110067067,LOC110067067,uncharacterized LOC110067067, C_EE_H_D_EE_H
870,14.77220293,-19.87283514,3.107445343,-6.3952324,1.60E-10,1.33E-08,LOC110048665,4,4_LOC110048665,LOC110048665,"beta-hexosaminidase-like, transcript variant X2", C_PE_H_C_EE_H
338,8.011669471,-19.86713885,5.357201241,-3.708492168,0.000208497,0.009802448,LOC110050834,1,1_LOC110050834,LOC110050834,"uncharacterized LOC110050834, transcript variant X2", C_EE_H_D_EE_H
1084,9.32605566,-19.86124006,5.70564552,-3.480980372,0.000499582,0.01955384,LOC110041897,4,4_LOC110041897,LOC110041897,uncharacterized LOC110041897, C_PE_H_C_EE_H
889,13.35037181,-19.8539669,3.187582833,-6.228533637,4.71E-10,3.55E-08,LOC110058779,4,4_LOC110058779,LOC110058779,uncharacterized LOC110058779, C_PE_H_C_EE_H
754,15.79488125,-19.8215924,2.495549313,-7.942777289,1.98E-15,4.08E-13,LOC110064622,4,4_LOC110064622,LOC110064622,"uncharacterized LOC110064622, transcript variant X2", C_PE_H_C_EE_H
307,6.482459625,-19.81332291,4.987086918,-3.972925123,7.10E-05,0.003674878,LOC110057904,1,1_LOC110057904,LOC110057904,uncharacterized LOC110057904, C_EE_H_D_EE_H
962,8.011669471,-19.79874048,3.678889021,-5.381717243,7.38E-08,4.13E-06,LOC110050834,4,4_LOC110050834,LOC110050834,"uncharacterized LOC110050834, transcript variant X2", C_PE_H_C_EE_H
335,8.917943875,-19.79695071,5.304839598,-3.731866033,0.000190067,0.009015964,LOC110050700,1,1_LOC110050700,LOC110050700,UDP-glucuronosyltransferase 2B33-like, C_EE_H_D_EE_H
269,15.56345351,-19.79534083,4.696627789,-4.214798729,2.50E-05,0.001476865,LOC110049641,1,1_LOC110049641,LOC110049641,"histone acetyltransferase KAT7-like, transcript variant X3", C_EE_H_D_EE_H
104,29.70030396,-19.79499992,3.586396384,-5.519467958,3.40E-08,5.20E-06,LOC110050490,1,1_LOC110050490,LOC110050490,sodium-coupled monocarboxylate transporter 1-like, C_EE_H_D_EE_H
888,16.4114474,-19.79471448,3.176335655,-6.2319341,4.61E-10,3.49E-08,LOC110045418,4,4_LOC110045418,LOC110045418,sodium-dependent dopamine transporter-like, C_PE_H_C_EE_H
75,16.48774386,-19.78991678,3.321298381,-5.95848807,2.55E-09,5.39E-07,LOC110054499,1,1_LOC110054499,LOC110054499,gamma-butyrobetaine dioxygenase-like, C_EE_H_D_EE_H
845,18.185449,-19.78627555,2.959558983,-6.685548647,2.30E-11,2.19E-09,LOC110052681,4,4_LOC110052681,LOC110052681,uncharacterized LOC110052681, C_PE_H_C_EE_H
992,12.21777091,-19.78511611,4.001002141,-4.945040122,7.61E-07,3.85E-05,LOC110050342,4,4_LOC110050342,LOC110050342,uncharacterized LOC110050342, C_PE_H_C_EE_H
345,7.679987272,-19.76374116,5.369051059,-3.68104921,0.000232276,0.010667921,LOC110040897,1,1_LOC110040897,LOC110040897,uncharacterized LOC110040897, C_EE_H_D_EE_H
882,10.65137486,-19.7603021,3.14051772,-6.292052414,3.13E-10,2.44E-08,LOC110054371,4,4_LOC110054371,LOC110054371,uncharacterized LOC110054371, C_PE_H_C_EE_H
233,15.71104955,-19.75453432,4.383071153,-4.507007445,6.57E-06,0.000448415,LOC110064193,1,1_LOC110064193,LOC110064193,"uncharacterized LOC110064193, transcript variant X2", C_EE_H_D_EE_H
960,14.29591687,-19.72978899,3.620471241,-5.449508552,5.05E-08,2.85E-06,LOC110055348,4,4_LOC110055348,LOC110055348,"golgin subfamily A member 6-like protein 6, transcript variant X2", C_PE_H_C_EE_H
256,13.35037181,-19.72759728,4.630079235,-4.260747232,2.04E-05,0.001259807,LOC110058779,1,1_LOC110058779,LOC110058779,uncharacterized LOC110058779, C_EE_H_D_EE_H
1022,6.221166298,-19.71993341,4.510031122,-4.372460606,1.23E-05,0.000567521,LOC110064052,4,4_LOC110064052,LOC110064052,kelch-like protein diablo, C_PE_H_C_EE_H
821,15.70415737,-19.71549782,2.85417871,-6.907590525,4.93E-12,5.48E-10,LOC110048425,4,4_LOC110048425,LOC110048425,14-3-3 protein 2-like, C_PE_H_C_EE_H
144,22.12038305,-19.70446307,3.832959816,-5.14079563,2.74E-07,3.02E-05,LOC110069374,1,1_LOC110069374,LOC110069374,uncharacterized LOC110069374, C_EE_H_D_EE_H
978,13.68546478,-19.69975705,3.804416073,-5.178128963,2.24E-07,1.19E-05,LOC110042692,4,4_LOC110042692,LOC110042692,dermatan-sulfate epimerase-like protein, C_PE_H_C_EE_H
283,7.771327218,-19.69687886,4.755976926,-4.141500089,3.45E-05,0.001937476,LOC110044341,1,1_LOC110044341,LOC110044341,UPF0573 protein C2orf70 homolog A-like, C_EE_H_D_EE_H
869,12.33850473,-19.69377153,3.073413126,-6.407785325,1.48E-10,1.23E-08,LOC110047837,4,4_LOC110047837,LOC110047837,growth/differentiation factor 8-like, C_PE_H_C_EE_H
232,15.42024078,-19.67477222,4.364297728,-4.508118704,6.54E-06,0.000447996,LOC110066600,1,1_LOC110066600,LOC110066600,"inosine-5'-monophosphate dehydrogenase 1b-like, transcript variant X2", C_EE_H_D_EE_H
251,10.27987411,-19.66230262,4.555642182,-4.316033138,1.59E-05,0.001005743,LOC110062420,1,1_LOC110062420,LOC110062420,"potassium voltage-gated channel subfamily A member 2-like, transcript variant X2", C_EE_H_D_EE_H
847,10.45344852,-19.66007568,2.945143526,-6.67542193,2.47E-11,2.32E-09,LOC110066265,4,4_LOC110066265,LOC110066265,uncharacterized LOC110066265, C_PE_H_C_EE_H
916,9.01594659,-19.65695404,3.363278337,-5.844581408,5.08E-09,3.39E-07,LOC110041798,4,4_LOC110041798,LOC110041798,"mevalonate kinase-like, transcript variant X1", C_PE_H_C_EE_H
239,8.322761244,-19.65514449,4.468557926,-4.398543068,1.09E-05,0.000721584,LOC110063531,1,1_LOC110063531,LOC110063531,uncharacterized LOC110063531, C_EE_H_D_EE_H
289,9.984978681,-19.64610065,4.821851716,-4.074389219,4.61E-05,0.002536801,LOC110063490,1,1_LOC110063490,LOC110063490,diphthine--ammonia ligase-like, C_EE_H_D_EE_H
290,8.120988948,-19.64592398,4.823844656,-4.072669288,4.65E-05,0.002538049,LOC110055825,1,1_LOC110055825,LOC110055825,uncharacterized LOC110055825, C_EE_H_D_EE_H
219,10.45344852,-19.63665729,4.270404675,-4.598312989,4.26E-06,0.000309059,LOC110066265,1,1_LOC110066265,LOC110066265,uncharacterized LOC110066265, C_EE_H_D_EE_H
320,13.89741486,-19.61288192,5.049486976,-3.88413358,0.000102695,0.005099791,LOC110067961,1,1_LOC110067961,LOC110067961,poly [ADP-ribose] polymerase 14-like, C_EE_H_D_EE_H
299,12.37905558,-19.60641714,4.881974811,-4.016083224,5.92E-05,0.003144896,LOC110065651,1,1_LOC110065651,LOC110065651,"poly [ADP-ribose] polymerase 14-like, transcript variant X3", C_EE_H_D_EE_H
215,12.31926483,-19.60564506,4.221105432,-4.644670779,3.41E-06,0.000251757,LOC110053225,1,1_LOC110053225,LOC110053225,collagen triple helix repeat-containing protein 1-like, C_EE_H_D_EE_H
119,17.00539816,-19.59610519,3.642864248,-5.379312503,7.48E-08,9.90E-06,LOC110068384,1,1_LOC110068384,LOC110068384,uncharacterized LOC110068384, C_EE_H_D_EE_H
248,6.727683723,-19.58486869,4.529404133,-4.323939335,1.53E-05,0.000980277,LOC110066624,1,1_LOC110066624,LOC110066624,uncharacterized LOC110066624, C_EE_H_D_EE_H
769,17.00539816,-19.58474366,2.523413922,-7.761209326,8.41E-15,1.47E-12,LOC110068384,4,4_LOC110068384,LOC110068384,uncharacterized LOC110068384, C_PE_H_C_EE_H
264,13.95051494,-19.56399873,4.62151209,-4.233246252,2.30E-05,0.001386502,LOC110040065,1,1_LOC110040065,LOC110040065,neuronal growth regulator 1-like, C_EE_H_D_EE_H
253,10.9168495,-19.54343353,4.549863735,-4.295388756,1.74E-05,0.001095333,LOC110057466,1,1_LOC110057466,LOC110057466,"uncharacterized LOC110057466, transcript variant X4", C_EE_H_D_EE_H
875,15.9945349,-19.53909794,3.069163675,-6.366261305,1.94E-10,1.56E-08,LOC110049717,4,4_LOC110049717,LOC110049717,F-box/WD repeat-containing protein 7-like, C_PE_H_C_EE_H
800,24.17473323,-19.52002535,2.690655819,-7.2547463,4.02E-13,5.24E-11,LOC110062326,4,4_LOC110062326,LOC110062326,uncharacterized LOC110062326, C_PE_H_C_EE_H
922,17.59043843,-19.47473985,3.358662862,-5.798361029,6.70E-09,4.36E-07,LOC110068256,4,4_LOC110068256,LOC110068256,tyramine/octopamine receptor-like, C_PE_H_C_EE_H
196,10.28906941,-19.45824025,4.095688535,-4.750908202,2.03E-06,0.000164184,LOC110059134,1,1_LOC110059134,LOC110059134,"beta-1,3-galactosyltransferase 5-like", C_EE_H_D_EE_H
346,4.774919322,-19.45789412,5.28589604,-3.681096634,0.000232233,0.010667921,LOC110056359,1,1_LOC110056359,LOC110056359,pterin-4-alpha-carbinolamine dehydratase-like, C_EE_H_D_EE_H
276,7.708759198,-19.45439974,4.663592094,-4.171548314,3.03E-05,0.001741889,LOC110068298,1,1_LOC110068298,LOC110068298,protein phosphatase 1 regulatory subunit 3C-like, C_EE_H_D_EE_H
991,10.57016605,-19.44814852,3.926194355,-4.953434997,7.29E-07,3.70E-05,LOC110045842,4,4_LOC110045842,LOC110045842,uncharacterized LOC110045842, C_PE_H_C_EE_H
908,8.653726507,-19.44176054,3.275434382,-5.935628157,2.93E-09,2.02E-07,LOC110043628,4,4_LOC110043628,LOC110043628,O-acetyl-ADP-ribose deacetylase 1-like, C_PE_H_C_EE_H
737,36.04349222,-19.43505885,2.335324286,-8.322209881,8.63E-17,2.33E-14,LOC110047027,4,4_LOC110047027,LOC110047027,uncharacterized LOC110047027, C_PE_H_C_EE_H
202,11.29211306,-19.41108254,4.143000148,-4.685271989,2.80E-06,0.000218706,LOC110059142,1,1_LOC110059142,LOC110059142,UDP-glucuronosyltransferase 2B19-like, C_EE_H_D_EE_H
986,11.33587953,-19.40262118,3.857261066,-5.030155038,4.90E-07,2.53E-05,LOC110041727,4,4_LOC110041727,LOC110041727,uncharacterized LOC110041727, C_PE_H_C_EE_H
373,5.332188431,-19.37833853,5.513229759,-3.514879549,0.000439953,0.018743434,LOC110061555,1,1_LOC110061555,LOC110061555,"uncharacterized LOC110061555, transcript variant X1", C_EE_H_D_EE_H
827,13.91643357,-19.37226374,2.842091736,-6.816199314,9.35E-12,9.97E-10,LOC110057786,4,4_LOC110057786,LOC110057786,homeobox protein ceh-19-like, C_PE_H_C_EE_H
226,13.3037258,-19.36579528,4.26062093,-4.54529882,5.49E-06,0.000385725,LOC110050547,1,1_LOC110050547,LOC110050547,deleted in malignant brain tumors 1 protein-like, C_EE_H_D_EE_H
891,13.3812533,-19.35934806,3.126858207,-6.191309863,5.97E-10,4.45E-08,LOC110048758,4,4_LOC110048758,LOC110048758,uncharacterized LOC110048758, C_PE_H_C_EE_H
813,15.17119865,-19.35626859,2.755658736,-7.024189293,2.15E-12,2.53E-10,LOC110044544,4,4_LOC110044544,LOC110044544,uncharacterized LOC110044544, C_PE_H_C_EE_H
865,15.04173147,-19.33827929,2.980287378,-6.488729722,8.66E-11,7.36E-09,LOC110056831,4,4_LOC110056831,LOC110056831,uncharacterized LOC110056831, C_PE_H_C_EE_H
250,13.25500393,-19.33604294,4.476543614,-4.319413504,1.56E-05,0.000994423,LOC110053132,1,1_LOC110053132,LOC110053132,"uncharacterized LOC110053132, transcript variant X2", C_EE_H_D_EE_H
357,10.23808203,-19.31183998,5.354817966,-3.606441918,0.000310424,0.013779197,LOC110039662,1,1_LOC110039662,LOC110039662,uncharacterized LOC110039662, C_EE_H_D_EE_H
230,14.82885086,-19.30957784,4.273931592,-4.517989449,6.24E-06,0.000431334,LOC110051143,1,1_LOC110051143,LOC110051143,"tolloid-like protein 2, transcript variant X1", C_EE_H_D_EE_H
799,22.12038305,-19.30069591,2.651954346,-7.277914095,3.39E-13,4.45E-11,LOC110069374,4,4_LOC110069374,LOC110069374,uncharacterized LOC110069374, C_PE_H_C_EE_H
82,28.1765426,-19.29875605,3.276910946,-5.889313555,3.88E-09,7.52E-07,LOC110067644,1,1_LOC110067644,LOC110067644,"neurocalcin homolog, transcript variant X1", C_EE_H_D_EE_H
903,7.708759198,-19.28094094,3.210012344,-6.00650056,1.90E-09,1.34E-07,LOC110068298,4,4_LOC110068298,LOC110068298,protein phosphatase 1 regulatory subunit 3C-like, C_PE_H_C_EE_H
114,18.39736395,-19.27527983,3.548088477,-5.432581503,5.55E-08,7.74E-06,LOC110062773,1,1_LOC110062773,LOC110062773,uncharacterized LOC110062773, C_EE_H_D_EE_H
410,5.431177505,-19.2683625,5.911065555,-3.259710507,0.00111526,0.043225839,LOC110053083,1,1_LOC110053083,LOC110053083,uncharacterized LOC110053083, C_EE_H_D_EE_H
396,8.068358084,-19.26791302,5.732884438,-3.360945651,0.000776761,0.031170481,LOC110052143,1,1_LOC110052143,LOC110052143,uncharacterized LOC110052143, C_EE_H_D_EE_H
292,13.7047188,-19.24623553,4.727727629,-4.070927312,4.68E-05,0.002548348,LOC110062755,1,1_LOC110062755,LOC110062755,fukutin-related protein-like, C_EE_H_D_EE_H
933,12.37905558,-19.23377232,3.358050127,-5.727660872,1.02E-08,6.35E-07,LOC110065651,4,4_LOC110065651,LOC110065651,"poly [ADP-ribose] polymerase 14-like, transcript variant X3", C_PE_H_C_EE_H
263,13.3812533,-19.22954187,4.541837426,-4.23386838,2.30E-05,0.001386502,LOC110048758,1,1_LOC110048758,LOC110048758,uncharacterized LOC110048758, C_EE_H_D_EE_H
665,3.807599401,-19.20991654,3.070650812,-6.255975595,3.95E-10,6.98E-07,LOC110040963,3,3_LOC110040963,LOC110040963,uncharacterized LOC110040963, C_PE_D_D_EE_D
142,8.681886301,-19.19696494,3.723899577,-5.155070525,2.54E-07,2.82E-05,LOC110058416,1,1_LOC110058416,LOC110058416,"phosphoglycolate phosphatase-like, transcript variant X1", C_EE_H_D_EE_H
252,15.80166519,-19.18739401,4.455360334,-4.306586352,1.66E-05,0.001045484,LOC110057028,1,1_LOC110057028,LOC110057028,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2-like, C_EE_H_D_EE_H
323,8.953009132,-19.18474253,4.988722217,-3.845622526,0.000120247,0.005897658,LOC110046286,1,1_LOC110046286,LOC110046286,uncharacterized LOC110046286, C_EE_H_D_EE_H
775,16.55473512,-19.15592509,2.483238759,-7.714089121,1.22E-14,2.00E-12,LOC110061801,4,4_LOC110061801,LOC110061801,XK-related protein 8-like, C_PE_H_C_EE_H
34,21.83561907,-19.15109203,2.981469516,-6.423373414,1.33E-10,6.23E-08,LOC110046058,1,1_LOC110046058,LOC110046058,galanin receptor type 1-like, C_EE_H_D_EE_H
885,15.21174516,-19.14799177,3.058613112,-6.260351037,3.84E-10,2.95E-08,LOC110043028,4,4_LOC110043028,LOC110043028,"uncharacterized LOC110043028, transcript variant X3", C_PE_H_C_EE_H
945,11.45006151,-19.14588721,3.431658315,-5.579193922,2.42E-08,1.44E-06,LOC110046690,4,4_LOC110046690,LOC110046690,translation initiation factor eIF-2B subunit gamma-like, C_PE_H_C_EE_H
39,35.19885966,-19.1239098,3.0196807,-6.333090052,2.40E-10,9.79E-08,LOC110053599,1,1_LOC110053599,LOC110053599,uncharacterized LOC110053599, C_EE_H_D_EE_H
794,25.38680759,-19.11505823,2.618886051,-7.298927048,2.90E-13,3.94E-11,LOC110052731,4,4_LOC110052731,LOC110052731,glycogen synthase kinase-3 beta-like, C_PE_H_C_EE_H
793,21.45628148,-19.11188671,2.61062833,-7.320799551,2.46E-13,3.41E-11,LOC110053631,4,4_LOC110053631,LOC110053631,C2 domain-containing protein 3-like, C_PE_H_C_EE_H
879,15.71104955,-19.11115683,3.022365353,-6.323245076,2.56E-10,2.02E-08,LOC110064193,4,4_LOC110064193,LOC110064193,"uncharacterized LOC110064193, transcript variant X2", C_PE_H_C_EE_H
318,17.59043843,-19.10681838,4.886291018,-3.910290712,9.22E-05,0.004606646,LOC110068256,1,1_LOC110068256,LOC110068256,tyramine/octopamine receptor-like, C_EE_H_D_EE_H
109,16.76579232,-19.09713807,3.47560489,-5.494622858,3.92E-08,5.74E-06,LOC110062629,1,1_LOC110062629,LOC110062629,uncharacterized LOC110062629, C_EE_H_D_EE_H
249,9.357035268,-19.09280011,4.416094271,-4.323458455,1.54E-05,0.000980277,LOC110066988,1,1_LOC110066988,LOC110066988,BTB/POZ domain-containing protein 6-B-like, C_EE_H_D_EE_H
246,14.20331274,-19.05487473,4.390015387,-4.340502948,1.42E-05,0.000918299,LOC110051454,1,1_LOC110051454,LOC110051454,"battenin-like, transcript variant X1", C_EE_H_D_EE_H
199,14.64740373,-19.0320754,4.052493696,-4.696386183,2.65E-06,0.000211458,LOC110060233,1,1_LOC110060233,LOC110060233,beta-2 adrenergic receptor-like, C_EE_H_D_EE_H
390,9.164072914,-19.01268974,5.609254658,-3.389521585,0.000700147,0.028455334,LOC110045334,1,1_LOC110045334,LOC110045334,uncharacterized LOC110045334, C_EE_H_D_EE_H
35,21.68498461,-18.9962314,2.963523223,-6.41001604,1.46E-10,6.61E-08,LOC110057236,1,1_LOC110057236,LOC110057236,"centrosomal protein POC5-like, transcript variant X1", C_EE_H_D_EE_H
222,15.03594828,-18.99131338,4.146816025,-4.579733768,4.66E-06,0.000333259,LOC110060934,1,1_LOC110060934,LOC110060934,"uncharacterized LOC110060934, transcript variant X4", C_EE_H_D_EE_H
327,11.45006151,-18.98851223,4.994457741,-3.801916687,0.000143581,0.00697751,LOC110046690,1,1_LOC110046690,LOC110046690,translation initiation factor eIF-2B subunit gamma-like, C_EE_H_D_EE_H
358,10.31261076,-18.98608462,5.263508536,-3.607115765,0.00030962,0.013779197,LOC110061607,1,1_LOC110061607,LOC110061607,uncharacterized LOC110061607, C_EE_H_D_EE_H
190,15.16265299,-18.97799412,3.953533764,-4.800261045,1.58E-06,0.00013253,LOC110053326,1,1_LOC110053326,LOC110053326,"putative histone-lysine N-methyltransferase PRDM6, transcript variant X1", C_EE_H_D_EE_H
1002,9.552111504,-18.97468229,3.935025137,-4.821997734,1.42E-06,6.97E-05,LOC110053869,4,4_LOC110053869,LOC110053869,uncharacterized LOC110053869, C_PE_H_C_EE_H
1019,31.81547475,-18.97346492,4.324740085,-4.387191957,1.15E-05,0.000535091,LOC110053159,4,4_LOC110053159,LOC110053159,"DBH-like monooxygenase protein 1, transcript variant X2", C_PE_H_C_EE_H
976,7.010854298,-18.97211631,3.624643138,-5.234202538,1.66E-07,8.84E-06,LOC110052046,4,4_LOC110052046,LOC110052046,MAM and LDL-receptor class A domain-containing protein 1-like, C_PE_H_C_EE_H
351,17.3917965,-18.94994948,5.186954959,-3.653386165,0.000258805,0.011650604,LOC110041899,1,1_LOC110041899,LOC110041899,E3 ubiquitin-protein ligase TRIM71-like, C_EE_H_D_EE_H
776,31.02365786,-18.94313507,2.466348833,-7.680639016,1.58E-14,2.57E-12,LOC110060001,4,4_LOC110060001,LOC110060001,BTB/POZ domain-containing protein 6-like, C_PE_H_C_EE_H
724,18.18188695,-18.90677339,2.222186309,-8.508185526,1.77E-17,6.10E-15,LOC110053099,4,4_LOC110053099,LOC110053099,"cytosolic 5'-nucleotidase 3-like, transcript variant X2", C_PE_H_C_EE_H
938,8.120988948,-18.90449483,3.319548851,-5.69489882,1.23E-08,7.54E-07,LOC110055825,4,4_LOC110055825,LOC110055825,uncharacterized LOC110055825, C_PE_H_C_EE_H
866,12.31926483,-18.88501731,2.913427927,-6.482060918,9.05E-11,7.65E-09,LOC110053225,4,4_LOC110053225,LOC110053225,collagen triple helix repeat-containing protein 1-like, C_PE_H_C_EE_H
841,12.19529159,-18.8580492,2.797056831,-6.742104411,1.56E-11,1.52E-09,LOC110040243,4,4_LOC110040243,LOC110040243,uncharacterized LOC110040243, C_PE_H_C_EE_H
136,14.49499471,-18.83878616,3.599391747,-5.233880469,1.66E-07,1.94E-05,LOC110059420,1,1_LOC110059420,LOC110059420,myosin-2 heavy chain-like, C_EE_H_D_EE_H
235,11.12371178,-18.83514481,4.208403721,-4.475603116,7.62E-06,0.000515246,LOC110067164,1,1_LOC110067164,LOC110067164,uncharacterized LOC110067164, C_EE_H_D_EE_H
306,8.532301412,-18.81813611,4.726424799,-3.981473715,6.85E-05,0.003556743,LOC110069436,1,1_LOC110069436,LOC110069436,"perlucin-like protein, transcript variant X2", C_EE_H_D_EE_H
717,19.9126933,-18.80133086,2.147327083,-8.755690278,2.03E-18,8.27E-16,LOC110043723,4,4_LOC110043723,LOC110043723,transcription factor Sox-17-beta.3-like, C_PE_H_C_EE_H
197,10.96513886,-18.79163629,3.963866939,-4.740733374,2.13E-06,0.000171773,LOC110047414,1,1_LOC110047414,LOC110047414,protein CIP2A homolog, C_EE_H_D_EE_H
266,12.00407834,-18.786125,4.441832561,-4.229363612,2.34E-05,0.001400041,LOC110065054,1,1_LOC110065054,LOC110065054,mitochondrial ribonuclease P protein 3-like, C_EE_H_D_EE_H
926,8.870699565,-18.78304668,3.263971003,-5.754661013,8.68E-09,5.56E-07,LOC110063528,4,4_LOC110063528,LOC110063528,"protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1-like", C_PE_H_C_EE_H
272,12.33850473,-18.77214098,4.467080045,-4.202329215,2.64E-05,0.001543428,LOC110047837,1,1_LOC110047837,LOC110047837,growth/differentiation factor 8-like, C_EE_H_D_EE_H
111,21.04134717,-18.75091785,3.444309984,-5.444027377,5.21E-08,7.45E-06,LOC110048050,1,1_LOC110048050,LOC110048050,collagen alpha-1(XII) chain-like, C_EE_H_D_EE_H
856,12.91228449,-18.74767294,2.851701039,-6.574207005,4.89E-11,4.38E-09,LOC110064527,4,4_LOC110064527,LOC110064527,transient receptor potential cation channel subfamily A member 1-like, C_PE_H_C_EE_H
934,7.320402136,-18.68853439,3.265433096,-5.723141107,1.05E-08,6.49E-07,LOC110047416,4,4_LOC110047416,LOC110047416,uncharacterized LOC110047416, C_PE_H_C_EE_H
897,13.36534141,-18.67150932,3.041413018,-6.139090354,8.30E-10,6.02E-08,LOC110039728,4,4_LOC110039728,LOC110039728,protein DD3-3-like, C_PE_H_C_EE_H
944,10.6867184,-18.66685559,3.345074233,-5.580400998,2.40E-08,1.43E-06,LOC110067067,4,4_LOC110067067,LOC110067067,uncharacterized LOC110067067, C_PE_H_C_EE_H
201,18.82058892,-18.65770469,3.978710484,-4.689384856,2.74E-06,0.000216645,LOC110056593,1,1_LOC110056593,LOC110056593,uncharacterized LOC110056593, C_EE_H_D_EE_H
270,11.91791726,-18.65499883,4.429838334,-4.211214366,2.54E-05,0.00149494,LOC110055594,1,1_LOC110055594,LOC110055594,dehydrogenase/reductase SDR family member on chromosome X-like, C_EE_H_D_EE_H
965,9.331471995,-18.64031825,3.475956259,-5.362644655,8.20E-08,4.54E-06,LOC110057534,4,4_LOC110057534,LOC110057534,sodium channel modifier 1-like, C_PE_H_C_EE_H
191,13.37077615,-18.64000395,3.897567067,-4.782471638,1.73E-06,0.000144061,LOC110068266,1,1_LOC110068266,LOC110068266,serine/threonine-protein phosphatase 4 regulatory subunit 1-like, C_EE_H_D_EE_H
411,10.57016605,-18.62550691,5.729333127,-3.250903115,0.001150391,0.044478968,LOC110045842,1,1_LOC110045842,LOC110045842,uncharacterized LOC110045842, C_EE_H_D_EE_H
666,5.805359396,-18.61606314,3.069245251,-6.065355361,1.32E-09,2.09E-06,LOC110045859,3,3_LOC110045859,LOC110045859,gamma-aminobutyric acid receptor subunit beta-2-like, C_PE_D_D_EE_D
326,8.611637324,-18.57534327,4.861209633,-3.821136028,0.000132838,0.006475259,LOC110058730,1,1_LOC110058730,LOC110058730,protein decapentaplegic-like, C_EE_H_D_EE_H
961,15.93819033,-18.57283034,3.421533605,-5.42821801,5.69E-08,3.20E-06,LOC110042328,4,4_LOC110042328,LOC110042328,uncharacterized LOC110042328, C_PE_H_C_EE_H
430,7.916003361,-18.56101177,6.091046091,-3.047261749,0.002309365,0.08534447,LOC110052431,1,1_LOC110052431,LOC110052431,"uncharacterized LOC110052431, transcript variant X2", C_EE_H_D_EE_H
273,8.893675594,-18.55154907,4.423343554,-4.194010446,2.74E-05,0.001595301,LOC110061326,1,1_LOC110061326,LOC110061326,matrix metalloproteinase-16-like, C_EE_H_D_EE_H
372,9.320771589,-18.53851716,5.258018093,-3.525761386,0.000422267,0.018038303,LOC110044200,1,1_LOC110044200,LOC110044200,"uncharacterized LOC110044200, transcript variant X3", C_EE_H_D_EE_H
220,14.14335469,-18.5379793,4.035508419,-4.593715926,4.35E-06,0.000314513,LOC110055237,1,1_LOC110055237,LOC110055237,vesicle transport protein GOT1B-like, C_EE_H_D_EE_H
211,11.79634333,-18.53535058,3.973947667,-4.664216074,3.10E-06,0.000233316,LOC110051705,1,1_LOC110051705,LOC110051705,uncharacterized LOC110051705, C_EE_H_D_EE_H
72,19.9126933,-18.53265139,3.087504137,-6.002470141,1.94E-09,4.29E-07,LOC110043723,1,1_LOC110043723,LOC110043723,transcription factor Sox-17-beta.3-like, C_EE_H_D_EE_H
397,6.910456338,-18.52025613,5.532898639,-3.347297202,0.000816037,0.032664079,LOC110066517,1,1_LOC110066517,LOC110066517,uncharacterized LOC110066517, C_EE_H_D_EE_H
842,19.89658491,-18.51872828,2.749592134,-6.735081926,1.64E-11,1.59E-09,LOC110055643,4,4_LOC110055643,LOC110055643,T-cell acute lymphocytic leukemia protein 1-like, C_PE_H_C_EE_H
210,16.24906596,-18.51013941,3.967472344,-4.665474087,3.08E-06,0.000232997,LOC110045356,1,1_LOC110045356,LOC110045356,nephrocystin-1-like, C_EE_H_D_EE_H
214,14.65079506,-18.5053227,3.981347582,-4.648004807,3.35E-06,0.000248881,LOC110045038,1,1_LOC110045038,LOC110045038,vacuolar protein sorting-associated protein 37A-like, C_EE_H_D_EE_H
391,4.04688094,-18.50500992,5.459445297,-3.389540313,0.000700099,0.028455334,LOC110039709,1,1_LOC110039709,LOC110039709,"target of rapamycin complex 2 subunit MAPKAP1-like, transcript variant X1", C_EE_H_D_EE_H
948,10.1226609,-18.49957687,3.334936776,-5.547204675,2.90E-08,1.71E-06,LOC110043445,4,4_LOC110043445,LOC110043445,prostaglandin D2 receptor-like, C_PE_H_C_EE_H
385,5.987536744,-18.49898153,5.382458051,-3.436902127,0.000588408,0.024286739,LOC110056647,1,1_LOC110056647,LOC110056647,uncharacterized LOC110056647, C_EE_H_D_EE_H
1005,11.61339856,-18.47413692,3.905563023,-4.730210934,2.24E-06,0.000108879,LOC110056894,4,4_LOC110056894,LOC110056894,"XK-related protein 6-like, transcript variant X4", C_PE_H_C_EE_H
319,8.870699565,-18.46873511,4.74916822,-3.888835741,0.000100726,0.005017683,LOC110063528,1,1_LOC110063528,LOC110063528,"protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1-like", C_EE_H_D_EE_H
378,7.010854298,-18.43753327,5.284188506,-3.489189162,0.000484488,0.020367729,LOC110052046,1,1_LOC110052046,LOC110052046,MAM and LDL-receptor class A domain-containing protein 1-like, C_EE_H_D_EE_H
368,9.432252452,-18.37943302,5.185353938,-3.544489583,0.000393374,0.017078701,LOC110068991,1,1_LOC110068991,LOC110068991,uncharacterized LOC110068991, C_EE_H_D_EE_H
884,14.50198738,-18.35623935,2.928242337,-6.268688598,3.64E-10,2.81E-08,LOC110065103,4,4_LOC110065103,LOC110065103,uncharacterized LOC110065103, C_PE_H_C_EE_H
152,16.55473512,-18.33419597,3.594352392,-5.100834301,3.38E-07,3.54E-05,LOC110061801,1,1_LOC110061801,LOC110061801,XK-related protein 8-like, C_EE_H_D_EE_H
394,6.624776761,-18.31513645,5.417628329,-3.380655767,0.000723131,0.029186346,LOC110059968,1,1_LOC110059968,LOC110059968,carbohydrate sulfotransferase 3-like, C_EE_H_D_EE_H
362,14.11813743,-18.31021877,5.115338355,-3.579473634,0.000344287,0.01513265,LOC110063098,1,1_LOC110063098,LOC110063098,"uncharacterized LOC110063098, transcript variant X2", C_EE_H_D_EE_H
332,10.1226609,-18.29240866,4.855401733,-3.767434636,0.000164934,0.007894462,LOC110043445,1,1_LOC110043445,LOC110043445,prostaglandin D2 receptor-like, C_EE_H_D_EE_H
298,9.566083556,-18.29229942,4.538572406,-4.030408195,5.57E-05,0.00297141,LOC110052700,1,1_LOC110052700,LOC110052700,uncharacterized LOC110052700, C_EE_H_D_EE_H
296,14.77220293,-18.23173573,4.523744812,-4.030230812,5.57E-05,0.00297141,LOC110048665,1,1_LOC110048665,LOC110048665,"beta-hexosaminidase-like, transcript variant X2", C_EE_H_D_EE_H
312,16.4114474,-18.2306731,4.625512866,-3.941330102,8.10E-05,0.004127128,LOC110045418,1,1_LOC110045418,LOC110045418,sodium-dependent dopamine transporter-like, C_EE_H_D_EE_H
262,10.61774758,-18.21979977,4.300091029,-4.237073042,2.26E-05,0.001373495,LOC110064402,1,1_LOC110064402,LOC110064402,uncharacterized LOC110064402, C_EE_H_D_EE_H
223,15.13043523,-18.21793017,3.984545802,-4.572147261,4.83E-06,0.000344009,LOC110041529,1,1_LOC110041529,LOC110041529,uncharacterized LOC110041529, C_EE_H_D_EE_H
141,28.46207146,-18.18120914,3.526010409,-5.156311817,2.52E-07,2.82E-05,LOC110047864,1,1_LOC110047864,LOC110047864,"uncharacterized LOC110047864, transcript variant X2", C_EE_H_D_EE_H
979,9.748331459,-18.17727394,3.520964092,-5.1625843,2.44E-07,1.29E-05,LOC110066484,4,4_LOC110066484,LOC110066484,kelch-like protein 2, C_PE_H_C_EE_H
1003,9.396402799,-18.16553911,3.787916711,-4.795654311,1.62E-06,7.93E-05,LOC110040441,4,4_LOC110040441,LOC110040441,uncharacterized LOC110040441, C_PE_H_C_EE_H
786,28.46207146,-18.15530201,2.4398137,-7.441265706,9.97E-14,1.47E-11,LOC110047864,4,4_LOC110047864,LOC110047864,"uncharacterized LOC110047864, transcript variant X2", C_PE_H_C_EE_H
330,8.148302775,-18.1292558,4.797132177,-3.779186217,0.000157342,0.007576719,LOC110045182,1,1_LOC110045182,LOC110045182,uncharacterized LOC110045182, C_EE_H_D_EE_H
868,12.15077083,-18.11666216,2.810858474,-6.445241667,1.15E-10,9.65E-09,LOC110041025,4,4_LOC110041025,LOC110041025,kelch-like protein 1, C_PE_H_C_EE_H
854,18.82058892,-18.0786274,2.748481859,-6.577677541,4.78E-11,4.31E-09,LOC110056593,4,4_LOC110056593,LOC110056593,uncharacterized LOC110056593, C_PE_H_C_EE_H
996,15.34453974,-18.02807618,3.666526008,-4.91693667,8.79E-07,4.39E-05,LOC110062593,4,4_LOC110062593,LOC110062593,receptor-type tyrosine-protein phosphatase R-like, C_PE_H_C_EE_H
1011,9.164072914,-17.98880094,3.850733792,-4.671525457,2.99E-06,0.000142671,LOC110045334,4,4_LOC110045334,LOC110045334,uncharacterized LOC110045334, C_PE_H_C_EE_H
966,29.551711,-17.98233929,3.354979786,-5.359894974,8.33E-08,4.59E-06,LOC110055858,4,4_LOC110055858,LOC110055858,"uncharacterized LOC110055858, transcript variant X2", C_PE_H_C_EE_H
168,15.79488125,-17.98161714,3.620845827,-4.966137195,6.83E-07,6.50E-05,LOC110064622,1,1_LOC110064622,LOC110064622,"uncharacterized LOC110064622, transcript variant X2", C_EE_H_D_EE_H
921,11.06174967,-17.92061891,3.087595724,-5.804069092,6.47E-09,4.23E-07,LOC110044274,4,4_LOC110044274,LOC110044274,"uncharacterized LOC110044274, transcript variant X1", C_PE_H_C_EE_H
304,11.06174967,-17.89493566,4.491805086,-3.98390743,6.78E-05,0.003532037,LOC110044274,1,1_LOC110044274,LOC110044274,"uncharacterized LOC110044274, transcript variant X1", C_EE_H_D_EE_H
956,13.7047188,-17.87027436,3.256954426,-5.486805162,4.09E-08,2.34E-06,LOC110062755,4,4_LOC110062755,LOC110062755,fukutin-related protein-like, C_PE_H_C_EE_H
1001,7.873200286,-17.79599151,3.69012771,-4.822595018,1.42E-06,6.97E-05,LOC110043862,4,4_LOC110043862,LOC110043862,uncharacterized protein YxeI-like, C_PE_H_C_EE_H
387,6.673629092,-17.71103595,5.175952172,-3.421792814,0.000622097,0.025544556,LOC110055249,1,1_LOC110055249,LOC110055249,neo-calmodulin-like, C_EE_H_D_EE_H
893,15.02290209,-17.70061061,2.868632318,-6.170400613,6.81E-10,5.03E-08,LOC110061367,4,4_LOC110061367,LOC110061367,nucleolar protein 14-like, C_PE_H_C_EE_H
258,10.63872114,-17.67685817,4.151919216,-4.257514959,2.07E-05,0.001273201,LOC110042671,1,1_LOC110042671,LOC110042671,protein lin-41-like, C_EE_H_D_EE_H
369,15.93819033,-17.6689504,4.992935385,-3.538790118,0.000401965,0.017310652,LOC110042328,1,1_LOC110042328,LOC110042328,uncharacterized LOC110042328, C_EE_H_D_EE_H
331,12.11812886,-17.63917504,4.680812001,-3.768400662,0.000164297,0.007887738,LOC110040778,1,1_LOC110040778,LOC110040778,probable E3 ubiquitin-protein ligase DTX2, C_EE_H_D_EE_H
1100,12.40394884,-17.63109576,5.289190817,-3.333420248,0.000857853,0.032303639,LOC110050129,4,4_LOC110050129,LOC110050129,"hydroxyacyl-coenzyme A dehydrogenase, mitochondrial-like", C_PE_H_C_EE_H
1009,7.451608309,-17.59177222,3.738900416,-4.70506573,2.54E-06,0.000121839,LOC110063383,4,4_LOC110063383,LOC110063383,uncharacterized LOC110063383, C_PE_H_C_EE_H
112,37.43951369,-17.58442524,3.230909886,-5.442561339,5.25E-08,7.45E-06,LOC110054576,1,1_LOC110054576,LOC110054576,uncharacterized LOC110054576, C_EE_H_D_EE_H
988,10.25903085,-17.58254026,3.519195639,-4.996181533,5.85E-07,3.00E-05,LOC110040308,4,4_LOC110040308,LOC110040308,probable E3 ubiquitin-protein ligase ARI11, C_PE_H_C_EE_H
952,11.23704164,-17.54441434,3.179110727,-5.518654695,3.42E-08,1.98E-06,LOC110040957,4,4_LOC110040957,LOC110040957,BLOC-1-related complex subunit 5-like, C_PE_H_C_EE_H
176,23.82108009,-17.50710018,3.563272258,-4.91320868,8.96E-07,8.09E-05,LOC110045499,1,1_LOC110045499,LOC110045499,lipopolysaccharide-induced tumor necrosis factor-alpha factor homolog, C_EE_H_D_EE_H
384,11.66527421,-17.5057688,5.091072706,-3.438522648,0.000584898,0.024204708,LOC110048022,1,1_LOC110048022,LOC110048022,ubiquitin-protein ligase E3C-like, C_EE_H_D_EE_H
873,15.16265299,-17.48095525,2.737501299,-6.385734047,1.71E-10,1.39E-08,LOC110053326,4,4_LOC110053326,LOC110053326,"putative histone-lysine N-methyltransferase PRDM6, transcript variant X1", C_PE_H_C_EE_H
400,9.733453567,-17.40643717,5.256449553,-3.311443778,0.000928159,0.036873432,LOC110052970,1,1_LOC110052970,LOC110052970,neural cell adhesion molecule 2-like, C_EE_H_D_EE_H
218,15.85395136,-17.4020777,3.776758309,-4.607675757,4.07E-06,0.000296823,LOC110058152,1,1_LOC110058152,LOC110058152,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A-like", C_EE_H_D_EE_H
977,11.18387365,-17.39724489,3.324718385,-5.232697291,1.67E-07,8.88E-06,LOC110060002,4,4_LOC110060002,LOC110060002,"BTB/POZ domain-containing protein 6-like, transcript variant X1", C_PE_H_C_EE_H
293,15.15242072,-17.33674018,4.280645489,-4.050029424,5.12E-05,0.002777464,LOC110065626,1,1_LOC110065626,LOC110065626,tetratricopeptide repeat protein 28-like, C_EE_H_D_EE_H
1028,7.916003361,-17.31534564,4.177841986,-4.144566908,3.40E-05,0.00154577,LOC110052431,4,4_LOC110052431,LOC110052431,"uncharacterized LOC110052431, transcript variant X2", C_PE_H_C_EE_H
244,14.36679424,-17.30695887,3.969472095,-4.360015251,1.30E-05,0.000846999,LOC110068357,1,1_LOC110068357,LOC110068357,"alternative oxidase, mitochondrial-like", C_EE_H_D_EE_H
375,17.27914701,-17.28899576,4.932334104,-3.50523614,0.000456202,0.019332035,LOC110045604,1,1_LOC110045604,LOC110045604,uncharacterized LOC110045604, C_EE_H_D_EE_H
207,13.18441493,-17.27058301,3.693259417,-4.676244222,2.92E-06,0.000225003,LOC110057599,1,1_LOC110057599,LOC110057599,acyl-CoA synthetase family member 4-like, C_EE_H_D_EE_H
1016,5.661814534,-17.22535623,3.779247241,-4.557880217,5.17E-06,0.000242937,LOC110056850,4,4_LOC110056850,LOC110056850,uncharacterized LOC110056850, C_PE_H_C_EE_H
1088,16.97349575,-17.06827889,4.962104417,-3.439725862,0.000582304,0.022569239,LOC110047843,4,4_LOC110047843,LOC110047843,testis-expressed protein 10-like, C_PE_H_C_EE_H
1069,2.399259415,-17.0360871,4.717669782,-3.611123263,0.000304874,0.01239066,LOC110064549,4,4_LOC110064549,LOC110064549,tctex1 domain-containing protein 2-like, C_PE_H_C_EE_H
964,10.9168495,-16.88309482,3.146049355,-5.36644309,8.03E-08,4.46E-06,LOC110057466,4,4_LOC110057466,LOC110057466,"uncharacterized LOC110057466, transcript variant X4", C_PE_H_C_EE_H
1027,10.36837764,-16.771637,4.043426971,-4.147876818,3.36E-05,0.001527962,LOC110066386,4,4_LOC110066386,LOC110066386,uncharacterized LOC110066386, C_PE_H_C_EE_H
857,13.18441493,-16.74779334,2.549733614,-6.568448267,5.08E-11,4.51E-09,LOC110057599,4,4_LOC110057599,LOC110057599,acyl-CoA synthetase family member 4-like, C_PE_H_C_EE_H
395,11.13078753,-16.73214053,4.954372105,-3.377247444,0.000732152,0.029454734,LOC110058795,1,1_LOC110058795,LOC110058795,peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase-like, C_EE_H_D_EE_H
995,17.14764936,-16.72415942,3.399909786,-4.919000937,8.70E-07,4.36E-05,LOC110052891,4,4_LOC110052891,LOC110052891,sacsin-like, C_PE_H_C_EE_H
900,11.79634333,-16.68369315,2.756587153,-6.052300261,1.43E-09,1.02E-07,LOC110051705,4,4_LOC110051705,LOC110051705,uncharacterized LOC110051705, C_PE_H_C_EE_H
404,11.10946331,-16.68305368,5.063256022,-3.294925955,0.000984476,0.038723541,LOC110046089,1,1_LOC110046089,LOC110046089,"uncharacterized LOC110046089, transcript variant X1", C_EE_H_D_EE_H
282,19.54120028,-16.66901649,4.018020115,-4.14856472,3.35E-05,0.001885317,LOC110046618,1,1_LOC110046618,LOC110046618,mitochondrial carnitine/acylcarnitine carrier protein-like, C_EE_H_D_EE_H
985,8.148302775,-16.63959463,3.306540354,-5.032327703,4.85E-07,2.51E-05,LOC110045182,4,4_LOC110045182,LOC110045182,uncharacterized LOC110045182, C_PE_H_C_EE_H
414,9.748331459,-16.61129758,5.166376395,-3.215270493,0.001303217,0.050022741,LOC110066484,1,1_LOC110066484,LOC110066484,kelch-like protein 2, C_EE_H_D_EE_H
959,12.57453693,-16.58149317,3.040929385,-5.452771529,4.96E-08,2.80E-06,LOC110045444,4,4_LOC110045444,LOC110045444,SHC SH2 domain-binding protein 1 homolog B-like, C_PE_H_C_EE_H
972,19.99326703,-16.56795625,3.156181715,-5.249367037,1.53E-07,8.25E-06,LOC110042118,4,4_LOC110042118,LOC110042118,"cAMP-dependent protein kinase catalytic subunit-like, transcript variant X2", C_PE_H_C_EE_H
1111,5.67795338,-16.4910671,5.164544976,-3.193130696,0.001407392,0.051650973,LOC110064832,4,4_LOC110064832,LOC110064832,tankyrase-1-like, C_PE_H_C_EE_H
1000,11.13078753,-16.41636629,3.393497325,-4.837595176,1.31E-06,6.49E-05,LOC110058795,4,4_LOC110058795,LOC110058795,peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase-like, C_PE_H_C_EE_H
418,9.272207476,-16.40376373,5.152813946,-3.183457408,0.001455275,0.055324829,LOC110069718,1,1_LOC110069718,LOC110069718,DNA polymerase delta subunit 2-like, C_EE_H_D_EE_H
927,10.28906941,-16.38773561,2.848176545,-5.753763978,8.73E-09,5.57E-07,LOC110059134,4,4_LOC110059134,LOC110059134,"beta-1,3-galactosyltransferase 5-like", C_PE_H_C_EE_H
1029,7.02457019,-16.38562576,3.959937124,-4.137849983,3.51E-05,0.001586992,LOC110068112,4,4_LOC110068112,LOC110068112,"gamma-2-syntrophin-like, transcript variant X2", C_PE_H_C_EE_H
998,8.899897964,-16.29194661,3.33796253,-4.880805719,1.06E-06,5.25E-05,LOC110067588,4,4_LOC110067588,LOC110067588,uncharacterized LOC110067588, C_PE_H_C_EE_H
316,7.812380515,-15.91881216,4.05445569,-3.926251358,8.63E-05,0.004338846,LOC110061296,1,1_LOC110061296,LOC110061296,uncharacterized LOC110061296, C_EE_H_D_EE_H
949,7.652599008,-15.70309253,2.834357847,-5.540264629,3.02E-08,1.77E-06,LOC110061154,4,4_LOC110061154,LOC110061154,uncharacterized LOC110061154, C_PE_H_C_EE_H
1057,7.586117847,-15.59766719,4.173447898,-3.737357594,0.000185964,0.007797255,LOC110048192,4,4_LOC110048192,LOC110048192,putative nuclease HARBI1, C_PE_H_C_EE_H
212,15.59451563,-15.26336251,3.276569155,-4.658336751,3.19E-06,0.000238946,LOC110047798,1,1_LOC110047798,LOC110047798,dimethylaniline monooxygenase [N-oxide-forming] 2-like, C_EE_H_D_EE_H
1061,6.696852863,-15.19109957,4.125826354,-3.681953206,0.000231454,0.009603222,LOC110043483,4,4_LOC110043483,LOC110043483,helicase with zinc finger domain 2-like, C_PE_H_C_EE_H
1110,8.19675064,-15.11877129,4.709201644,-3.210474393,0.001325161,0.04874567,LOC110054377,4,4_LOC110054377,LOC110054377,twist-related protein-like, C_PE_H_C_EE_H
405,12.44458191,-15.11231703,4.594703578,-3.289073336,0.001005178,0.039440218,LOC110055775,1,1_LOC110055775,LOC110055775,uncharacterized LOC110055775, C_EE_H_D_EE_H
366,15.02290209,-15.07185846,4.253072081,-3.543758058,0.000394467,0.017078701,LOC110061367,1,1_LOC110061367,LOC110061367,nucleolar protein 14-like, C_EE_H_D_EE_H
302,12.42205274,-15.02971113,3.768123122,-3.988646506,6.65E-05,0.003490994,LOC110048542,1,1_LOC110048542,LOC110048542,zinc phosphodiesterase ELAC protein 2-like, C_EE_H_D_EE_H
322,16.00430886,-14.86184563,3.847492132,-3.862735809,0.000112124,0.005533436,LOC110053046,1,1_LOC110053046,LOC110053046,maltase 1-like, C_EE_H_D_EE_H
426,12.7121887,-14.70821857,4.79408789,-3.067991015,0.002155031,0.080388726,LOC110068397,1,1_LOC110068397,LOC110068397,"uncharacterized LOC110068397, transcript variant X2", C_EE_H_D_EE_H
989,11.41687605,-14.54246083,2.922862632,-4.975417138,6.51E-07,3.33E-05,LOC110043451,4,4_LOC110043451,LOC110043451,protein phosphatase 1 regulatory subunit 27-like, C_PE_H_C_EE_H
1014,6.255005425,-14.10342353,3.062922034,-4.604564978,4.13E-06,0.000195482,LOC110058803,4,4_LOC110058803,LOC110058803,"hemicentin-1-like, transcript variant X2", C_PE_H_C_EE_H
1050,10.31261076,-14.02728777,3.646203066,-3.847094502,0.000119527,0.005105918,LOC110061607,4,4_LOC110061607,LOC110061607,uncharacterized LOC110061607, C_PE_H_C_EE_H
360,14.56710071,-13.76564282,3.823548108,-3.600227442,0.000317939,0.014034355,LOC110042096,1,1_LOC110042096,LOC110042096,potassium channel subfamily K member 15-like, C_EE_H_D_EE_H
415,28.85657506,-13.75509957,4.280021105,-3.213792464,0.001309943,0.050159776,LOC110052232,1,1_LOC110052232,LOC110052232,uncharacterized LOC110052232, C_EE_H_D_EE_H
1047,12.92363649,-13.01063039,3.344500757,-3.89015621,0.00010018,0.004305788,LOC110045829,4,4_LOC110045829,LOC110045829,leucine-rich repeat-containing protein 27-like, C_PE_H_C_EE_H
1024,10.01883545,-12.9670447,3.044183385,-4.25961352,2.05E-05,0.000940511,LOC110052824,4,4_LOC110052824,LOC110052824,"synaptotagmin-7-like, transcript variant X1", C_PE_H_C_EE_H
1076,13.30897963,-12.88424579,3.664702524,-3.515768527,0.000438483,0.017507374,LOC110042054,4,4_LOC110042054,LOC110042054,FUN14 domain-containing protein 1-like, C_PE_H_C_EE_H
1072,11.66527421,-12.57611138,3.517532626,-3.575265026,0.000349873,0.01411126,LOC110048022,4,4_LOC110048022,LOC110048022,ubiquitin-protein ligase E3C-like, C_PE_H_C_EE_H
1079,6.673629092,-12.53631423,3.577043863,-3.504657677,0.000457195,0.018117909,LOC110055249,4,4_LOC110055249,LOC110055249,neo-calmodulin-like, C_PE_H_C_EE_H
1130,4.962080715,-12.40245153,4.041227663,-3.068981151,0.002147901,0.075513941,LOC110057808,4,4_LOC110057808,LOC110057808,uncharacterized protein YwnB-like, C_PE_H_C_EE_H
1065,10.88480087,-12.15927583,3.320826651,-3.661520791,0.000250723,0.010295172,LOC110049607,4,4_LOC110049607,LOC110049607,"adenylosuccinate lyase-like, transcript variant X2", C_PE_H_C_EE_H
1077,6.617960423,-12.02058893,3.422541787,-3.512181786,0.000444444,0.017700897,LOC110048821,4,4_LOC110048821,LOC110048821,uncharacterized LOC110048821, C_PE_H_C_EE_H
389,46.97207778,-11.50973971,3.379314263,-3.405939433,0.000659368,0.026935778,LOC110062713,1,1_LOC110062713,LOC110062713,uncharacterized LOC110062713, C_EE_H_D_EE_H
1098,27.15200191,-9.89992476,2.944864876,-3.361758578,0.000774478,0.02930293,LOC110043526,4,4_LOC110043526,LOC110043526,ATP-dependent rRNA helicase spb4-like, C_PE_H_C_EE_H
1054,19.84365755,-9.702561392,2.579189875,-3.761863943,0.000168652,0.007127781,LOC110067618,4,4_LOC110067618,LOC110067618,"trifunctional enzyme subunit alpha, mitochondrial-like", C_PE_H_C_EE_H
1066,14.52255545,-9.607412932,2.635422604,-3.645492347,0.00026688,0.010930401,LOC110057227,4,4_LOC110057227,LOC110057227,"phosphatidylinositol 4-phosphate 5-kinase type-1 alpha-like, transcript variant X2", C_PE_H_C_EE_H
432,27.29931005,-9.564575871,3.190323876,-2.997995264,0.002717619,0.099735988,LOC110059633,1,1_LOC110059633,LOC110059633,bifunctional purine biosynthesis protein PURH-like, C_EE_H_D_EE_H
1080,14.6849834,-9.31015981,2.657014307,-3.503993105,0.000458337,0.018118002,LOC110039873,4,4_LOC110039873,LOC110039873,"peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase-like, transcript variant X3", C_PE_H_C_EE_H
1105,15.08202911,-9.245676664,2.82570743,-3.271986535,0.001067947,0.039744121,LOC110064787,4,4_LOC110064787,LOC110064787,hepatocyte nuclear factor 1-beta-A-like, C_PE_H_C_EE_H
1138,21.76638754,-9.169813248,3.03594993,-3.020409907,0.002524328,0.087204555,LOC110067976,4,4_LOC110067976,LOC110067976,"troponin T, cardiac muscle-like", C_PE_H_C_EE_H
1086,12.04316414,-9.03343934,2.613255996,-3.456775515,0.00054668,0.021292384,LOC110055572,4,4_LOC110055572,LOC110055572,"uncharacterized LOC110055572, transcript variant X1", C_PE_H_C_EE_H
1030,9.340987739,-8.892824582,2.149466564,-4.137223966,3.52E-05,0.001586992,LOC110068603,4,4_LOC110068603,LOC110068603,uncharacterized LOC110068603, C_PE_H_C_EE_H
1117,14.66730912,-8.884149702,2.8354072,-3.133288828,0.001728593,0.062571899,LOC110047766,4,4_LOC110047766,LOC110047766,zinc finger protein 765-like, C_PE_H_C_EE_H
1074,23.89298982,-8.871717484,2.495273655,-3.555408628,0.000377392,0.015144287,LOC110039813,4,4_LOC110039813,LOC110039813,peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase-like, C_PE_H_C_EE_H
1058,14.72894448,-8.771292763,2.356712521,-3.721833989,0.000197781,0.008270891,LOC110056943,4,4_LOC110056943,LOC110056943,craniofacial development protein 2-like, C_PE_H_C_EE_H
1041,24.93333305,-8.735469349,2.19066912,-3.987580447,6.68E-05,0.00292213,LOC110057145,4,4_LOC110057145,LOC110057145,vicilin-like seed storage protein At2g18540, C_PE_H_C_EE_H
1099,12.36460393,-8.726394092,2.612815588,-3.339843092,0.000838257,0.031640731,LOC110055394,4,4_LOC110055394,LOC110055394,uncharacterized LOC110055394, C_PE_H_C_EE_H
1039,52.20506334,-8.647471482,2.155262012,-4.012259963,6.01E-05,0.002647336,LOC110057150,4,4_LOC110057150,LOC110057150,"uncharacterized LOC110057150, transcript variant X1", C_PE_H_C_EE_H
1141,9.054514903,-8.63360755,2.870674834,-3.007518458,0.002633901,0.090400271,LOC110050942,4,4_LOC110050942,LOC110050942,"phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN-like, transcript variant X1", C_PE_H_C_EE_H
422,34.22864586,-8.574353354,2.7439579,-3.124812284,0.001779186,0.066997721,LOC110052817,1,1_LOC110052817,LOC110052817,"uncharacterized LOC110052817, transcript variant X1", C_EE_H_D_EE_H
1118,15.67566799,-8.540894489,2.727566053,-3.13132453,0.001740197,0.062848812,LOC110065901,4,4_LOC110065901,LOC110065901,"paired mesoderm homeobox protein 2-like, transcript variant X1", C_PE_H_C_EE_H
1045,19.0819601,-8.493619745,2.174539582,-3.90593936,9.39E-05,0.004064115,LOC110068987,4,4_LOC110068987,LOC110068987,uncharacterized LOC110068987, C_PE_H_C_EE_H
1040,25.04180091,-8.488843694,2.124464131,-3.995757599,6.45E-05,0.002830867,LOC110066210,4,4_LOC110066210,LOC110066210,adhesion G-protein coupled receptor D1-like, C_PE_H_C_EE_H
1114,15.14827416,-8.465416001,2.65786989,-3.185037775,0.001447351,0.052751966,LOC110059003,4,4_LOC110059003,LOC110059003,"GRAM domain-containing protein 1B-like, transcript variant X3", C_PE_H_C_EE_H
1092,13.28545131,-8.446385215,2.465712179,-3.425535748,0.000613588,0.023552004,LOC110065708,4,4_LOC110065708,LOC110065708,"pancreatic secretory granule membrane major glycoprotein GP2-like, transcript variant X1", C_PE_H_C_EE_H
1134,15.30905733,-8.425672669,2.782910639,-3.027647583,0.002464653,0.085889925,LOC110058385,4,4_LOC110058385,LOC110058385,uncharacterized LOC110058385, C_PE_H_C_EE_H
1139,13.21503967,-8.253778632,2.737005477,-3.015623718,0.002564513,0.088400597,LOC110043365,4,4_LOC110043365,LOC110043365,uncharacterized LOC110043365, C_PE_H_C_EE_H
1112,24.32974159,-8.252645131,2.590088373,-3.186240754,0.001441346,0.052677709,LOC110050883,4,4_LOC110050883,LOC110050883,DNA/RNA-binding protein KIN17-like, C_PE_H_C_EE_H
1102,19.11872887,-8.227786912,2.475261449,-3.324007214,0.000887339,0.033256378,LOC110040575,4,4_LOC110040575,LOC110040575,uncharacterized LOC110040575, C_PE_H_C_EE_H
1038,20.21424518,-8.149452535,2.030716284,-4.013092621,5.99E-05,0.002645339,LOC110059617,4,4_LOC110059617,LOC110059617,tubulin polyglutamylase ttll6-like, C_PE_H_C_EE_H
1119,11.60011973,-8.11847239,2.598551119,-3.124230395,0.001782708,0.064238127,LOC110040316,4,4_LOC110040316,LOC110040316,heme transporter HRG1-like, C_PE_H_C_EE_H
1129,20.25728085,-8.074233142,2.629618458,-3.070496071,0.002137035,0.075425417,LOC110063956,4,4_LOC110063956,LOC110063956,"sorting nexin-14-like, transcript variant X1", C_PE_H_C_EE_H
1068,27.29931005,-8.058487388,2.224820791,-3.62208382,0.000292239,0.011907631,LOC110059633,4,4_LOC110059633,LOC110059633,bifunctional purine biosynthesis protein PURH-like, C_PE_H_C_EE_H
1085,22.66543108,-8.010432229,2.307722278,-3.471142219,0.000518249,0.020234648,LOC110041753,4,4_LOC110041753,LOC110041753,"uncharacterized LOC110041753, transcript variant X1", C_PE_H_C_EE_H
1031,46.01889966,-7.960130814,1.926967984,-4.13090974,3.61E-05,0.001626601,LOC110059166,4,4_LOC110059166,LOC110059166,"protein capicua homolog, transcript variant X2", C_PE_H_C_EE_H
1096,46.97207778,-7.955105462,2.351815723,-3.38253775,0.000718194,0.027303402,LOC110062713,4,4_LOC110062713,LOC110062713,uncharacterized LOC110062713, C_PE_H_C_EE_H
1059,19.91414968,-7.927829487,2.136707533,-3.710301652,0.000207012,0.008634212,LOC110057749,4,4_LOC110057749,LOC110057749,"tetratricopeptide repeat protein 28-like, transcript variant X2", C_PE_H_C_EE_H
1034,21.6396313,-7.88975807,1.920414618,-4.108361807,3.98E-05,0.001779899,LOC110061129,4,4_LOC110061129,LOC110061129,"substance-P receptor-like, transcript variant X1", C_PE_H_C_EE_H
1113,33.55449138,-7.663231882,2.405200221,-3.186109754,0.001441999,0.052677709,LOC110043844,4,4_LOC110043844,LOC110043844,uncharacterized LOC110043844, C_PE_H_C_EE_H
1042,34.22864586,-7.638883926,1.928284991,-3.96149115,7.45E-05,0.00325168,LOC110052817,4,4_LOC110052817,LOC110052817,"uncharacterized LOC110052817, transcript variant X1", C_PE_H_C_EE_H
1115,33.33112642,-7.635550607,2.421788329,-3.152856307,0.001616814,0.058793563,LOC110060120,4,4_LOC110060120,LOC110060120,"uncharacterized LOC110060120, transcript variant X2", C_PE_H_C_EE_H
1055,20.05336378,-7.501895231,1.998833941,-3.753135805,0.000174636,0.007361124,LOC110053018,4,4_LOC110053018,LOC110053018,methyltransferase-like protein 9, C_PE_H_C_EE_H
1144,23.0740861,-7.49931154,2.514540778,-2.982378177,0.002860185,0.097534747,LOC110049764,4,4_LOC110049764,LOC110049764,"neurogenic locus notch homolog protein 1-like, transcript variant X2", C_PE_H_C_EE_H
1090,21.92317229,-7.431307359,2.165604505,-3.431516392,0.000600217,0.023150597,LOC110042398,4,4_LOC110042398,LOC110042398,uncharacterized LOC110042398, C_PE_H_C_EE_H
1094,14.47804357,-7.36310364,2.171721814,-3.390445126,0.000697792,0.026655328,LOC110057549,4,4_LOC110057549,LOC110057549,uncharacterized LOC110057549, C_PE_H_C_EE_H
1097,29.40212755,-7.345611685,2.177818257,-3.372922263,0.000743749,0.028207453,LOC110044290,4,4_LOC110044290,LOC110044290,uncharacterized LOC110044290, C_PE_H_C_EE_H
1083,18.20710671,-7.265892035,2.083136232,-3.487958168,0.000486724,0.019097616,LOC110042711,4,4_LOC110042711,LOC110042711,acid-sensing ion channel 1C-like, C_PE_H_C_EE_H
1093,18.40629213,-7.250071082,2.119130753,-3.421247637,0.000623345,0.023868874,LOC110069638,4,4_LOC110069638,LOC110069638,"cAMP-regulated phosphoprotein 21-like, transcript variant X4", C_PE_H_C_EE_H
1087,34.85763754,-7.175627827,2.082764078,-3.445242743,0.000570547,0.022167625,LOC110056708,4,4_LOC110056708,LOC110056708,gamma-aminobutyric acid receptor subunit beta-1-like, C_PE_H_C_EE_H
1026,45.99404528,-7.143017964,1.699661264,-4.202612672,2.64E-05,0.001204848,LOC110055945,4,4_LOC110055945,LOC110055945,orexin receptor type 2-like, C_PE_H_C_EE_H
1116,25.22279972,-7.013355965,2.230615991,-3.144134174,0.00166579,0.060436246,LOC110062256,4,4_LOC110062256,LOC110062256,uncharacterized LOC110062256, C_PE_H_C_EE_H
1107,18.06520684,-6.949252238,2.142453249,-3.243595743,0.001180311,0.043721043,LOC110057776,4,4_LOC110057776,LOC110057776,"uncharacterized LOC110057776, transcript variant X4", C_PE_H_C_EE_H
667,19.66751696,-6.875885878,1.450365838,-4.740794148,2.13E-06,0.003075373,LOC110062461,3,3_LOC110062461,LOC110062461,ADP-ribosylation factor 1, C_PE_D_D_EE_D
1053,83.37198403,-6.863478447,1.817243027,-3.776863274,0.000158816,0.006729981,LOC110059581,4,4_LOC110059581,LOC110059581,muscle LIM protein 1-like, C_PE_H_C_EE_H
1106,36.83017439,-6.836413781,2.093716455,-3.265205164,0.001093848,0.040612947,LOC110067294,4,4_LOC110067294,LOC110067294,"receptor-type tyrosine-protein phosphatase F-like, transcript variant X3", C_PE_H_C_EE_H
1062,22.32741024,-6.823075164,1.853785103,-3.680618187,0.000232669,0.009628505,LOC110055325,4,4_LOC110055325,LOC110055325,transcription factor 24-like, C_PE_H_C_EE_H
1081,31.02988624,-6.81171321,1.948182836,-3.496444524,0.000471503,0.018592175,LOC110065144,4,4_LOC110065144,LOC110065144,ribonuclease H2 subunit A-like, C_PE_H_C_EE_H
1135,19.49710115,-6.562002108,2.168069837,-3.026656243,0.00247275,0.085948502,LOC110068594,4,4_LOC110068594,LOC110068594,putative beta-lactamase-like 1, C_PE_H_C_EE_H
1082,23.35246214,-6.552241235,1.874396325,-3.49565412,0.000472901,0.018601173,LOC110057230,4,4_LOC110057230,LOC110057230,"uncharacterized LOC110057230, transcript variant X2", C_PE_H_C_EE_H
1120,22.46029526,-6.543435465,2.099435869,-3.116758916,0.00182851,0.065739498,LOC110054934,4,4_LOC110054934,LOC110054934,uncharacterized LOC110054934, C_PE_H_C_EE_H
1109,11.0259474,-6.484723326,2.018718448,-3.212297056,0.001316781,0.048549824,LOC110041158,4,4_LOC110041158,LOC110041158,uncharacterized LOC110041158, C_PE_H_C_EE_H
1131,29.53837034,-6.44424372,2.103227993,-3.063977725,0.002184152,0.076618885,LOC110051265,4,4_LOC110051265,LOC110051265,"uncharacterized LOC110051265, transcript variant X1", C_PE_H_C_EE_H
1063,45.07020309,-6.405351964,1.741998022,-3.677014488,0.00023598,0.009714903,LOC110043343,4,4_LOC110043343,LOC110043343,dentin sialophosphoprotein-like, C_PE_H_C_EE_H
1064,31.12354724,-6.384727741,1.736096108,-3.677634961,0.000235407,0.009714903,LOC110049219,4,4_LOC110049219,LOC110049219,protein fem-1 homolog B-like, C_PE_H_C_EE_H
1126,55.93999528,-6.372419458,2.066980499,-3.082960609,0.002049523,0.072698587,LOC110039846,4,4_LOC110039846,LOC110039846,"uncharacterized LOC110039846, transcript variant X2", C_PE_H_C_EE_H
1123,36.44002469,-6.309094778,2.035671961,-3.09926889,0.001939989,0.069277213,LOC110065836,4,4_LOC110065836,LOC110065836,leucine-rich repeat and coiled-coil domain-containing protein 1-like, C_PE_H_C_EE_H
1067,37.12655209,-6.281170974,1.723788354,-3.643817966,0.000268623,0.010973509,LOC110058955,4,4_LOC110058955,LOC110058955,uncharacterized LOC110058955, C_PE_H_C_EE_H
1101,29.09005672,-6.212177593,1.867262566,-3.326890234,0.00087821,0.03299203,LOC110040354,4,4_LOC110040354,LOC110040354,"zinc finger protein 709-like, transcript variant X1", C_PE_H_C_EE_H
1143,24.70156802,-6.167907022,2.064412608,-2.987729778,0.002810579,0.096049282,LOC110046796,4,4_LOC110046796,LOC110046796,ATP-dependent RNA helicase ded1-like, C_PE_H_C_EE_H
1095,30.5934486,-6.051718609,1.785780912,-3.388835981,0.0007019,0.026747938,LOC110065621,4,4_LOC110065621,LOC110065621,uncharacterized LOC110065621, C_PE_H_C_EE_H
1032,65.55953191,-6.031560635,1.460401911,-4.130068983,3.63E-05,0.001627949,LOC110065785,4,4_LOC110065785,LOC110065785,neuromedin-U receptor 1-like, C_PE_H_C_EE_H
676,21.14674158,-5.967891972,1.480853857,-4.030034392,5.58E-05,0.044311015,LOC110042644,3,3_LOC110042644,LOC110042644,TNF receptor-associated factor 4-like, C_PE_D_D_EE_D
1070,74.14032397,-5.772497297,1.600078161,-3.607634576,0.000309001,0.012526376,LOC110049138,4,4_LOC110049138,LOC110049138,"protein Wnt-1-like, transcript variant X4", C_PE_H_C_EE_H
1132,27.47562368,-5.737208393,1.892419678,-3.031678681,0.002431979,0.085124634,LOC110039763,4,4_LOC110039763,LOC110039763,short-chain dehydrogenase/reductase family 9C member 7-like, C_PE_H_C_EE_H
1127,28.48223415,-5.705991128,1.852421029,-3.080288465,0.002068002,0.073190689,LOC110066648,4,4_LOC110066648,LOC110066648,collagen alpha-2(I) chain-like, C_PE_H_C_EE_H
1091,98.21867053,-5.458754409,1.591438676,-3.430075247,0.000603414,0.023217555,LOC110061085,4,4_LOC110061085,LOC110061085,titin homolog, C_PE_H_C_EE_H
1073,45.28964934,-5.082172032,1.427290366,-3.56071347,0.000369848,0.014879145,LOC110067343,4,4_LOC110067343,LOC110067343,crooked neck-like protein 1, C_PE_H_C_EE_H
1140,39.72533925,-4.786348832,1.590698692,-3.00896006,0.002621436,0.090167176,LOC110046428,4,4_LOC110046428,LOC110046428,rab-like protein 3, C_PE_H_C_EE_H
1048,71.08359204,-4.744006545,1.21954662,-3.889975558,0.000100254,0.004305788,LOC110061427,4,4_LOC110061427,LOC110061427,glucose-fructose oxidoreductase domain-containing protein 1-like, C_PE_H_C_EE_H
1142,47.37980493,-4.471499519,1.490011919,-3.000982383,0.002691101,0.092164421,LOC110040372,4,4_LOC110040372,LOC110040372,Golgi-associated PDZ and coiled-coil motif-containing protein-like, C_PE_H_C_EE_H
1121,89.44432238,-4.27210102,1.371322543,-3.115314513,0.001837489,0.065913168,LOC110053805,4,4_LOC110053805,LOC110053805,"dynein heavy chain 6, axonemal-like", C_PE_H_C_EE_H
1122,155.8621773,-3.088084137,0.995151677,-3.10312911,0.001914861,0.068533904,LOC110067225,4,4_LOC110067225,LOC110067225,"coadhesin-like, transcript variant X1", C_PE_H_C_EE_H
433,5147.211126,-1.529322934,0.510031488,-2.998487287,0.002713235,0.099735988,LOC110063756,1,1_LOC110063756,LOC110063756,"glyceraldehyde-3-phosphate dehydrogenase, cytosolic-like", C_EE_H_D_EE_H
678,2351.386718,0.99164131,0.258846139,3.83100677,0.00012762,0.092182242,LOC110055441,3,3_LOC110055441,LOC110055441,uncharacterized LOC110055441, C_PE_D_D_EE_D
1136,3018.294719,1.027418885,0.339517062,3.026118567,0.002477151,0.085948502,LOC110039715,4,4_LOC110039715,LOC110039715,sodium/glucose cotransporter 5-like, C_PE_H_C_EE_H
420,3018.294719,1.577823831,0.498474756,3.165303383,0.001549213,0.05861559,LOC110039715,1,1_LOC110039715,LOC110039715,sodium/glucose cotransporter 5-like, C_EE_H_D_EE_H
673,431.5585581,3.899334851,0.951563403,4.097819271,4.17E-05,0.038985362,LOC110062310,3,3_LOC110062310,LOC110062310,uncharacterized LOC110062310, C_PE_D_D_EE_D
669,423.8781687,4.249159814,0.956352856,4.443087913,8.87E-06,0.010839729,LOC110056792,3,3_LOC110056792,LOC110056792,"zinc metalloproteinase nas-15-like, transcript variant X3", C_PE_D_D_EE_D
427,94.39665424,5.058320188,1.652309233,3.061364112,0.00220331,0.08199718,LOC110052694,1,1_LOC110052694,LOC110052694,uncharacterized LOC110052694, C_EE_H_D_EE_H
674,10.6587925,5.549765335,1.360667031,4.078709344,4.53E-05,0.039980354,LOC110052662,3,3_LOC110052662,LOC110052662,uncharacterized skeletal organic matrix protein 5-like, C_PE_D_D_EE_D
1133,23.76308933,6.054692958,1.998231386,3.030025953,0.002445327,0.085403726,LOC110054902,4,4_LOC110054902,LOC110054902,transcription factor MafK-like, C_PE_H_C_EE_H
670,15.86402464,6.130369669,1.388593844,4.414804009,1.01E-05,0.011475748,LOC110062987,3,3_LOC110062987,LOC110062987,plasma kallikrein-like, C_PE_D_D_EE_D
677,18.49709098,6.153914687,1.597228411,3.852870789,0.000116741,0.088339584,LOC110062643,3,3_LOC110062643,LOC110062643,uncharacterized LOC110062643, C_PE_D_D_EE_D
654,93.46235543,6.430195103,1.975322632,3.255263215,0.001132873,0.081459221,LOC110062556,2,2_LOC110062556,LOC110062556,"transmembrane cell adhesion receptor mua-3-like, transcript variant X1", D_EE_D_D_EE_H
668,39.07078466,6.570816578,1.418063957,4.633653189,3.59E-06,0.004757616,LOC110069208,3,3_LOC110069208,LOC110069208,CUB domain-containing protein-like, C_PE_D_D_EE_D
416,71.58875337,7.058977558,2.20279253,3.204558514,0.001352698,0.05167241,LOC110065972,1,1_LOC110065972,LOC110065972,WD repeat-containing protein 13-like, C_EE_H_D_EE_H
1128,29.64734634,7.257843021,2.364123546,3.06999312,0.002140637,0.075425417,LOC110050242,4,4_LOC110050242,LOC110050242,uncharacterized LOC110050242, C_PE_H_C_EE_H
672,716.128401,7.327936483,1.753264741,4.179594965,2.92E-05,0.029003931,LOC110042039,3,3_LOC110042039,LOC110042039,"uncharacterized LOC110042039, transcript variant X2", C_PE_D_D_EE_D
1104,25.20733143,7.354174994,2.243008609,3.278710106,0.001042827,0.038900385,LOC110062476,4,4_LOC110062476,LOC110062476,uncharacterized LOC110062476, C_PE_H_C_EE_H
675,11.70710598,7.527784195,1.853191807,4.062064255,4.86E-05,0.040681532,LOC110062618,3,3_LOC110062618,LOC110062618,"b(0,+)-type amino acid transporter 1-like", C_PE_D_D_EE_D
1051,21.64616643,7.745525503,2.029880902,3.815753671,0.000135768,0.005784149,LOC110054839,4,4_LOC110054839,LOC110054839,"uncharacterized LOC110054839, transcript variant X1", C_PE_H_C_EE_H
1124,11.23475365,7.802627833,2.518962963,3.0975556,0.001951238,0.069522694,LOC110064015,4,4_LOC110064015,LOC110064015,zinc metalloproteinase nas-4-like, C_PE_H_C_EE_H
1078,31.77621547,8.166567786,2.328400475,3.507372496,0.000452555,0.017978886,LOC110060844,4,4_LOC110060844,LOC110060844,"muscle, skeletal receptor tyrosine-protein kinase-like, transcript variant X2", C_PE_H_C_EE_H
1089,15.35128982,8.208524985,2.386927405,3.438950413,0.000583974,0.022578914,LOC110066194,4,4_LOC110066194,LOC110066194,"uncharacterized LOC110066194, transcript variant X6", C_PE_H_C_EE_H
1049,18.43112749,8.606011737,2.23571161,3.84933893,0.000118437,0.005073,LOC110067625,4,4_LOC110067625,LOC110067625,eukaryotic translation initiation factor 2 subunit 1-like, C_PE_H_C_EE_H
1125,24.15692469,8.697831319,2.820822086,3.083438463,0.002046234,0.072698587,LOC110057963,4,4_LOC110057963,LOC110057963,ETS-related transcription factor Elf-4-like, C_PE_H_C_EE_H
1103,19.64887787,8.770233695,2.663500545,3.2927471,0.000992137,0.037096576,LOC110045769,4,4_LOC110045769,LOC110045769,uncharacterized LOC110045769, C_PE_H_C_EE_H
1020,47.46009459,9.052261468,2.065467111,4.38267035,1.17E-05,0.000544724,LOC110063905,4,4_LOC110063905,LOC110063905,WD repeat-containing protein on Y chromosome-like, C_PE_H_C_EE_H
1108,13.22114526,9.282540476,2.873837523,3.230015755,0.001237834,0.045745162,LOC110044960,4,4_LOC110044960,LOC110044960,DEP domain-containing protein 7-like, C_PE_H_C_EE_H
621,256.1170345,9.328794723,2.175125989,4.288852585,1.80E-05,0.001518085,LOC110066923,2,2_LOC110066923,LOC110066923,RNA-binding protein cabeza-like, D_EE_D_D_EE_H
1137,7.600587272,9.452978391,3.127409549,3.022622475,0.002505947,0.086758163,LOC110044974,4,4_LOC110044974,LOC110044974,"uncharacterized LOC110044974, transcript variant X1", C_PE_H_C_EE_H
419,69.3404012,9.4770532,2.992526919,3.166906583,0.001540698,0.058432535,LOC110060023,1,1_LOC110060023,LOC110060023,"uncharacterized LOC110060023, transcript variant X1", C_EE_H_D_EE_H
281,256.1170345,9.818578979,2.36541393,4.150892516,3.31E-05,0.001872883,LOC110066923,1,1_LOC110066923,LOC110066923,RNA-binding protein cabeza-like, C_EE_H_D_EE_H
671,4.353835066,13.18110706,3.133142733,4.206992205,2.59E-05,0.027416431,LOC110065008,3,3_LOC110065008,LOC110065008,"D(3) dopamine receptor-like, transcript variant X1", C_PE_D_D_EE_D
431,9.552927323,13.48531848,4.475007615,3.013473861,0.002582753,0.095226279,LOC110051255,1,1_LOC110051255,LOC110051255,"uncharacterized LOC110051255, transcript variant X2", C_EE_H_D_EE_H
417,15.08202911,13.48773441,4.213216273,3.201291729,0.001368129,0.052136557,LOC110064787,1,1_LOC110064787,LOC110064787,hepatocyte nuclear factor 1-beta-A-like, C_EE_H_D_EE_H
363,24.32974159,13.79148517,3.872508322,3.561382966,0.000368907,0.01614957,LOC110050883,1,1_LOC110050883,LOC110050883,DNA/RNA-binding protein KIN17-like, C_EE_H_D_EE_H
334,13.28545131,13.80986674,3.693742551,3.738719347,0.00018496,0.008800001,LOC110065708,1,1_LOC110065708,LOC110065708,"pancreatic secretory granule membrane major glycoprotein GP2-like, transcript variant X1", C_EE_H_D_EE_H
356,14.16437647,13.94111028,3.848738815,3.622254184,0.000292047,0.013036286,LOC110067391,1,1_LOC110067391,LOC110067391,"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A-like", C_EE_H_D_EE_H
388,26.03542902,13.95333741,4.091984601,3.409919335,0.000649821,0.026614188,LOC110062309,1,1_LOC110062309,LOC110062309,uncharacterized LOC110062309, C_EE_H_D_EE_H
393,15.30905733,14.03476926,4.151044146,3.381021441,0.000722169,0.029186346,LOC110058385,1,1_LOC110058385,LOC110058385,uncharacterized LOC110058385, C_EE_H_D_EE_H
402,13.42181571,14.5861142,4.414309099,3.30428021,0.000952206,0.037562394,LOC110066730,1,1_LOC110066730,LOC110066730,probable proline dehydrogenase 2, C_EE_H_D_EE_H
379,8.540799667,15.43136865,4.429164502,3.484036018,0.000493913,0.02070916,LOC110056841,1,1_LOC110056841,LOC110056841,uncharacterized LOC110056841, C_EE_H_D_EE_H
615,17.15070632,15.58712302,3.553620682,4.386265282,1.15E-05,0.001006839,LOC110059708,2,2_LOC110059708,LOC110059708,"WD repeat-containing protein 59-like, transcript variant X1", D_EE_D_D_EE_H
1060,9.238662503,15.59964419,4.217978155,3.698370075,0.000216988,0.009026603,LOC110064862,4,4_LOC110064862,LOC110064862,"uncharacterized LOC110064862, transcript variant X1", C_PE_H_C_EE_H
1033,11.62019822,15.61988809,3.802118765,4.108206255,3.99E-05,0.001779899,LOC110055228,4,4_LOC110055228,LOC110055228,"FYVE, RhoGEF and PH domain-containing protein 2-like", C_PE_H_C_EE_H
1052,4.826460359,15.95691238,4.204474915,3.795221212,0.000147512,0.006267677,LOC110050660,4,4_LOC110050660,LOC110050660,"acyl-coenzyme A synthetase ACSM4, mitochondrial-like", C_PE_H_C_EE_H
408,8.777416147,16.05795532,4.903493563,3.274798898,0.001057372,0.04118309,LOC110042472,1,1_LOC110042472,LOC110042472,uncharacterized LOC110042472, C_EE_H_D_EE_H
950,12.93200831,16.12706102,2.916390835,5.529801022,3.21E-08,1.87E-06,LOC110062882,4,4_LOC110062882,LOC110062882,uncharacterized WD repeat-containing protein alr3466-like, C_PE_H_C_EE_H
370,13.23355501,16.15589607,4.57460028,3.531651966,0.000412972,0.017736611,LOC110059938,1,1_LOC110059938,LOC110059938,uncharacterized LOC110059938, C_EE_H_D_EE_H
280,15.11030033,16.17768486,3.895197945,4.153238188,3.28E-05,0.0018604,LOC110064761,1,1_LOC110064761,LOC110064761,"G patch domain and KOW motifs-containing protein-like, transcript variant X2", C_EE_H_D_EE_H
371,10.96011573,16.37663369,4.638689381,3.530444128,0.000414863,0.017769763,LOC110046642,1,1_LOC110046642,LOC110046642,"metalloproteinase inhibitor 2-like, transcript variant X1", C_EE_H_D_EE_H
650,2.921313349,16.38951511,4.832559997,3.3914768,0.00069517,0.050907623,LOC110067369,2,2_LOC110067369,LOC110067369,N-acetylated-alpha-linked acidic dipeptidase 2-like, D_EE_D_D_EE_H
637,8.489802959,16.39614313,4.239781206,3.867214446,0.000110086,0.008575346,LOC110043027,2,2_LOC110043027,LOC110043027,"sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X2", D_EE_D_D_EE_H
593,11.13397527,16.45792729,3.375425265,4.875808527,1.08E-06,0.000107625,LOC110057480,2,2_LOC110057480,LOC110057480,uncharacterized LOC110057480, D_EE_D_D_EE_H
1013,8.045414352,16.49433535,3.571981991,4.61769835,3.88E-06,0.00018406,LOC110056436,4,4_LOC110056436,LOC110056436,neuromedin-K receptor-like, C_PE_H_C_EE_H
906,10.18146535,16.51276731,2.764049147,5.974122178,2.31E-09,1.61E-07,LOC110049938,4,4_LOC110049938,LOC110049938,polypeptide N-acetylgalactosaminyltransferase 1-like, C_PE_H_C_EE_H
353,13.36534141,16.5161566,4.519273146,3.654604639,0.000257579,0.011650604,LOC110039728,1,1_LOC110039728,LOC110039728,protein DD3-3-like, C_EE_H_D_EE_H
631,10.10645099,16.60373254,4.130835488,4.019461095,5.83E-05,0.004681538,LOC110067349,2,2_LOC110067349,LOC110067349,"uncharacterized LOC110067349, transcript variant X1", D_EE_D_D_EE_H
376,11.80255635,16.61794772,4.749524966,3.498865222,0.000467243,0.019747217,LOC110042185,1,1_LOC110042185,LOC110042185,uncharacterized LOC110042185, C_EE_H_D_EE_H
340,8.409779626,16.61795894,4.49876878,3.693890429,0.000220849,0.010322092,LOC110063979,1,1_LOC110063979,LOC110063979,somatostatin receptor type 5-like, C_EE_H_D_EE_H
257,12.53832212,16.62306324,3.901308901,4.260893885,2.04E-05,0.001259807,LOC110065909,1,1_LOC110065909,LOC110065909,"diencephalon/mesencephalon homeobox protein 1-B-like, transcript variant X1", C_EE_H_D_EE_H
333,17.17787919,16.85191339,4.493901132,3.749951968,0.000176868,0.00844029,LOC110069424,1,1_LOC110069424,LOC110069424,AMMECR1-like protein, C_EE_H_D_EE_H
1025,6.72767411,16.96003679,3.998371422,4.241736196,2.22E-05,0.001015729,LOC110067434,4,4_LOC110067434,LOC110067434,adenosine receptor A2a-like, C_PE_H_C_EE_H
364,9.60074948,17.1699852,4.831383889,3.553844115,0.000379644,0.016573971,LOC110045559,1,1_LOC110045559,LOC110045559,uncharacterized LOC110045559, C_EE_H_D_EE_H
628,10.98662821,17.24937543,4.191298908,4.115520226,3.86E-05,0.003148106,LOC110064594,2,2_LOC110064594,LOC110064594,"uncharacterized LOC110064594, transcript variant X1", D_EE_D_D_EE_H
644,7.104425272,17.39648108,4.845288441,3.59039122,0.000330182,0.02486693,LOC110049075,2,2_LOC110049075,LOC110049075,probable alpha-ketoglutarate-dependent hypophosphite dioxygenase, D_EE_D_D_EE_H
278,15.3558239,17.43613666,4.187124387,4.164227056,3.12E-05,0.001785789,LOC110065290,1,1_LOC110065290,LOC110065290,octopamine receptor-like, C_EE_H_D_EE_H
607,8.698248359,17.47532517,3.826422799,4.567013655,4.95E-06,0.000451817,LOC110047176,2,2_LOC110047176,LOC110047176,uncharacterized LOC110047176, D_EE_D_D_EE_H
625,12.94699175,17.52907541,4.229970722,4.144018143,3.41E-05,0.002824565,LOC110044614,2,2_LOC110044614,LOC110044614,"E3 ubiquitin-protein ligase MIB2-like, transcript variant X4", D_EE_D_D_EE_H
285,25.59595167,17.65069543,4.278279286,4.125652919,3.70E-05,0.002061283,LOC110050932,1,1_LOC110050932,LOC110050932,"gelsolin-like protein 2, transcript variant X2", C_EE_H_D_EE_H
403,14.29591687,17.72096254,5.36321715,3.304166519,0.000952592,0.037562394,LOC110055348,1,1_LOC110055348,LOC110055348,"golgin subfamily A member 6-like protein 6, transcript variant X2", C_EE_H_D_EE_H
354,6.708704036,17.73535395,4.867915427,3.643315956,0.000269148,0.012082013,LOC110043216,1,1_LOC110043216,LOC110043216,"calcium-binding protein P-like, transcript variant X2", C_EE_H_D_EE_H
237,15.53862406,17.76313856,4.033002036,4.40444572,1.06E-05,0.000711103,LOC110066055,1,1_LOC110066055,LOC110066055,tumor necrosis factor receptor superfamily member 1A-like, C_EE_H_D_EE_H
352,19.81314115,17.77114396,4.863388107,3.654066582,0.000258119,0.011650604,LOC110056301,1,1_LOC110056301,LOC110056301,UNC93-like protein MFSD11, C_EE_H_D_EE_H
329,14.41695048,17.80048921,4.708820596,3.780243662,0.000156675,0.007567543,LOC110048955,1,1_LOC110048955,LOC110048955,trace amine-associated receptor 8b-like, C_EE_H_D_EE_H
635,27.5389078,17.8081275,4.529576854,3.931521216,8.44E-05,0.006640396,LOC110043600,2,2_LOC110043600,LOC110043600,uncharacterized LOC110043600, D_EE_D_D_EE_H
305,19.09743479,17.86048091,4.483065195,3.983988664,6.78E-05,0.003532037,LOC110065512,1,1_LOC110065512,LOC110065512,lipase member K-like, C_EE_H_D_EE_H
186,11.13397527,17.92319012,3.708989714,4.832364471,1.35E-06,0.00011527,LOC110057480,1,1_LOC110057480,LOC110057480,uncharacterized LOC110057480, C_EE_H_D_EE_H
645,13.75850134,17.94754204,5.022408686,3.573492952,0.000352251,0.026403851,LOC110062864,2,2_LOC110062864,LOC110062864,acyl-lipid (8-3)-desaturase-like, D_EE_D_D_EE_H
618,13.23355501,17.97305536,4.118263382,4.364231641,1.28E-05,0.001099824,LOC110059938,2,2_LOC110059938,LOC110059938,uncharacterized LOC110059938, D_EE_D_D_EE_H
87,31.10071365,18.0155287,3.121742821,5.770984265,7.88E-09,1.44E-06,LOC110055642,1,1_LOC110055642,LOC110055642,uncharacterized LOC110055642, C_EE_H_D_EE_H
157,17.71870674,18.01750909,3.567120586,5.050995237,4.40E-07,4.46E-05,LOC110066675,1,1_LOC110066675,LOC110066675,uncharacterized LOC110066675, C_EE_H_D_EE_H
115,28.61278433,18.05972429,3.34030669,5.406606627,6.42E-08,8.88E-06,LOC110043387,1,1_LOC110043387,LOC110043387,uncharacterized LOC110043387, C_EE_H_D_EE_H
617,16.83773704,18.07756115,4.142971225,4.363429088,1.28E-05,0.001099824,LOC110056255,2,2_LOC110056255,LOC110056255,uncharacterized LOC110056255, D_EE_D_D_EE_H
649,8.766399701,18.20738019,5.269819475,3.455029205,0.000550233,0.040480352,LOC110067882,2,2_LOC110067882,LOC110067882,"TNF receptor-associated factor 4-like, transcript variant X2", D_EE_D_D_EE_H
652,3.926380318,18.22647697,5.440703499,3.350022101,0.000808051,0.058633518,LOC110069365,2,2_LOC110069365,LOC110069365,uncharacterized LOC110069365, D_EE_D_D_EE_H
616,10.96011573,18.27602158,4.176201161,4.376231143,1.21E-05,0.001048537,LOC110046642,2,2_LOC110046642,LOC110046642,"metalloproteinase inhibitor 2-like, transcript variant X1", D_EE_D_D_EE_H
401,13.75850134,18.37325279,5.552204213,3.309181738,0.000935691,0.037079956,LOC110062864,1,1_LOC110062864,LOC110062864,acyl-lipid (8-3)-desaturase-like, C_EE_H_D_EE_H
367,7.608070482,18.46858654,5.212600988,3.543065465,0.000395505,0.017078701,LOC110064465,1,1_LOC110064465,LOC110064465,uncharacterized LOC110064465, C_EE_H_D_EE_H
348,16.84589926,18.55853,5.043209244,3.679904819,0.000233321,0.010670958,LOC110064011,1,1_LOC110064011,LOC110064011,furin-like, C_EE_H_D_EE_H
600,51.97633798,18.57116291,3.871818062,4.796496791,1.61E-06,0.000153643,LOC110055756,2,2_LOC110055756,LOC110055756,coadhesin-like, D_EE_D_D_EE_H
130,35.97919054,18.68229985,3.524804598,5.30023703,1.16E-07,1.41E-05,LOC110050669,1,1_LOC110050669,LOC110050669,uncharacterized LOC110050669, C_EE_H_D_EE_H
542,19.30995455,18.70501403,3.187532675,5.868179541,4.41E-09,6.42E-07,LOC110040924,2,2_LOC110040924,LOC110040924,high affinity cationic amino acid transporter 1-like, D_EE_D_D_EE_H
192,20.50153069,18.7520165,3.93487933,4.765588707,1.88E-06,0.00015585,LOC110059810,1,1_LOC110059810,LOC110059810,uncharacterized LOC110059810, C_EE_H_D_EE_H
624,12.85238276,18.78500604,4.492695045,4.18123328,2.90E-05,0.002412206,LOC110063037,2,2_LOC110063037,LOC110063037,"uncharacterized LOC110063037, transcript variant X1", D_EE_D_D_EE_H
929,7.133819651,18.84165739,3.28218589,5.740582046,9.44E-09,5.95E-07,LOC110043870,4,4_LOC110043870,LOC110043870,uncharacterized N-acetyltransferase YitH-like, C_PE_H_C_EE_H
641,3.791031949,18.89238662,5.09213732,3.710109417,0.00020717,0.015827565,LOC110055700,2,2_LOC110055700,LOC110055700,AAC-rich mRNA clone AAC4 protein-like, D_EE_D_D_EE_H
170,18.49680895,18.94504309,3.824329996,4.953820176,7.28E-07,6.80E-05,LOC110039847,1,1_LOC110039847,LOC110039847,uncharacterized LOC110039847, C_EE_H_D_EE_H
425,8.643826804,18.95982784,6.1787839,3.068537133,0.002151096,0.080388726,LOC110068152,1,1_LOC110068152,LOC110068152,hemicentin-2-like, C_EE_H_D_EE_H
787,18.57487131,18.97124998,2.552714366,7.431795048,1.07E-13,1.55E-11,LOC110060588,4,4_LOC110060588,LOC110060588,"prolactin-releasing peptide receptor-like, transcript variant X2", C_PE_H_C_EE_H
651,2.706014578,19.13317836,5.677141373,3.370213475,0.0007511,0.054751035,LOC110068608,2,2_LOC110068608,LOC110068608,acetylserotonin O-methyltransferase-like, D_EE_D_D_EE_H
647,10.02627736,19.18046264,5.499790742,3.487489532,0.000487578,0.036206085,LOC110046269,2,2_LOC110046269,LOC110046269,potassium voltage-gated channel subfamily D member 3-like, D_EE_D_D_EE_H
586,12.66987494,19.22874516,3.816177442,5.038745041,4.69E-07,4.87E-05,LOC110068705,2,2_LOC110068705,LOC110068705,uncharacterized LOC110068705, D_EE_D_D_EE_H
630,7.608070482,19.27551409,4.715115567,4.088025801,4.35E-05,0.003509409,LOC110064465,2,2_LOC110064465,LOC110064465,uncharacterized LOC110064465, D_EE_D_D_EE_H
570,10.17563034,19.28040019,3.673099554,5.249081846,1.53E-07,1.77E-05,LOC110040722,2,2_LOC110040722,LOC110040722,"beta-1,4-N-acetylgalactosaminyltransferase 3-like", D_EE_D_D_EE_H
194,14.61092707,19.28420509,4.049407886,4.762228365,1.91E-06,0.000157057,LOC110053846,1,1_LOC110053846,LOC110053846,endoribonuclease Dicer-like, C_EE_H_D_EE_H
582,10.68478928,19.28716167,3.780553381,5.101676851,3.37E-07,3.59E-05,LOC110059740,2,2_LOC110059740,LOC110059740,kelch-like protein 25, D_EE_D_D_EE_H
509,15.70760917,19.2994687,2.9906158,6.45334272,1.09E-10,2.27E-08,LOC110064912,2,2_LOC110064912,LOC110064912,protein transport protein Sec23A-like, D_EE_D_D_EE_H
629,13.88804404,19.33390202,4.727831836,4.089380226,4.33E-05,0.003506782,LOC110064312,2,2_LOC110064312,LOC110064312,uncharacterized LOC110064312, D_EE_D_D_EE_H
208,21.19740694,19.33447783,4.136500578,4.674114622,2.95E-06,0.000225549,LOC110053069,1,1_LOC110053069,LOC110053069,E3 ubiquitin-protein ligase rnf213-alpha-like, C_EE_H_D_EE_H
155,26.76592727,19.34160861,3.804307081,5.084134428,3.69E-07,3.79E-05,LOC110062626,1,1_LOC110062626,LOC110062626,suppressor protein SRP40-like, C_EE_H_D_EE_H
311,20.50363394,19.40211917,4.91304448,3.949103097,7.84E-05,0.00400824,LOC110056626,1,1_LOC110056626,LOC110056626,uncharacterized LOC110056626, C_EE_H_D_EE_H
1010,6.040606979,19.40294763,4.127695524,4.700673175,2.59E-06,0.000124115,LOC110042143,4,4_LOC110042143,LOC110042143,uncharacterized LOC110042143, C_PE_H_C_EE_H
546,12.71140828,19.43727685,3.36283208,5.780031944,7.47E-09,1.05E-06,LOC110058382,2,2_LOC110058382,LOC110058382,forkhead box protein J3-like, D_EE_D_D_EE_H
610,5.659298806,19.47406359,4.340600144,4.486491025,7.24E-06,0.000647043,LOC110055294,2,2_LOC110055294,LOC110055294,uncharacterized LOC110055294, D_EE_D_D_EE_H
139,22.51537619,19.53096063,3.754067839,5.202612598,1.97E-07,2.25E-05,LOC110047380,1,1_LOC110047380,LOC110047380,collagen alpha-2(IX) chain-like, C_EE_H_D_EE_H
609,9.019018878,19.53436174,4.300016607,4.542857277,5.55E-06,0.00050108,LOC110044004,2,2_LOC110044004,LOC110044004,"DAZ protein 1-like, transcript variant X2", D_EE_D_D_EE_H
535,17.71870674,19.53445327,3.233212601,6.041809086,1.52E-09,2.37E-07,LOC110066675,2,2_LOC110066675,LOC110066675,uncharacterized LOC110066675, D_EE_D_D_EE_H
643,37.57959409,19.55743825,5.369431326,3.642366773,0.000270143,0.020442091,LOC110060083,2,2_LOC110060083,LOC110060083,uncharacterized LOC110060083, D_EE_D_D_EE_H
163,17.15070632,19.55978734,3.905915223,5.007734737,5.51E-07,5.37E-05,LOC110059708,1,1_LOC110059708,LOC110059708,"WD repeat-containing protein 59-like, transcript variant X1", C_EE_H_D_EE_H
572,12.83289327,19.59173078,3.737745014,5.24159104,1.59E-07,1.82E-05,LOC110065341,2,2_LOC110065341,LOC110065341,COMM domain-containing protein 6-like, D_EE_D_D_EE_H
655,104.9632647,19.6029253,6.039596324,3.245734359,0.001171481,0.083855874,LOC110055865,2,2_LOC110055865,LOC110055865,uncharacterized LOC110055865, D_EE_D_D_EE_H
613,6.708704036,19.64839032,4.398397754,4.467169961,7.93E-06,0.000699744,LOC110043216,2,2_LOC110043216,LOC110043216,"calcium-binding protein P-like, transcript variant X2", D_EE_D_D_EE_H
622,6.422965324,19.69597285,4.685326104,4.203757093,2.63E-05,0.002207257,LOC110062662,2,2_LOC110062662,LOC110062662,"sodium- and chloride-dependent taurine transporter-like, transcript variant X1", D_EE_D_D_EE_H
569,16.66138526,19.73065832,3.698386258,5.33493717,9.56E-08,1.12E-05,LOC110069339,2,2_LOC110069339,LOC110069339,dickkopf-related protein 3-like, D_EE_D_D_EE_H
103,24.1519551,19.7603744,3.571231313,5.533210446,3.14E-08,4.85E-06,LOC110046180,1,1_LOC110046180,LOC110046180,"PP2C-like domain-containing protein CG9801, transcript variant X3", C_EE_H_D_EE_H
591,19.09743479,19.79154487,4.052248077,4.884090138,1.04E-06,0.000104506,LOC110065512,2,2_LOC110065512,LOC110065512,lipase member K-like, D_EE_D_D_EE_H
551,18.49680895,19.80990852,3.470536543,5.708024762,1.14E-08,1.54E-06,LOC110039847,2,2_LOC110039847,LOC110039847,uncharacterized LOC110039847, D_EE_D_D_EE_H
297,14.81595733,19.81528648,4.915447664,4.031227232,5.55E-05,0.00297141,LOC110050671,1,1_LOC110050671,LOC110050671,5-hydroxytryptamine receptor 1-like, C_EE_H_D_EE_H
1056,4.46512948,19.82113601,5.283709804,3.751367268,0.000175873,0.007393639,LOC110069676,4,4_LOC110069676,LOC110069676,uncharacterized LOC110069676, C_PE_H_C_EE_H
946,5.891946803,19.82153617,3.558069639,5.570867964,2.53E-08,1.50E-06,LOC110046774,4,4_LOC110046774,LOC110046774,uncharacterized LOC110046774, C_PE_H_C_EE_H
180,14.50134025,19.84694086,4.082091993,4.861953355,1.16E-06,0.000102614,LOC110041370,1,1_LOC110041370,LOC110041370,"potassium voltage-gated channel subfamily C member 4-like, transcript variant X2", C_EE_H_D_EE_H
217,17.35241842,19.85729414,4.291122838,4.627528712,3.70E-06,0.000270993,LOC110057527,1,1_LOC110057527,LOC110057527,transient receptor potential cation channel subfamily M member 6-like, C_EE_H_D_EE_H
999,8.437325109,19.87547562,4.088801939,4.860953383,1.17E-06,5.78E-05,LOC110065112,4,4_LOC110065112,LOC110065112,uncharacterized LOC110065112, C_PE_H_C_EE_H
598,7.809990283,19.88990047,4.138918878,4.805578717,1.54E-06,0.000147714,LOC110043460,2,2_LOC110043460,LOC110043460,uncharacterized LOC110043460, D_EE_D_D_EE_H
614,12.66584057,19.89113338,4.484895438,4.435138712,9.20E-06,0.000807834,LOC110065127,2,2_LOC110065127,LOC110065127,uncharacterized LOC110065127, D_EE_D_D_EE_H
520,29.30322637,19.90736987,3.180816616,6.258572019,3.89E-10,7.09E-08,LOC110057003,2,2_LOC110057003,LOC110057003,uncharacterized LOC110057003, D_EE_D_D_EE_H
990,11.10423024,19.9319624,4.018229548,4.960384209,7.04E-07,3.58E-05,LOC110055402,4,4_LOC110055402,LOC110055402,uncharacterized LOC110055402, C_PE_H_C_EE_H
611,16.13198844,19.93926716,4.444498412,4.486280636,7.25E-06,0.000647043,LOC110055566,2,2_LOC110055566,LOC110055566,uncharacterized LOC110055566, D_EE_D_D_EE_H
587,10.35047735,19.94288934,3.992343602,4.995283804,5.87E-07,6.06E-05,LOC110043607,2,2_LOC110043607,LOC110043607,"proprotein convertase subtilisin/kexin type 5-like, transcript variant X1", D_EE_D_D_EE_H
623,4.865835173,19.95245709,4.765339401,4.186996018,2.83E-05,0.002364169,LOC110062817,2,2_LOC110062817,LOC110062817,protein angel homolog 2-like, D_EE_D_D_EE_H
568,16.23558033,19.98806488,3.719125806,5.374398694,7.68E-08,9.04E-06,LOC110060582,2,2_LOC110060582,LOC110060582,uncharacterized LOC110060582, D_EE_D_D_EE_H
809,17.50998221,19.99412972,2.838656327,7.043518983,1.87E-12,2.27E-10,LOC110041239,4,4_LOC110041239,LOC110041239,progestin and adipoQ receptor family member 3-like, C_PE_H_C_EE_H
646,4.422355058,20.02911097,5.732598023,3.493897687,0.000476023,0.035514028,LOC110043946,2,2_LOC110043946,LOC110043946,melanocortin receptor 4-like, D_EE_D_D_EE_H
534,28.17024991,20.04021959,3.294439381,6.083043964,1.18E-09,1.87E-07,LOC110069580,2,2_LOC110069580,LOC110069580,carbonic anhydrase 2-like, D_EE_D_D_EE_H
640,4.834566572,20.04740322,5.398240614,3.713692045,0.000204257,0.01568045,LOC110056049,2,2_LOC110056049,LOC110056049,uncharacterized LOC110056049, D_EE_D_D_EE_H
578,16.38703873,20.17074487,3.908753256,5.160403727,2.46E-07,2.70E-05,LOC110051767,2,2_LOC110051767,LOC110051767,protein PRY1-like, D_EE_D_D_EE_H
543,18.41501641,20.21470072,3.458476029,5.844973494,5.07E-09,7.32E-07,LOC110042683,2,2_LOC110042683,LOC110042683,uncharacterized LOC110042683, D_EE_D_D_EE_H
268,5.659298806,20.2198912,4.789902275,4.221357774,2.43E-05,0.001439886,LOC110055294,1,1_LOC110055294,LOC110055294,uncharacterized LOC110055294, C_EE_H_D_EE_H
573,12.66128106,20.22756352,3.864415856,5.234313355,1.66E-07,1.88E-05,LOC110040598,2,2_LOC110040598,LOC110040598,"E3 ubiquitin-protein ligase TRIM71-like, transcript variant X3", D_EE_D_D_EE_H
896,14.936548,20.25182855,3.298084233,6.14048251,8.23E-10,6.00E-08,LOC110043368,4,4_LOC110043368,LOC110043368,amiloride-sensitive sodium channel subunit alpha-like, C_PE_H_C_EE_H
286,12.66584057,20.25546468,4.951227429,4.09099864,4.30E-05,0.002386537,LOC110065127,1,1_LOC110065127,LOC110065127,uncharacterized LOC110065127, C_EE_H_D_EE_H
632,9.275541007,20.2664567,5.062520571,4.003234439,6.25E-05,0.004989481,LOC110050042,2,2_LOC110050042,LOC110050042,uncharacterized LOC110050042, D_EE_D_D_EE_H
565,12.9046043,20.2688708,3.708982945,5.46480561,4.63E-08,5.58E-06,LOC110051046,2,2_LOC110051046,LOC110051046,"sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like", D_EE_D_D_EE_H
531,26.79313831,20.29516468,3.325821159,6.102301871,1.05E-09,1.70E-07,LOC110051805,2,2_LOC110051805,LOC110051805,"leukocyte tyrosine kinase receptor-like, transcript variant X2", D_EE_D_D_EE_H
639,6.775119134,20.29899225,5.381902268,3.771713279,0.00016213,0.012506872,LOC110057057,2,2_LOC110057057,LOC110057057,contactin-associated protein-like 3, D_EE_D_D_EE_H
648,5.378383318,20.32660325,5.852748824,3.473001124,0.000514673,0.038040334,LOC110050985,2,2_LOC110050985,LOC110050985,arrestin domain-containing protein 4-like, D_EE_D_D_EE_H
336,8.010204096,20.33132008,5.45569272,3.726624854,0.000194061,0.009178044,LOC110068593,1,1_LOC110068593,LOC110068593,inactive serine protease 35-like, C_EE_H_D_EE_H
538,13.1307331,20.35353003,3.441378109,5.91435448,3.33E-09,5.01E-07,LOC110062180,2,2_LOC110062180,LOC110062180,"uncharacterized LOC110062180, transcript variant X1", D_EE_D_D_EE_H
567,15.3558239,20.35509064,3.784226058,5.378930944,7.49E-08,8.89E-06,LOC110065290,2,2_LOC110065290,LOC110065290,octopamine receptor-like, D_EE_D_D_EE_H
642,4.826460359,20.37249249,5.553419641,3.668459041,0.000244017,0.018553448,LOC110050660,2,2_LOC110050660,LOC110050660,"acyl-coenzyme A synthetase ACSM4, mitochondrial-like", D_EE_D_D_EE_H
518,12.62913837,20.37329688,3.221705125,6.323762135,2.55E-10,4.77E-08,LOC110066999,2,2_LOC110066999,LOC110066999,gamma-glutamyltranspeptidase 1-like, D_EE_D_D_EE_H
627,8.010204096,20.37461034,4.937485092,4.126515818,3.68E-05,0.003016838,LOC110068593,2,2_LOC110068593,LOC110068593,inactive serine protease 35-like, D_EE_D_D_EE_H
588,10.69939259,20.38450978,4.147211329,4.915232952,8.87E-07,9.03E-05,LOC110052494,2,2_LOC110052494,LOC110052494,deubiquitinating protein VCIP135-like, D_EE_D_D_EE_H
122,18.41501641,20.38846282,3.806257282,5.356564549,8.48E-08,1.10E-05,LOC110042683,1,1_LOC110042683,LOC110042683,uncharacterized LOC110042683, C_EE_H_D_EE_H
510,31.30692371,20.41936818,3.16466615,6.452297718,1.10E-10,2.27E-08,LOC110048964,2,2_LOC110048964,LOC110048964,putative helicase MOV-10, D_EE_D_D_EE_H
530,19.75307584,20.44353373,3.348618563,6.105064925,1.03E-09,1.68E-07,LOC110065588,2,2_LOC110065588,LOC110065588,uncharacterized LOC110065588, D_EE_D_D_EE_H
634,8.153200257,20.45404601,5.175036239,3.952444982,7.74E-05,0.006115799,LOC110047970,2,2_LOC110047970,LOC110047970,"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A-like", D_EE_D_D_EE_H
165,16.23558033,20.46067928,4.096799874,4.994307731,5.90E-07,5.69E-05,LOC110060582,1,1_LOC110060582,LOC110060582,uncharacterized LOC110060582, C_EE_H_D_EE_H
664,4.390519646,20.47103429,3.210633111,6.376011704,1.82E-10,3.61E-07,LOC110067499,3,3_LOC110067499,LOC110067499,uncharacterized LOC110067499, C_PE_D_D_EE_D
243,17.2539615,20.47762588,4.68502013,4.370872549,1.24E-05,0.000809271,LOC110052780,1,1_LOC110052780,LOC110052780,"GPI mannosyltransferase 4-like, transcript variant X2", C_EE_H_D_EE_H
620,15.36182138,20.47822456,4.740700913,4.319661783,1.56E-05,0.001327948,LOC110055732,2,2_LOC110055732,LOC110055732,uncharacterized LOC110055732, D_EE_D_D_EE_H
350,9.275541007,20.49199484,5.594543708,3.66285365,0.000249421,0.011324428,LOC110050042,1,1_LOC110050042,LOC110050042,uncharacterized LOC110050042, C_EE_H_D_EE_H
612,10.14673643,20.49772848,4.571831116,4.483483305,7.34E-06,0.000651925,LOC110039960,2,2_LOC110039960,LOC110039960,protein DENND6A-like, D_EE_D_D_EE_H
590,9.247212147,20.50641873,4.184120121,4.901010997,9.53E-07,9.65E-05,LOC110040899,2,2_LOC110040899,LOC110040899,uncharacterized LOC110040899, D_EE_D_D_EE_H
526,14.03851299,20.51643313,3.330618805,6.159946344,7.28E-10,1.24E-07,LOC110067916,2,2_LOC110067916,LOC110067916,peptidase M20 domain-containing protein 2-like, D_EE_D_D_EE_H
606,14.66966247,20.51987224,4.379259494,4.685694527,2.79E-06,0.000256288,LOC110062846,2,2_LOC110062846,LOC110062846,"protein MAK16 homolog, transcript variant X4", D_EE_D_D_EE_H
585,13.68212169,20.5214916,4.060382012,5.054079035,4.32E-07,4.52E-05,LOC110068832,2,2_LOC110068832,LOC110068832,kelch-like protein 5, D_EE_D_D_EE_H
597,17.2539615,20.54366687,4.245847302,4.838531725,1.31E-06,0.000126742,LOC110052780,2,2_LOC110052780,LOC110052780,"GPI mannosyltransferase 4-like, transcript variant X2", D_EE_D_D_EE_H
604,9.60074948,20.54403885,4.359245877,4.712750652,2.44E-06,0.000227116,LOC110045559,2,2_LOC110045559,LOC110045559,uncharacterized LOC110045559, D_EE_D_D_EE_H
505,21.57230762,20.56372747,3.15194285,6.524143505,6.84E-11,1.51E-08,LOC110068067,2,2_LOC110068067,LOC110068067,deleted in malignant brain tumors 1 protein-like, D_EE_D_D_EE_H
524,22.66275868,20.56620968,3.30634006,6.220234249,4.96E-10,8.67E-08,LOC110046035,2,2_LOC110046035,LOC110046035,"collagen alpha-1(XII) chain-like, transcript variant X2", D_EE_D_D_EE_H
1015,15.16582212,20.57984276,4.484738136,4.588861631,4.46E-06,0.000210152,LOC110068145,4,4_LOC110068145,LOC110068145,uncharacterized LOC110068145, C_PE_H_C_EE_H
407,2.706014578,20.58203453,6.277340456,3.278782579,0.001042559,0.04070592,LOC110068608,1,1_LOC110068608,LOC110068608,acetylserotonin O-methyltransferase-like, C_EE_H_D_EE_H
383,4.834566572,20.58381925,5.96789443,3.449092388,0.000562474,0.02333754,LOC110056049,1,1_LOC110056049,LOC110056049,uncharacterized LOC110056049, C_EE_H_D_EE_H
580,18.04025383,20.6163825,4.022885931,5.124774316,2.98E-07,3.22E-05,LOC110050267,2,2_LOC110050267,LOC110050267,dopamine receptor 2-like, D_EE_D_D_EE_H
158,13.92454557,20.63585512,4.092548148,5.042299901,4.60E-07,4.63E-05,LOC110065139,1,1_LOC110065139,LOC110065139,"substance-K receptor-like, transcript variant X2", C_EE_H_D_EE_H
516,24.1519551,20.66849127,3.246867016,6.365672252,1.94E-10,3.72E-08,LOC110046180,2,2_LOC110046180,LOC110046180,"PP2C-like domain-containing protein CG9801, transcript variant X3", D_EE_D_D_EE_H
44,38.49161237,20.67216773,3.29617905,6.271554856,3.57E-10,1.29E-07,LOC110039944,1,1_LOC110039944,LOC110039944,uncharacterized LOC110039944, C_EE_H_D_EE_H
575,8.540799667,20.68232224,3.976820519,5.200718046,1.99E-07,2.22E-05,LOC110056841,2,2_LOC110056841,LOC110056841,uncharacterized LOC110056841, D_EE_D_D_EE_H
92,22.66275868,20.71431405,3.635072941,5.69845898,1.21E-08,2.09E-06,LOC110046035,1,1_LOC110046035,LOC110046035,"collagen alpha-1(XII) chain-like, transcript variant X2", C_EE_H_D_EE_H
32,29.01677855,20.73180607,3.207959892,6.462613864,1.03E-10,5.11E-08,LOC110059474,1,1_LOC110059474,LOC110059474,carboxypeptidase B-like, C_EE_H_D_EE_H
636,6.513248605,20.74105108,5.284867521,3.924611354,8.69E-05,0.006800242,LOC110056449,2,2_LOC110056449,LOC110056449,uncharacterized LOC110056449, D_EE_D_D_EE_H
541,16.25597994,20.7427939,3.533676681,5.870031633,4.36E-09,6.41E-07,LOC110044207,2,2_LOC110044207,LOC110044207,uncharacterized LOC110044207, D_EE_D_D_EE_H
365,6.513248605,20.75719343,5.842006514,3.553093167,0.00038073,0.016575819,LOC110056449,1,1_LOC110056449,LOC110056449,uncharacterized LOC110056449, C_EE_H_D_EE_H
341,3.791031949,20.76102887,5.625694923,3.690393658,0.000223907,0.0103735,LOC110055700,1,1_LOC110055700,LOC110055700,AAC-rich mRNA clone AAC4 protein-like, C_EE_H_D_EE_H
561,15.30905733,20.76862748,3.724464502,5.576272098,2.46E-08,3.05E-06,LOC110058385,2,2_LOC110058385,LOC110058385,uncharacterized LOC110058385, D_EE_D_D_EE_H
594,11.80255635,20.77136969,4.276432158,4.857172738,1.19E-06,0.000117528,LOC110042185,2,2_LOC110042185,LOC110042185,uncharacterized LOC110042185, D_EE_D_D_EE_H
224,16.83773704,20.7834377,4.565480452,4.552300227,5.31E-06,0.000376436,LOC110056255,1,1_LOC110056255,LOC110056255,uncharacterized LOC110056255, C_EE_H_D_EE_H
242,15.96642883,20.78494695,4.729663251,4.394593409,1.11E-05,0.000729524,LOC110066243,1,1_LOC110066243,LOC110066243,"REST corepressor 3-like, transcript variant X2", C_EE_H_D_EE_H
638,24.02258658,20.79076138,5.488096826,3.788337203,0.000151659,0.011756156,LOC110040087,2,2_LOC110040087,LOC110040087,uncharacterized LOC110040087, D_EE_D_D_EE_H
76,19.30995455,20.79333752,3.499883424,5.941151461,2.83E-09,5.92E-07,LOC110040924,1,1_LOC110040924,LOC110040924,high affinity cationic amino acid transporter 1-like, C_EE_H_D_EE_H
581,16.76791595,20.79812462,4.065143979,5.116208608,3.12E-07,3.35E-05,LOC110061052,2,2_LOC110061052,LOC110061052,cytosolic phospholipase A2-like, D_EE_D_D_EE_H
552,16.63268319,20.81124823,3.652526595,5.697767746,1.21E-08,1.62E-06,LOC110048190,2,2_LOC110048190,LOC110048190,uncharacterized LOC110048190, D_EE_D_D_EE_H
553,14.61092707,20.83010395,3.673406845,5.670513731,1.42E-08,1.89E-06,LOC110053846,2,2_LOC110053846,LOC110053846,endoribonuclease Dicer-like, D_EE_D_D_EE_H
413,5.378383318,20.85406095,6.473485299,3.221457991,0.001275402,0.049073624,LOC110050985,1,1_LOC110050985,LOC110050985,arrestin domain-containing protein 4-like, C_EE_H_D_EE_H
36,57.05291101,20.85924537,3.260492298,6.397575417,1.58E-10,6.83E-08,LOC110055245,1,1_LOC110055245,LOC110055245,"uncharacterized LOC110055245, transcript variant X1", C_EE_H_D_EE_H
247,50.63163942,20.87298406,4.822174875,4.328541499,1.50E-05,0.000965684,LOC110041679,1,1_LOC110041679,LOC110041679,"uncharacterized LOC110041679, transcript variant X1", C_EE_H_D_EE_H
498,14.38545185,20.87976382,3.074225542,6.791877673,1.11E-11,2.71E-09,LOC110057721,2,2_LOC110057721,LOC110057721,zinc finger protein 345-like, D_EE_D_D_EE_H
315,2.921313349,20.91019976,5.325438472,3.926474763,8.62E-05,0.004338846,LOC110067369,1,1_LOC110067369,LOC110067369,N-acetylated-alpha-linked acidic dipeptidase 2-like, C_EE_H_D_EE_H
592,15.96642883,20.91134328,4.286058468,4.87892161,1.07E-06,0.000106607,LOC110066243,2,2_LOC110066243,LOC110066243,"REST corepressor 3-like, transcript variant X2", D_EE_D_D_EE_H
73,29.30322637,20.91692202,3.494020843,5.98649034,2.14E-09,4.67E-07,LOC110057003,1,1_LOC110057003,LOC110057003,uncharacterized LOC110057003, C_EE_H_D_EE_H
221,7.809990283,20.91937369,4.564622737,4.582935961,4.58E-06,0.000329679,LOC110043460,1,1_LOC110043460,LOC110043460,uncharacterized LOC110043460, C_EE_H_D_EE_H
179,16.38703873,20.98590053,4.307979439,4.871402203,1.11E-06,9.84E-05,LOC110051767,1,1_LOC110051767,LOC110051767,protein PRY1-like, C_EE_H_D_EE_H
605,185.7638508,21.00973658,4.479443198,4.690256278,2.73E-06,0.000252097,LOC110060064,2,2_LOC110060064,LOC110060064,uncharacterized LOC110060064, D_EE_D_D_EE_H
560,11.78790043,21.03259576,3.768734519,5.580811187,2.39E-08,3.00E-06,LOC110063912,2,2_LOC110063912,LOC110063912,endochitinase A1-like, D_EE_D_D_EE_H
571,14.29259256,21.03514499,4.009772539,5.245969636,1.55E-07,1.79E-05,LOC110063939,2,2_LOC110063939,LOC110063939,uncharacterized LOC110063939, D_EE_D_D_EE_H
492,23.31206471,21.03687864,3.047332114,6.903375756,5.08E-12,1.37E-09,LOC110063784,2,2_LOC110063784,LOC110063784,uncharacterized LOC110063784, D_EE_D_D_EE_H
47,21.36002077,21.03904475,3.368019047,6.246711928,4.19E-10,1.42E-07,LOC110053579,1,1_LOC110053579,LOC110053579,zinc finger protein 724-like, C_EE_H_D_EE_H
173,12.66128106,21.04305147,4.258490467,4.941434442,7.75E-07,7.12E-05,LOC110040598,1,1_LOC110040598,LOC110040598,"E3 ubiquitin-protein ligase TRIM71-like, transcript variant X3", C_EE_H_D_EE_H
26,53.27857963,21.05253905,3.180820375,6.618587841,3.63E-11,2.22E-08,LOC110041920,1,1_LOC110041920,LOC110041920,"uncharacterized LOC110041920, transcript variant X2", C_EE_H_D_EE_H
313,7.104425272,21.05505722,5.34602607,3.938450157,8.20E-05,0.004163626,LOC110049075,1,1_LOC110049075,LOC110049075,probable alpha-ketoglutarate-dependent hypophosphite dioxygenase, C_EE_H_D_EE_H
536,15.11030033,21.08037615,3.496946753,6.028223374,1.66E-09,2.56E-07,LOC110064761,2,2_LOC110064761,LOC110064761,"G patch domain and KOW motifs-containing protein-like, transcript variant X2", D_EE_D_D_EE_H
532,24.32974159,21.11492994,3.471768119,6.081895225,1.19E-09,1.87E-07,LOC110050883,2,2_LOC110050883,LOC110050883,DNA/RNA-binding protein KIN17-like, D_EE_D_D_EE_H
503,24.65853774,21.11886535,3.206746528,6.58576073,4.53E-11,1.03E-08,LOC110057123,2,2_LOC110057123,LOC110057123,angiopoietin-1 receptor-like, D_EE_D_D_EE_H
844,9.897314013,21.13580641,3.160385743,6.687729957,2.27E-11,2.17E-09,LOC110041551,4,4_LOC110041551,LOC110041551,"uncharacterized LOC110041551, transcript variant X2", C_PE_H_C_EE_H
562,24.15692469,21.14435013,3.809530226,5.55038256,2.85E-08,3.51E-06,LOC110057963,2,2_LOC110057963,LOC110057963,ETS-related transcription factor Elf-4-like, D_EE_D_D_EE_H
49,30.43147634,21.15407404,3.421984505,6.181814678,6.34E-10,2.06E-07,LOC110052793,1,1_LOC110052793,LOC110052793,"uncharacterized protein C7orf72 homolog, transcript variant X2", C_EE_H_D_EE_H
550,14.50134025,21.15858984,3.703985876,5.712384049,1.11E-08,1.51E-06,LOC110041370,2,2_LOC110041370,LOC110041370,"potassium voltage-gated channel subfamily C member 4-like, transcript variant X2", D_EE_D_D_EE_H
599,19.81314115,21.16089343,4.402322985,4.806756228,1.53E-06,0.000147714,LOC110056301,2,2_LOC110056301,LOC110056301,UNC93-like protein MFSD11, D_EE_D_D_EE_H
574,8.409779626,21.17261044,4.04984539,5.228004627,1.71E-07,1.93E-05,LOC110063979,2,2_LOC110063979,LOC110063979,somatostatin receptor type 5-like, D_EE_D_D_EE_H
584,16.41155067,21.19049486,4.175286838,5.075218945,3.87E-07,4.07E-05,LOC110063159,2,2_LOC110063159,LOC110063159,"melanocortin receptor 5-like, transcript variant X2", D_EE_D_D_EE_H
559,16.16420549,21.19199845,3.78092669,5.604974703,2.08E-08,2.63E-06,LOC110062379,2,2_LOC110062379,LOC110062379,uncharacterized LOC110062379, D_EE_D_D_EE_H
556,17.94298264,21.19673274,3.767190534,5.626668615,1.84E-08,2.37E-06,LOC110050412,2,2_LOC110050412,LOC110050412,"uncharacterized LOC110050412, transcript variant X1", D_EE_D_D_EE_H
566,14.33905679,21.19683727,3.881511694,5.46097473,4.74E-08,5.66E-06,LOC110049123,2,2_LOC110049123,LOC110049123,exostosin-like 3, D_EE_D_D_EE_H
169,14.33905679,21.20711348,4.2780734,4.957164474,7.15E-07,6.73E-05,LOC110049123,1,1_LOC110049123,LOC110049123,exostosin-like 3, C_EE_H_D_EE_H
43,14.38545185,21.20948605,3.375251654,6.283823616,3.30E-10,1.22E-07,LOC110057721,1,1_LOC110057721,LOC110057721,zinc finger protein 345-like, C_EE_H_D_EE_H
522,27.27095457,21.22903926,3.410983226,6.223730182,4.85E-10,8.66E-08,LOC110059449,2,2_LOC110059449,LOC110059449,trichohyalin-like, D_EE_D_D_EE_H
241,14.66966247,21.23735769,4.832862343,4.394364288,1.11E-05,0.000729524,LOC110062846,1,1_LOC110062846,LOC110062846,"protein MAK16 homolog, transcript variant X4", C_EE_H_D_EE_H
18,34.02942205,21.2471794,3.00306966,7.075153694,1.49E-12,1.32E-09,LOC110043889,1,1_LOC110043889,LOC110043889,protein NLRC3-like, C_EE_H_D_EE_H
178,23.16028919,21.27268752,4.349769654,4.890531962,1.01E-06,8.98E-05,LOC110055386,1,1_LOC110055386,LOC110055386,uncharacterized LOC110055386, C_EE_H_D_EE_H
512,13.28545131,21.28198595,3.309523283,6.430529152,1.27E-10,2.56E-08,LOC110065708,2,2_LOC110065708,LOC110065708,"pancreatic secretory granule membrane major glycoprotein GP2-like, transcript variant X1", D_EE_D_D_EE_H
203,10.10645099,21.28278543,4.542300537,4.685463953,2.79E-06,0.000218706,LOC110067349,1,1_LOC110067349,LOC110067349,"uncharacterized LOC110067349, transcript variant X1", C_EE_H_D_EE_H
506,28.84133085,21.30981537,3.272907476,6.510973966,7.47E-11,1.63E-08,LOC110055559,2,2_LOC110055559,LOC110055559,RYamide receptor-like, D_EE_D_D_EE_H
549,13.92454557,21.31381428,3.714653813,5.737765982,9.59E-09,1.31E-06,LOC110065139,2,2_LOC110065139,LOC110065139,"substance-K receptor-like, transcript variant X2", D_EE_D_D_EE_H
537,20.1615652,21.36847751,3.56666303,5.991168028,2.08E-09,3.18E-07,LOC110058395,2,2_LOC110058395,LOC110058395,tryptophanase-like, D_EE_D_D_EE_H
527,23.91879947,21.39399815,3.48179804,6.144525875,8.02E-10,1.35E-07,LOC110048447,2,2_LOC110048447,LOC110048447,"proline dehydrogenase 1, mitochondrial-like", D_EE_D_D_EE_H
37,23.31206471,21.39543077,3.344947813,6.396342175,1.59E-10,6.83E-08,LOC110063784,1,1_LOC110063784,LOC110063784,uncharacterized LOC110063784, C_EE_H_D_EE_H
116,26.70323426,21.40712246,3.9671718,5.396066403,6.81E-08,9.33E-06,LOC110067624,1,1_LOC110067624,LOC110067624,eukaryotic translation initiation factor 2 subunit 1-like, C_EE_H_D_EE_H
182,21.55242951,21.41749073,4.4126781,4.853626356,1.21E-06,0.000105845,LOC110058814,1,1_LOC110058814,LOC110058814,uncharacterized LOC110058814, C_EE_H_D_EE_H
468,38.9276213,21.43398766,2.755180215,7.779522929,7.28E-15,3.31E-12,LOC110069312,2,2_LOC110069312,LOC110069312,"soluble guanylate cyclase gcy-33-like, transcript variant X4", D_EE_D_D_EE_H
259,10.14673643,21.45038766,5.047311689,4.249863884,2.14E-05,0.001312391,LOC110039960,1,1_LOC110039960,LOC110039960,protein DENND6A-like, C_EE_H_D_EE_H
129,10.17563034,21.46699792,4.043231951,5.309365917,1.10E-07,1.36E-05,LOC110040722,1,1_LOC110040722,LOC110040722,"beta-1,4-N-acetylgalactosaminyltransferase 3-like", C_EE_H_D_EE_H
200,10.69939259,21.47229672,4.573826011,4.69460287,2.67E-06,0.000212244,LOC110052494,1,1_LOC110052494,LOC110052494,deubiquitinating protein VCIP135-like, C_EE_H_D_EE_H
143,10.68478928,21.4730853,4.163306631,5.157699684,2.50E-07,2.82E-05,LOC110059740,1,1_LOC110059740,LOC110059740,kelch-like protein 25, C_EE_H_D_EE_H
488,21.36002077,21.48191325,3.067369927,7.00336567,2.50E-12,7.22E-10,LOC110053579,2,2_LOC110053579,LOC110053579,zinc finger protein 724-like, D_EE_D_D_EE_H
127,13.80317621,21.48201943,4.031101488,5.329069361,9.87E-08,1.24E-05,LOC110054875,1,1_LOC110054875,LOC110054875,protein piccolo-like, C_EE_H_D_EE_H
150,8.698248359,21.48317206,4.208296592,5.104956742,3.31E-07,3.51E-05,LOC110047176,1,1_LOC110047176,LOC110047176,uncharacterized LOC110047176, C_EE_H_D_EE_H
147,12.66987494,21.48681274,4.203035708,5.112212752,3.18E-07,3.44E-05,LOC110068705,1,1_LOC110068705,LOC110068705,uncharacterized LOC110068705, C_EE_H_D_EE_H
65,22.17895042,21.50784118,3.541107443,6.073761254,1.25E-09,3.04E-07,LOC110057766,1,1_LOC110057766,LOC110057766,"ephrin type-A receptor 2-like, transcript variant X2", C_EE_H_D_EE_H
508,12.01579453,21.5167532,3.320287177,6.480389212,9.15E-11,1.94E-08,LOC110065655,2,2_LOC110065655,LOC110065655,"nephrocystin-3-like, transcript variant X4", D_EE_D_D_EE_H
398,3.658129901,21.5428991,6.462294184,3.333630208,0.000857205,0.034225756,LOC110053610,1,1_LOC110053610,LOC110053610,"neuronal acetylcholine receptor subunit alpha-10-like, transcript variant X2", C_EE_H_D_EE_H
17,46.55897843,21.54489282,3.02243659,7.128319215,1.02E-12,1.00E-09,LOC110052323,1,1_LOC110052323,LOC110052323,"collagen alpha chain-like, transcript variant X1", C_EE_H_D_EE_H
513,32.32211762,21.55891175,3.360845433,6.414728727,1.41E-10,2.80E-08,LOC110069659,2,2_LOC110069659,LOC110069659,caspase-8-like, D_EE_D_D_EE_H
528,12.53832212,21.56157642,3.509813292,6.143226042,8.09E-10,1.35E-07,LOC110065909,2,2_LOC110065909,LOC110065909,"diencephalon/mesencephalon homeobox protein 1-B-like, transcript variant X1", D_EE_D_D_EE_H
540,13.80317621,21.56249435,3.660460754,5.890650331,3.85E-09,5.71E-07,LOC110054875,2,2_LOC110054875,LOC110054875,protein piccolo-like, D_EE_D_D_EE_H
539,15.53862406,21.57313837,3.647990205,5.913705125,3.34E-09,5.01E-07,LOC110066055,2,2_LOC110066055,LOC110066055,tumor necrosis factor receptor superfamily member 1A-like, D_EE_D_D_EE_H
496,29.3359796,21.57680344,3.166984671,6.81304322,9.56E-12,2.41E-09,LOC110062632,2,2_LOC110062632,LOC110062632,uncharacterized LOC110062632, D_EE_D_D_EE_H
61,12.62913837,21.58307046,3.539606582,6.097590213,1.08E-09,2.81E-07,LOC110066999,1,1_LOC110066999,LOC110066999,gamma-glutamyltranspeptidase 1-like, C_EE_H_D_EE_H
452,64.14445028,21.58703951,2.480966329,8.701061058,3.29E-18,2.75E-15,LOC110065252,2,2_LOC110065252,LOC110065252,"CAP-Gly domain-containing linker protein 1-like, transcript variant X2", D_EE_D_D_EE_H
140,16.16420549,21.60392277,4.165423251,5.186489216,2.14E-07,2.43E-05,LOC110062379,1,1_LOC110062379,LOC110062379,uncharacterized LOC110062379, C_EE_H_D_EE_H
595,14.81595733,21.60534239,4.451103177,4.853929809,1.21E-06,0.000118042,LOC110050671,2,2_LOC110050671,LOC110050671,5-hydroxytryptamine receptor 1-like, D_EE_D_D_EE_H
603,16.84589926,21.60566945,4.561649282,4.736372332,2.18E-06,0.000203384,LOC110064011,2,2_LOC110064011,LOC110064011,furin-like, D_EE_D_D_EE_H
931,6.059821893,21.6063994,3.764934792,5.738850897,9.53E-09,5.99E-07,LOC110062869,4,4_LOC110062869,LOC110062869,"uncharacterized LOC110062869, transcript variant X2", C_PE_H_C_EE_H
107,20.1615652,21.6092572,3.926133727,5.503953431,3.71E-08,5.52E-06,LOC110058395,1,1_LOC110058395,LOC110058395,tryptophanase-like, C_EE_H_D_EE_H
56,24.65853774,21.6407732,3.523361929,6.14208067,8.14E-10,2.34E-07,LOC110057123,1,1_LOC110057123,LOC110057123,angiopoietin-1 receptor-like, C_EE_H_D_EE_H
137,17.94298264,21.64106017,4.150049084,5.214651617,1.84E-07,2.14E-05,LOC110050412,1,1_LOC110050412,LOC110050412,"uncharacterized LOC110050412, transcript variant X1", C_EE_H_D_EE_H
355,5.788515713,21.66969121,5.950121668,3.641890438,0.000270643,0.012114907,LOC110050619,1,1_LOC110050619,LOC110050619,adenosine receptor A2b-like, C_EE_H_D_EE_H
359,3.926380318,21.67237597,6.011908183,3.604908011,0.000312264,0.013822227,LOC110069365,1,1_LOC110069365,LOC110069365,uncharacterized LOC110069365, C_EE_H_D_EE_H
547,21.19740694,21.67362937,3.750978604,5.778126632,7.55E-09,1.05E-06,LOC110053069,2,2_LOC110053069,LOC110053069,E3 ubiquitin-protein ligase rnf213-alpha-like, D_EE_D_D_EE_H
406,3.591607034,21.68160267,6.612631196,3.278816258,0.001042435,0.04070592,LOC110063380,1,1_LOC110063380,LOC110063380,"pleckstrin homology domain-containing family M member 2-like, transcript variant X2", C_EE_H_D_EE_H
46,31.30692371,21.7246579,3.475668299,6.250498042,4.09E-10,1.41E-07,LOC110048964,1,1_LOC110048964,LOC110048964,putative helicase MOV-10, C_EE_H_D_EE_H
184,16.76791595,21.74419031,4.482360719,4.851057661,1.23E-06,0.000106444,LOC110061052,1,1_LOC110061052,LOC110061052,cytosolic phospholipase A2-like, C_EE_H_D_EE_H
491,45.42158988,21.75653271,3.142475323,6.923374241,4.41E-12,1.21E-09,LOC110066954,2,2_LOC110066954,LOC110066954,gamma-glutamyltranspeptidase 1-like, D_EE_D_D_EE_H
499,25.62765889,21.77553344,3.221275389,6.759910536,1.38E-11,3.32E-09,LOC110060042,2,2_LOC110060042,LOC110060042,uncharacterized LOC110060042, D_EE_D_D_EE_H
80,12.71140828,21.77603467,3.696292228,5.891318469,3.83E-09,7.52E-07,LOC110058382,1,1_LOC110058382,LOC110058382,forkhead box protein J3-like, C_EE_H_D_EE_H
79,32.32211762,21.79660032,3.695937932,5.897447609,3.69E-09,7.43E-07,LOC110069659,1,1_LOC110069659,LOC110069659,caspase-8-like, C_EE_H_D_EE_H
563,23.16028919,21.80364472,3.945824009,5.525751953,3.28E-08,4.01E-06,LOC110055386,2,2_LOC110055386,LOC110055386,uncharacterized LOC110055386, D_EE_D_D_EE_H
205,8.489802959,21.80502792,4.663578026,4.675600537,2.93E-06,0.000225003,LOC110043027,1,1_LOC110043027,LOC110043027,"sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X2", C_EE_H_D_EE_H
275,13.88804404,21.81692302,5.219817624,4.179633196,2.92E-05,0.001687218,LOC110064312,1,1_LOC110064312,LOC110064312,uncharacterized LOC110064312, C_EE_H_D_EE_H
557,17.35241842,21.8235618,3.891042833,5.608666555,2.04E-08,2.59E-06,LOC110057527,2,2_LOC110057527,LOC110057527,transient receptor potential cation channel subfamily M member 6-like, D_EE_D_D_EE_H
517,14.16437647,21.8236347,3.449710042,6.32622291,2.51E-10,4.75E-08,LOC110067391,2,2_LOC110067391,LOC110067391,"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A-like", D_EE_D_D_EE_H
507,36.18975587,21.85452961,3.357632842,6.508909889,7.57E-11,1.63E-08,LOC110062895,2,2_LOC110062895,LOC110062895,uncharacterized LOC110062895, D_EE_D_D_EE_H
198,10.98662821,21.85692422,4.614317879,4.736761705,2.17E-06,0.000174288,LOC110064594,1,1_LOC110064594,LOC110064594,"uncharacterized LOC110064594, transcript variant X1", C_EE_H_D_EE_H
463,46.55897843,21.86134966,2.759641708,7.921807242,2.34E-15,1.24E-12,LOC110052323,2,2_LOC110052323,LOC110052323,"collagen alpha chain-like, transcript variant X1", D_EE_D_D_EE_H
134,11.78790043,21.86143663,4.151550381,5.265848811,1.40E-07,1.65E-05,LOC110063912,1,1_LOC110063912,LOC110063912,endochitinase A1-like, C_EE_H_D_EE_H
24,15.70760917,21.86944075,3.278783485,6.669986245,2.56E-11,1.69E-08,LOC110064912,1,1_LOC110064912,LOC110064912,protein transport protein Sec23A-like, C_EE_H_D_EE_H
171,14.29259256,21.88146952,4.420614095,4.949871002,7.43E-07,6.90E-05,LOC110063939,1,1_LOC110063939,LOC110063939,uncharacterized LOC110063939, C_EE_H_D_EE_H
545,15.08202911,21.88756205,3.780032912,5.790309914,7.03E-09,9.97E-07,LOC110064787,2,2_LOC110064787,LOC110064787,hepatocyte nuclear factor 1-beta-A-like, D_EE_D_D_EE_H
40,21.57230762,21.88764181,3.461427465,6.323299286,2.56E-10,1.02E-07,LOC110068067,1,1_LOC110068067,LOC110068067,deleted in malignant brain tumors 1 protein-like, C_EE_H_D_EE_H
380,4.422355058,21.89671514,6.338947687,3.454313905,0.000551695,0.023071006,LOC110043946,1,1_LOC110043946,LOC110043946,melanocortin receptor 4-like, C_EE_H_D_EE_H
86,13.1307331,21.90374719,3.785226419,5.786641212,7.18E-09,1.34E-06,LOC110062180,1,1_LOC110062180,LOC110062180,"uncharacterized LOC110062180, transcript variant X1", C_EE_H_D_EE_H
236,32.18545167,21.9240125,4.97293668,4.408665123,1.04E-05,0.000700347,LOC110050594,1,1_LOC110050594,LOC110050594,uncharacterized LOC110050594, C_EE_H_D_EE_H
619,6.165643096,21.94990362,5.063835598,4.334639857,1.46E-05,0.001247349,LOC110056657,2,2_LOC110056657,LOC110056657,DNA excision repair protein ERCC-6-like, D_EE_D_D_EE_H
342,6.775119134,21.95517674,5.949023745,3.690551203,0.000223769,0.0103735,LOC110057057,1,1_LOC110057057,LOC110057057,contactin-associated protein-like 3, C_EE_H_D_EE_H
511,22.51537619,21.95872232,3.409288756,6.440851418,1.19E-10,2.42E-08,LOC110047380,2,2_LOC110047380,LOC110047380,collagen alpha-2(IX) chain-like, D_EE_D_D_EE_H
193,9.247212147,21.9706427,4.614802968,4.760905906,1.93E-06,0.000157057,LOC110040899,1,1_LOC110040899,LOC110040899,uncharacterized LOC110040899, C_EE_H_D_EE_H
479,28.61278433,21.98099927,3.030538828,7.253165367,4.07E-13,1.39E-10,LOC110043387,2,2_LOC110043387,LOC110043387,uncharacterized LOC110043387, D_EE_D_D_EE_H
164,10.35047735,21.98864072,4.400341145,4.99703091,5.82E-07,5.64E-05,LOC110043607,1,1_LOC110043607,LOC110043607,"proprotein convertase subtilisin/kexin type 5-like, transcript variant X1", C_EE_H_D_EE_H
324,8.153200257,21.99418667,5.718839138,3.845918051,0.000120102,0.005897658,LOC110047970,1,1_LOC110047970,LOC110047970,"alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A-like", C_EE_H_D_EE_H
175,13.68212169,22.00292875,4.476755616,4.914927381,8.88E-07,8.06E-05,LOC110068832,1,1_LOC110068832,LOC110068832,kelch-like protein 5, C_EE_H_D_EE_H
577,14.41695048,22.00784355,4.255447087,5.171687744,2.32E-07,2.56E-05,LOC110048955,2,2_LOC110048955,LOC110048955,trace amine-associated receptor 8b-like, D_EE_D_D_EE_H
88,23.91879947,22.00982943,3.831005055,5.745184127,9.18E-09,1.66E-06,LOC110048447,1,1_LOC110048447,LOC110048447,"proline dehydrogenase 1, mitochondrial-like", C_EE_H_D_EE_H
485,26.45069613,22.01269782,3.077628354,7.152487332,8.52E-13,2.60E-10,LOC110044195,2,2_LOC110044195,LOC110044195,"probable serine/threonine-protein kinase drkD, transcript variant X1", D_EE_D_D_EE_H
110,16.63268319,22.02163019,4.021523316,5.475942438,4.35E-08,6.29E-06,LOC110048190,1,1_LOC110048190,LOC110048190,uncharacterized LOC110048190, C_EE_H_D_EE_H
515,26.76592727,22.03232737,3.453401844,6.379891006,1.77E-10,3.43E-08,LOC110062626,2,2_LOC110062626,LOC110062626,suppressor protein SRP40-like, D_EE_D_D_EE_H
994,7.674481659,22.06638781,4.476601316,4.929272511,8.25E-07,4.15E-05,LOC110040356,4,4_LOC110040356,LOC110040356,uncharacterized LOC110040356, C_PE_H_C_EE_H
95,16.25597994,22.07411467,3.888592004,5.676634281,1.37E-08,2.27E-06,LOC110044207,1,1_LOC110044207,LOC110044207,uncharacterized LOC110044207, C_EE_H_D_EE_H
917,9.552677104,22.07605794,3.785935254,5.831071177,5.51E-09,3.66E-07,LOC110045603,4,4_LOC110045603,LOC110045603,uncharacterized LOC110045603, C_PE_H_C_EE_H
564,9.552927323,22.10908078,4.017177096,5.503636074,3.72E-08,4.51E-06,LOC110051255,2,2_LOC110051255,LOC110051255,"uncharacterized LOC110051255, transcript variant X2", D_EE_D_D_EE_H
71,14.03851299,22.12243864,3.661350945,6.04215192,1.52E-09,3.40E-07,LOC110067916,1,1_LOC110067916,LOC110067916,peptidase M20 domain-containing protein 2-like, C_EE_H_D_EE_H
231,16.13198844,22.12692215,4.904789767,4.511288598,6.44E-06,0.000443262,LOC110055566,1,1_LOC110055566,LOC110055566,uncharacterized LOC110055566, C_EE_H_D_EE_H
209,9.019018878,22.14558006,4.743087681,4.66902186,3.03E-06,0.000230106,LOC110044004,1,1_LOC110044004,LOC110044004,"DAZ protein 1-like, transcript variant X2", C_EE_H_D_EE_H
78,27.27095457,22.14940967,3.751639766,5.903927628,3.55E-09,7.23E-07,LOC110059449,1,1_LOC110059449,LOC110059449,trichohyalin-like, C_EE_H_D_EE_H
525,20.50153069,22.1706883,3.567324512,6.214934534,5.13E-10,8.87E-08,LOC110059810,2,2_LOC110059810,LOC110059810,uncharacterized LOC110059810, D_EE_D_D_EE_H
261,15.36182138,22.19032457,5.235097554,4.238760471,2.25E-05,0.001368436,LOC110055732,1,1_LOC110055732,LOC110055732,uncharacterized LOC110055732, C_EE_H_D_EE_H
63,12.01579453,22.20955224,3.650294633,6.084317698,1.17E-09,2.95E-07,LOC110065655,1,1_LOC110065655,LOC110065655,"nephrocystin-3-like, transcript variant X4", C_EE_H_D_EE_H
69,19.75307584,22.25433612,3.68133353,6.04518334,1.49E-09,3.39E-07,LOC110065588,1,1_LOC110065588,LOC110065588,uncharacterized LOC110065588, C_EE_H_D_EE_H
54,28.17024991,22.25993487,3.620418718,6.148442102,7.82E-10,2.30E-07,LOC110069580,1,1_LOC110069580,LOC110069580,carbonic anhydrase 2-like, C_EE_H_D_EE_H
477,38.49161237,22.28083831,3.002448205,7.420890147,1.16E-13,4.20E-11,LOC110039944,2,2_LOC110039944,LOC110039944,uncharacterized LOC110039944, D_EE_D_D_EE_H
464,31.10071365,22.30114456,2.831886043,7.875014822,3.41E-15,1.75E-12,LOC110055642,2,2_LOC110055642,LOC110055642,uncharacterized LOC110055642, D_EE_D_D_EE_H
601,9.836569662,22.30189492,4.695419889,4.749712582,2.04E-06,0.000192684,LOC110053088,2,2_LOC110053088,LOC110053088,dipeptidyl peptidase 4-like, D_EE_D_D_EE_H
474,29.01677855,22.3071182,2.923770954,7.62957104,2.36E-14,9.13E-12,LOC110059474,2,2_LOC110059474,LOC110059474,carboxypeptidase B-like, D_EE_D_D_EE_H
533,26.03542902,22.32217234,3.670104584,6.082162464,1.19E-09,1.87E-07,LOC110062309,2,2_LOC110062309,LOC110062309,uncharacterized LOC110062309, D_EE_D_D_EE_H
815,8.690703965,22.32442723,3.202531744,6.970868368,3.15E-12,3.65E-10,LOC110058967,4,4_LOC110058967,LOC110058967,uncharacterized LOC110058967, C_PE_H_C_EE_H
27,26.45069613,22.33130458,3.37866546,6.609504504,3.86E-11,2.27E-08,LOC110044195,1,1_LOC110044195,LOC110044195,"probable serine/threonine-protein kinase drkD, transcript variant X1", C_EE_H_D_EE_H
514,25.67031368,22.34105976,3.496828942,6.388948425,1.67E-10,3.28E-08,LOC110050439,2,2_LOC110050439,LOC110050439,"uncharacterized LOC110050439, transcript variant X1", D_EE_D_D_EE_H
484,29.8447607,22.34353214,3.120308705,7.160679999,8.03E-13,2.50E-10,LOC110050596,2,2_LOC110050596,LOC110050596,uncharacterized LOC110050596, D_EE_D_D_EE_H
554,13.42181571,22.34717723,3.96211342,5.640216434,1.70E-08,2.23E-06,LOC110066730,2,2_LOC110066730,LOC110066730,probable proline dehydrogenase 2, D_EE_D_D_EE_H
1043,1.456009573,22.35825068,5.69265567,3.927560699,8.58E-05,0.003735986,LOC110044929,4,4_LOC110044929,LOC110044929,"uncharacterized LOC110044929, transcript variant X1", C_PE_H_C_EE_H
457,34.02942205,22.36022061,2.741987165,8.154750285,3.50E-16,2.32E-13,LOC110043889,2,2_LOC110043889,LOC110043889,protein NLRC3-like, D_EE_D_D_EE_H
325,8.766399701,22.36397964,5.821480164,3.841631167,0.000122219,0.005975964,LOC110067882,1,1_LOC110067882,LOC110067882,"TNF receptor-associated factor 4-like, transcript variant X2", C_EE_H_D_EE_H
108,16.66138526,22.36823932,4.071700399,5.49358674,3.94E-08,5.74E-06,LOC110069339,1,1_LOC110069339,LOC110069339,dickkopf-related protein 3-like, C_EE_H_D_EE_H
633,8.627035621,22.38672955,5.629615038,3.976600424,6.99E-05,0.005554499,LOC110061126,2,2_LOC110061126,LOC110061126,complement C1q subcomponent subunit C-like, D_EE_D_D_EE_H
58,26.79313831,22.39507796,3.655623791,6.126198766,9.00E-10,2.45E-07,LOC110051805,1,1_LOC110051805,LOC110051805,"leukocyte tyrosine kinase receptor-like, transcript variant X2", C_EE_H_D_EE_H
490,22.17895042,22.39821894,3.222070396,6.951498937,3.61E-12,1.01E-09,LOC110057766,2,2_LOC110057766,LOC110057766,"ephrin type-A receptor 2-like, transcript variant X2", D_EE_D_D_EE_H
483,30.43147634,22.4068888,3.11539144,7.192318922,6.37E-13,2.02E-10,LOC110052793,2,2_LOC110052793,LOC110052793,"uncharacterized protein C7orf72 homolog, transcript variant X2", D_EE_D_D_EE_H
33,29.3359796,22.40896572,3.478578562,6.441989256,1.18E-10,5.68E-08,LOC110062632,1,1_LOC110062632,LOC110062632,uncharacterized LOC110062632, C_EE_H_D_EE_H
523,26.70323426,22.41765731,3.602919253,6.222081522,4.91E-10,8.66E-08,LOC110067624,2,2_LOC110067624,LOC110067624,eukaryotic translation initiation factor 2 subunit 1-like, D_EE_D_D_EE_H
548,21.36606775,22.43721144,3.891381091,5.765873584,8.12E-09,1.12E-06,LOC110049853,2,2_LOC110049853,LOC110049853,laccase-4-like, D_EE_D_D_EE_H
229,12.85238276,22.4395641,4.957531507,4.526358345,6.00E-06,0.000416419,LOC110063037,1,1_LOC110063037,LOC110063037,"uncharacterized LOC110063037, transcript variant X1", C_EE_H_D_EE_H
558,21.55242951,22.44641382,4.001910826,5.608924036,2.04E-08,2.59E-06,LOC110058814,2,2_LOC110058814,LOC110058814,uncharacterized LOC110058814, D_EE_D_D_EE_H
683,25.09551566,22.47221473,2.074231079,10.8339977,2.38E-27,7.55E-24,LOC110048046,4,4_LOC110048046,LOC110048046,uncharacterized LOC110048046, C_PE_H_C_EE_H
544,25.59595167,22.48691055,3.868306777,5.813114587,6.13E-09,8.78E-07,LOC110050932,2,2_LOC110050932,LOC110050932,"gelsolin-like protein 2, transcript variant X2", D_EE_D_D_EE_H
472,94.06311702,22.50301103,2.936904067,7.662153926,1.83E-14,7.45E-12,LOC110068557,2,2_LOC110068557,LOC110068557,"uncharacterized LOC110068557, transcript variant X1", D_EE_D_D_EE_H
177,16.41155067,22.5277558,4.605071684,4.891944653,9.98E-07,8.96E-05,LOC110063159,1,1_LOC110063159,LOC110063159,"melanocortin receptor 5-like, transcript variant X2", C_EE_H_D_EE_H
377,7.805843487,22.53439019,6.45575352,3.490590234,0.000481955,0.020314971,LOC110047367,1,1_LOC110047367,LOC110047367,L-rhamnose-binding lectin CSL3-like, C_EE_H_D_EE_H
13,38.9276213,22.5355332,3.016505388,7.4707419,7.97E-14,9.75E-11,LOC110069312,1,1_LOC110069312,LOC110069312,"soluble guanylate cyclase gcy-33-like, transcript variant X4", C_EE_H_D_EE_H
121,24.15692469,22.54073024,4.196852186,5.370865887,7.84E-08,1.03E-05,LOC110057963,1,1_LOC110057963,LOC110057963,ETS-related transcription factor Elf-4-like, C_EE_H_D_EE_H
937,7.017672967,22.57339757,3.957307928,5.70423075,1.17E-08,7.17E-07,LOC110069479,4,4_LOC110069479,LOC110069479,uncharacterized LOC110069479, C_PE_H_C_EE_H
28,29.8447607,22.59903047,3.426540792,6.595290073,4.24E-11,2.41E-08,LOC110050596,1,1_LOC110050596,LOC110050596,uncharacterized LOC110050596, C_EE_H_D_EE_H
337,24.02258658,22.60440255,6.06729709,3.72561327,0.000194841,0.009187588,LOC110040087,1,1_LOC110040087,LOC110040087,uncharacterized LOC110040087, C_EE_H_D_EE_H
466,53.27857963,22.61503798,2.900411364,7.797182929,6.33E-15,3.05E-12,LOC110041920,2,2_LOC110041920,LOC110041920,"uncharacterized LOC110041920, transcript variant X2", D_EE_D_D_EE_H
1,99.08634905,22.71348917,2.261912034,10.04172082,9.99E-24,7.94E-20,LOC110046011,1,1_LOC110046011,LOC110046011,DNA-directed RNA polymerase I subunit RPA43-like, C_EE_H_D_EE_H
493,154.7011407,22.7278874,3.302741942,6.88152081,5.92E-12,1.57E-09,LOC110056271,2,2_LOC110056271,LOC110056271,group XV phospholipase A2-like, D_EE_D_D_EE_H
225,27.5389078,22.73165609,4.994678831,4.551174733,5.33E-06,0.000376774,LOC110043600,1,1_LOC110043600,LOC110043600,uncharacterized LOC110043600, C_EE_H_D_EE_H
935,5.79270713,22.73645201,3.976637258,5.717507163,1.08E-08,6.68E-07,KEG21_p09,4,4_KEG21_p09,NA,NA,NA
909,6.064260233,22.76120901,3.842982645,5.922797764,3.17E-09,2.18E-07,LOC110057889,4,4_LOC110057889,LOC110057889,uncharacterized LOC110057889, C_PE_H_C_EE_H
834,11.2104492,22.78925472,3.36114016,6.780215532,1.20E-11,1.22E-09,LOC110056412,4,4_LOC110056412,LOC110056412,"transcriptional activator Myb-like, transcript variant X2", C_PE_H_C_EE_H
555,17.17787919,22.79743015,4.049911816,5.629117667,1.81E-08,2.36E-06,LOC110069424,2,2_LOC110069424,LOC110069424,AMMECR1-like protein, D_EE_D_D_EE_H
51,36.18975587,22.80751526,3.691931113,6.177665446,6.51E-10,2.07E-07,LOC110062895,1,1_LOC110062895,LOC110062895,uncharacterized LOC110062895, C_EE_H_D_EE_H
126,21.36606775,22.85346464,4.288515944,5.328991413,9.88E-08,1.24E-05,LOC110049853,1,1_LOC110049853,LOC110049853,laccase-4-like, C_EE_H_D_EE_H
435,68.39467854,22.85658536,2.14086783,10.67631782,1.31E-26,1.04E-22,LOC110063807,2,2_LOC110063807,LOC110063807,uncharacterized LOC110063807, D_EE_D_D_EE_H
101,12.83289327,22.88514831,4.115276872,5.561022752,2.68E-08,4.22E-06,LOC110065341,1,1_LOC110065341,LOC110065341,COMM domain-containing protein 6-like, C_EE_H_D_EE_H
770,10.64345402,22.89682423,2.957924584,7.740841111,9.88E-15,1.71E-12,LOC110067285,4,4_LOC110067285,LOC110067285,E3 ubiquitin-protein ligase TRIM71-like, C_PE_H_C_EE_H
1037,2.774947465,22.90914635,5.692075025,4.024744271,5.70E-05,0.002524733,LOC110066663,4,4_LOC110066663,LOC110066663,substance-P receptor-like, C_PE_H_C_EE_H
583,32.18545167,22.91063875,4.504687135,5.085955597,3.66E-07,3.88E-05,LOC110050594,2,2_LOC110050594,LOC110050594,uncharacterized LOC110050594, D_EE_D_D_EE_H
579,20.50363394,22.93493307,4.44774782,5.156527304,2.52E-07,2.74E-05,LOC110056626,2,2_LOC110056626,LOC110056626,uncharacterized LOC110056626, D_EE_D_D_EE_H
328,10.02627736,23.01157469,6.079008001,3.785416088,0.000153452,0.00743445,LOC110046269,1,1_LOC110046269,LOC110046269,potassium voltage-gated channel subfamily D member 3-like, C_EE_H_D_EE_H
1036,2.836407161,23.11907233,5.691888679,4.06175764,4.87E-05,0.002161914,LOC110041560,4,4_LOC110041560,LOC110041560,uncharacterized LOC110041560, C_PE_H_C_EE_H
166,12.94699175,23.13902135,4.660573323,4.964844398,6.88E-07,6.50E-05,LOC110044614,1,1_LOC110044614,LOC110044614,"E3 ubiquitin-protein ligase MIB2-like, transcript variant X4", C_EE_H_D_EE_H
662,8.895019662,23.18352497,2.406140826,9.635148832,5.68E-22,1.50E-18,LOC110069668,3,3_LOC110069668,LOC110069668,FH protein interacting protein FIP2-like, C_PE_D_D_EE_D
848,11.33126496,23.19056465,3.477717765,6.668328546,2.59E-11,2.42E-09,LOC110051644,4,4_LOC110051644,LOC110051644,proline-rich transmembrane protein 4-like, C_PE_H_C_EE_H
481,35.97919054,23.20072797,3.199530857,7.251290581,4.13E-13,1.39E-10,LOC110050669,2,2_LOC110050669,LOC110050669,uncharacterized LOC110050669, D_EE_D_D_EE_H
451,93.77131507,23.20152284,2.658090307,8.728643558,2.58E-18,2.28E-15,LOC110045208,2,2_LOC110045208,LOC110045208,uncharacterized LOC110045208, D_EE_D_D_EE_H
30,25.62765889,23.23849683,3.539170122,6.566086407,5.17E-11,2.74E-08,LOC110060042,1,1_LOC110060042,LOC110060042,uncharacterized LOC110060042, C_EE_H_D_EE_H
974,4.90343338,23.25481622,4.436654567,5.241520579,1.59E-07,8.55E-06,LOC110047908,4,4_LOC110047908,LOC110047908,tuftelin-interacting protein 11-like, C_PE_H_C_EE_H
22,45.42158988,23.25726759,3.450892664,6.739493185,1.59E-11,1.15E-08,LOC110066954,1,1_LOC110066954,LOC110066954,gamma-glutamyltranspeptidase 1-like, C_EE_H_D_EE_H
434,99.08634905,23.298105,2.086003502,11.16877559,5.80E-29,9.21E-25,LOC110046011,2,2_LOC110046011,LOC110046011,DNA-directed RNA polymerase I subunit RPA43-like, D_EE_D_D_EE_H
67,25.67031368,23.31907083,3.847606804,6.060668881,1.36E-09,3.22E-07,LOC110050439,1,1_LOC110050439,LOC110050439,"uncharacterized LOC110050439, transcript variant X1", C_EE_H_D_EE_H
853,6.893914303,23.32345189,3.539269978,6.589904708,4.40E-11,4.00E-09,LOC110052767,4,4_LOC110052767,LOC110052767,mediator of RNA polymerase II transcription subunit 4-like, C_PE_H_C_EE_H
91,12.9046043,23.32618646,4.083769275,5.711925648,1.12E-08,1.95E-06,LOC110051046,1,1_LOC110051046,LOC110051046,"sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like", C_EE_H_D_EE_H
1035,12.89491213,23.33347706,5.691718268,4.099548846,4.14E-05,0.001842627,LOC110065162,4,4_LOC110065162,LOC110065162,uncharacterized LOC110065162, C_PE_H_C_EE_H
260,11.17590464,23.37262232,5.511546672,4.240664865,2.23E-05,0.001362095,LOC110040336,1,1_LOC110040336,LOC110040336,RYamide receptor-like, C_EE_H_D_EE_H
967,3.540863784,23.38377385,4.394737571,5.320857839,1.03E-07,5.68E-06,LOC110040934,4,4_LOC110040934,LOC110040934,"malectin-like, transcript variant X2", C_PE_H_C_EE_H
132,18.04025383,23.43597316,4.434549266,5.284860254,1.26E-07,1.51E-05,LOC110050267,1,1_LOC110050267,LOC110050267,dopamine receptor 2-like, C_EE_H_D_EE_H
3,86.08451211,23.43609389,2.569696751,9.120178824,7.50E-20,3.97E-16,LOC110064269,1,1_LOC110064269,LOC110064269,uncharacterized LOC110064269, C_EE_H_D_EE_H
374,104.9632647,23.43786385,6.680055318,3.508633198,0.000450416,0.019137847,LOC110055865,1,1_LOC110055865,LOC110055865,uncharacterized LOC110055865, C_EE_H_D_EE_H
2,68.39467854,23.45456122,2.323731955,10.09348826,5.90E-24,7.94E-20,LOC110063807,1,1_LOC110063807,LOC110063807,uncharacterized LOC110063807, C_EE_H_D_EE_H
438,86.08451211,23.4579183,2.358211644,9.947333759,2.59E-23,8.90E-20,LOC110064269,2,2_LOC110064269,LOC110064269,uncharacterized LOC110064269, D_EE_D_D_EE_H
895,13.12740735,23.46715247,3.8181718,6.146175106,7.94E-10,5.81E-08,LOC110056551,4,4_LOC110056551,LOC110056551,uncharacterized LOC110056551, C_PE_H_C_EE_H
105,51.97633798,23.49990827,4.263355922,5.512068123,3.55E-08,5.32E-06,LOC110055756,1,1_LOC110055756,LOC110055756,coadhesin-like, C_EE_H_D_EE_H
308,37.57959409,23.5100388,5.934231402,3.961766438,7.44E-05,0.003838466,LOC110060083,1,1_LOC110060083,LOC110060083,uncharacterized LOC110060083, C_EE_H_D_EE_H
31,28.84133085,23.54680651,3.596723281,6.546738427,5.88E-11,3.01E-08,LOC110055559,1,1_LOC110055559,LOC110055559,RYamide receptor-like, C_EE_H_D_EE_H
822,11.70365102,23.59765404,3.422138067,6.895587957,5.36E-12,5.92E-10,LOC110054739,4,4_LOC110054739,LOC110054739,"E3 ubiquitin-protein ligase DZIP3-like, transcript variant X2", C_PE_H_C_EE_H
968,9.145920061,23.63978587,4.460642375,5.299637112,1.16E-07,6.36E-06,LOC110040078,4,4_LOC110040078,LOC110040078,igLON family member 5-like, C_PE_H_C_EE_H
8,93.77131507,23.6440318,2.907485565,8.132123537,4.22E-16,8.38E-13,LOC110045208,1,1_LOC110045208,LOC110045208,uncharacterized LOC110045208, C_EE_H_D_EE_H
441,111.9625751,23.65936605,2.49106161,9.497704092,2.15E-21,4.26E-18,LOC110066286,2,2_LOC110066286,LOC110066286,nucleotide pyrophosphatase/phosphodiesterase-like, D_EE_D_D_EE_H
860,11.66332484,23.69289826,3.630322565,6.526389278,6.74E-11,5.88E-09,LOC110064897,4,4_LOC110064897,LOC110064897,uncharacterized LOC110064897, C_PE_H_C_EE_H
14,94.06311702,23.74698662,3.220524953,7.37363845,1.66E-13,1.88E-10,LOC110068557,1,1_LOC110068557,LOC110068557,"uncharacterized LOC110068557, transcript variant X1", C_EE_H_D_EE_H
971,6.934106926,23.8194205,4.536102618,5.251076201,1.51E-07,8.20E-06,LOC110041059,4,4_LOC110041059,LOC110041059,uncharacterized LOC110041059, C_PE_H_C_EE_H
864,14.25815306,23.85704961,3.67618165,6.48962752,8.60E-11,7.35E-09,LOC110041693,4,4_LOC110041693,LOC110041693,uncharacterized LOC110041693, C_PE_H_C_EE_H
802,8.282118539,23.94282229,3.345096564,7.157587781,8.21E-13,1.05E-10,LOC110066452,4,4_LOC110066452,LOC110066452,ketosamine-3-kinase-like, C_PE_H_C_EE_H
459,57.05291101,23.98098644,2.970711413,8.072472583,6.89E-16,4.21E-13,LOC110055245,2,2_LOC110055245,LOC110055245,"uncharacterized LOC110055245, transcript variant X1", D_EE_D_D_EE_H
5,111.9625751,24.040316,2.719421828,8.840230581,9.55E-19,3.04E-15,LOC110066286,1,1_LOC110066286,LOC110066286,nucleotide pyrophosphatase/phosphodiesterase-like, C_EE_H_D_EE_H
846,7.78277475,24.0701339,3.605622104,6.67572286,2.46E-11,2.32E-09,LOC110051965,4,4_LOC110051965,LOC110051965,isocitrate lyase-like, C_PE_H_C_EE_H
764,9.791189206,24.09294916,3.066436392,7.856986444,3.93E-15,7.27E-13,LOC110063755,4,4_LOC110063755,LOC110063755,"uncharacterized LOC110063755, transcript variant X4", C_PE_H_C_EE_H
4,64.14445028,24.16830794,2.70757252,8.926190438,4.41E-19,1.75E-15,LOC110065252,1,1_LOC110065252,LOC110065252,"CAP-Gly domain-containing linker protein 1-like, transcript variant X2", C_EE_H_D_EE_H
758,14.20331274,24.20367264,3.064488726,7.898111172,2.83E-15,5.59E-13,LOC110051454,4,4_LOC110051454,LOC110051454,"battenin-like, transcript variant X1", C_PE_H_C_EE_H
743,18.14077939,24.21539274,2.951867671,8.203414057,2.34E-16,5.71E-14,LOC110060995,4,4_LOC110060995,LOC110060995,uncharacterized LOC110060995, C_PE_H_C_EE_H
1023,1.480058076,24.34684122,5.692718424,4.276839185,1.90E-05,0.000873156,LOC110054247,4,4_LOC110054247,LOC110054247,"homeobox even-skipped homolog protein 2-like, transcript variant X2", C_PE_H_C_EE_H
687,12.21164038,24.36345271,2.301290252,10.58686651,3.43E-26,6.05E-23,LOC110054048,4,4_LOC110054048,LOC110054048,"uncharacterized protein YJR142W-like, transcript variant X1", C_PE_H_C_EE_H
784,28.94259676,24.3898488,3.256270033,7.490118619,6.88E-14,1.03E-11,LOC110067145,4,4_LOC110067145,LOC110067145,"uncharacterized LOC110067145, transcript variant X1", C_PE_H_C_EE_H
748,9.30582716,24.51863987,3.029569507,8.093110197,5.82E-16,1.32E-13,LOC110064317,4,4_LOC110064317,LOC110064317,"D(2) dopamine receptor A-like, transcript variant X2", C_PE_H_C_EE_H
886,9.95460717,24.52229598,3.918129613,6.258674012,3.88E-10,2.97E-08,LOC110060533,4,4_LOC110060533,LOC110060533,uncharacterized LOC110060533, C_PE_H_C_EE_H
20,154.7011407,24.58569767,3.630399811,6.772173577,1.27E-11,1.01E-08,LOC110056271,1,1_LOC110056271,LOC110056271,group XV phospholipase A2-like, C_EE_H_D_EE_H
596,27.06715273,24.59985508,5.068099884,4.853861536,1.21E-06,0.000118042,LOC110065968,2,2_LOC110065968,LOC110065968,vegetative cell wall protein gp1-like, D_EE_D_D_EE_H
713,21.53648162,24.61214903,2.769856326,8.885713243,6.35E-19,2.89E-16,LOC110056167,4,4_LOC110056167,LOC110056167,otolin-1-like, C_PE_H_C_EE_H
942,5.90195449,24.62369923,4.380782328,5.620845179,1.90E-08,1.14E-06,LOC110044082,4,4_LOC110044082,LOC110044082,uncharacterized LOC110044082, C_PE_H_C_EE_H
692,12.97299667,24.66423918,2.540006827,9.710304286,2.73E-22,3.09E-19,LOC110056455,4,4_LOC110056455,LOC110056455,trace amine-associated receptor 6-like, C_PE_H_C_EE_H
695,16.4199193,24.72308684,2.572700744,9.609779488,7.27E-22,6.80E-19,LOC110065467,4,4_LOC110065467,LOC110065467,"uncharacterized LOC110065467, transcript variant X4", C_PE_H_C_EE_H
925,8.156383219,24.86113303,4.300957869,5.780371207,7.45E-09,4.80E-07,LOC110050353,4,4_LOC110050353,LOC110050353,major facilitator superfamily domain-containing protein 3-like, C_PE_H_C_EE_H
742,19.57711694,24.87635858,3.026917579,8.218379896,2.06E-16,5.12E-14,LOC110060507,4,4_LOC110060507,LOC110060507,phenazine biosynthesis-like domain-containing protein, C_PE_H_C_EE_H
709,31.05002789,24.98440382,2.783921843,8.974534929,2.85E-19,1.46E-16,LOC110055875,4,4_LOC110055875,LOC110055875,"uncharacterized LOC110055875, transcript variant X2", C_PE_H_C_EE_H
146,185.7638508,25.35717859,4.943832185,5.129053261,2.91E-07,3.17E-05,LOC110060064,1,1_LOC110060064,LOC110060064,uncharacterized LOC110060064, C_EE_H_D_EE_H
718,28.86731509,25.45896428,2.916740787,8.728565935,2.58E-18,1.02E-15,LOC110054551,4,4_LOC110054551,LOC110054551,"glutamate dehydrogenase, mitochondrial-like", C_PE_H_C_EE_H
981,4.353835066,25.71056775,5.020714025,5.120898666,3.04E-07,1.59E-05,LOC110065008,4,4_LOC110065008,LOC110065008,"D(3) dopamine receptor-like, transcript variant X1", C_PE_H_C_EE_H
728,22.24875319,25.71405692,3.039642686,8.459565672,2.68E-17,8.47E-15,LOC110045257,4,4_LOC110045257,LOC110045257,alpha-1D adrenergic receptor-like, C_PE_H_C_EE_H
658,50.63163942,25.94224062,2.022813564,12.82483027,1.19E-37,9.46E-34,LOC110041679,3,3_LOC110041679,LOC110041679,"uncharacterized LOC110041679, transcript variant X1", C_PE_D_D_EE_D
872,8.974013359,26.15005019,4.091579718,6.391186778,1.65E-10,1.35E-08,LOC110058106,4,4_LOC110058106,LOC110058106,uncharacterized LOC110058106, C_PE_H_C_EE_H
765,12.85238276,26.24243104,3.345073267,7.845099029,4.33E-15,7.90E-13,LOC110063037,4,4_LOC110063037,LOC110063037,"uncharacterized LOC110063037, transcript variant X1", C_PE_H_C_EE_H
589,8.437325109,26.53773339,5.398071096,4.916151142,8.83E-07,9.03E-05,LOC110065112,2,2_LOC110065112,LOC110065112,uncharacterized LOC110065112, D_EE_D_D_EE_H
741,19.81314115,27.03774532,3.284239945,8.232573069,1.83E-16,4.62E-14,LOC110056301,4,4_LOC110056301,LOC110056301,UNC93-like protein MFSD11, C_PE_H_C_EE_H
993,2.681002087,28.09936231,5.692098267,4.936556081,7.95E-07,4.01E-05,LOC110042365,4,4_LOC110042365,LOC110042365,uncharacterized LOC110042365, C_PE_H_C_EE_H
626,4.996980597,28.11060639,6.78884274,4.140706666,3.46E-05,0.002850808,LOC110047813,2,2_LOC110047813,LOC110047813,protein FAM173B-like, D_EE_D_D_EE_H
740,14.0969625,29.06306977,3.525166781,8.244452414,1.66E-16,4.25E-14,LOC110068550,4,4_LOC110068550,LOC110068550,D-inositol 3-phosphate glycosyltransferase-like, C_PE_H_C_EE_H
982,15.0213022,29.0791286,5.691016299,5.109654773,3.23E-07,1.69E-05,LOC110049037,4,4_LOC110049037,LOC110049037,uncharacterized LOC110049037, C_PE_H_C_EE_H
819,4.817511735,29.11979873,4.195915879,6.940033969,3.92E-12,4.42E-10,LOC110040700,4,4_LOC110040700,LOC110040700,"beta-1,4-N-acetylgalactosaminyltransferase 3-like", C_PE_H_C_EE_H
826,4.422355058,29.28944943,4.29396982,6.821065508,9.04E-12,9.70E-10,LOC110043946,4,4_LOC110043946,LOC110043946,melanocortin receptor 4-like, C_PE_H_C_EE_H
504,17.14764936,29.57662325,4.511209682,6.556251059,5.52E-11,1.23E-08,LOC110052891,2,2_LOC110052891,LOC110052891,sacsin-like, D_EE_D_D_EE_H
975,1.763108736,29.80626869,5.691985451,5.236532832,1.64E-07,8.75E-06,LOC110069315,4,4_LOC110069315,LOC110069315,uncharacterized LOC110069315, C_PE_H_C_EE_H
973,1.966050336,29.84626785,5.692219596,5.243344418,1.58E-07,8.49E-06,LOC110065214,4,4_LOC110065214,LOC110065214,heat shock 70 kDa protein 12A-like, C_PE_H_C_EE_H
919,3.484472985,29.923574,5.136867849,5.825256729,5.70E-09,3.76E-07,LOC110066206,4,4_LOC110066206,LOC110066206,BTB/POZ domain-containing protein 6-like, C_PE_H_C_EE_H
762,3.791031949,29.95858603,3.805197338,7.87307027,3.46E-15,6.55E-13,LOC110055700,4,4_LOC110055700,LOC110055700,AAC-rich mRNA clone AAC4 protein-like, C_PE_H_C_EE_H
798,10.02627736,29.98529091,4.11536686,7.286176891,3.19E-13,4.22E-11,LOC110046269,4,4_LOC110046269,LOC110046269,potassium voltage-gated channel subfamily D member 3-like, C_PE_H_C_EE_H
680,17.15070632,29.99988244,2.619837908,11.45104525,2.32E-30,1.85E-26,LOC110059708,4,4_LOC110059708,LOC110059708,"WD repeat-containing protein 59-like, transcript variant X1", C_PE_H_C_EE_H
471,22.55665089,31.64628252,4.106138835,7.70706588,1.29E-14,5.38E-12,LOC110056376,2,2_LOC110056376,LOC110056376,uncharacterized LOC110056376, D_EE_D_D_EE_H
480,15.93293761,31.91022521,4.401749515,7.249441409,4.18E-13,1.39E-10,LOC110043480,2,2_LOC110043480,LOC110043480,tumor necrosis factor receptor superfamily member 27-like, D_EE_D_D_EE_H
500,15.34453974,32.56732783,4.875608104,6.679644289,2.40E-11,5.68E-09,LOC110062593,2,2_LOC110062593,LOC110062593,receptor-type tyrosine-protein phosphatase R-like, D_EE_D_D_EE_H
519,9.552111504,32.8423105,5.235218258,6.273341221,3.53E-10,6.53E-08,LOC110053869,2,2_LOC110053869,LOC110053869,uncharacterized LOC110053869, D_EE_D_D_EE_H
476,8.777416147,32.85773433,4.412003978,7.447349207,9.52E-14,3.52E-11,LOC110042472,2,2_LOC110042472,LOC110042472,uncharacterized LOC110042472, D_EE_D_D_EE_H
576,18.72425984,33.20976689,6.400191963,5.188870441,2.12E-07,2.35E-05,LOC110067870,2,2_LOC110067870,LOC110067870,polycystic kidney disease protein 1-like 3, D_EE_D_D_EE_H
497,7.512101115,33.45056121,4.921548655,6.796755159,1.07E-11,2.66E-09,LOC110053460,2,2_LOC110053460,LOC110053460,uncharacterized LOC110053460, D_EE_D_D_EE_H
602,3.662025027,33.56024009,7.071956757,4.74553808,2.08E-06,0.000195537,LOC110064503,2,2_LOC110064503,LOC110064503,uncharacterized LOC110064503, D_EE_D_D_EE_H
453,21.79876206,33.95266819,3.954143827,8.58660425,8.96E-18,7.12E-15,LOC110048539,2,2_LOC110048539,LOC110048539,uncharacterized LOC110048539, D_EE_D_D_EE_H
458,10.65137486,34.12943417,4.193391294,8.138862266,3.99E-16,2.54E-13,LOC110054371,2,2_LOC110054371,LOC110054371,uncharacterized LOC110054371, D_EE_D_D_EE_H
442,15.29580865,34.42395093,3.668937295,9.382540001,6.44E-21,1.14E-17,LOC110069143,2,2_LOC110069143,LOC110069143,"tensin-3-like, transcript variant X1", D_EE_D_D_EE_H
460,42.34002475,34.51227465,4.325499775,7.978794694,1.48E-15,8.70E-13,LOC110048391,2,2_LOC110048391,LOC110048391,uncharacterized LOC110048391, D_EE_D_D_EE_H
661,2.522286356,35.05050647,3.537497709,9.908276797,3.83E-23,1.22E-19,LOC110069478,3,3_LOC110069478,LOC110069478,"uncharacterized LOC110069478, transcript variant X1", C_PE_D_D_EE_D
495,11.33587953,35.12189525,5.135072636,6.839610214,7.94E-12,2.04E-09,LOC110041727,2,2_LOC110041727,LOC110041727,uncharacterized LOC110041727, D_EE_D_D_EE_H
449,10.01883545,35.36343811,4.01053709,8.817631484,1.17E-18,1.16E-15,LOC110052824,2,2_LOC110052824,LOC110052824,"synaptotagmin-7-like, transcript variant X1", D_EE_D_D_EE_H
469,12.74835016,35.46651964,4.579802515,7.744115499,9.62E-15,4.13E-12,LOC110043323,2,2_LOC110043323,LOC110043323,coiled-coil domain-containing protein 15-like, D_EE_D_D_EE_H
487,5.708759375,35.49830207,5.031982886,7.054535533,1.73E-12,5.10E-10,LOC110061335,2,2_LOC110061335,LOC110061335,fez family zinc finger protein 1-like, D_EE_D_D_EE_H
450,17.10320846,35.62574732,4.066746157,8.760258434,1.95E-18,1.82E-15,LOC110054147,2,2_LOC110054147,LOC110054147,serine/threonine-protein kinase CTR1-like, D_EE_D_D_EE_H
494,11.61339856,35.6535863,5.19328749,6.865321122,6.63E-12,1.73E-09,LOC110056894,2,2_LOC110056894,LOC110056894,"XK-related protein 6-like, transcript variant X4", D_EE_D_D_EE_H
437,6.485786337,35.67429879,3.589110921,9.939592163,2.80E-23,8.90E-20,LOC110057547,2,2_LOC110057547,LOC110057547,uncharacterized LOC110057547, D_EE_D_D_EE_H
470,11.80520943,35.83323612,4.625739348,7.746488383,9.45E-15,4.13E-12,LOC110051193,2,2_LOC110051193,LOC110051193,major facilitator superfamily domain-containing protein 6-like, D_EE_D_D_EE_H
439,12.19529159,35.87617159,3.737260211,9.599591562,8.03E-22,2.13E-18,LOC110040243,2,2_LOC110040243,LOC110040243,uncharacterized LOC110040243, D_EE_D_D_EE_H
440,18.34832084,35.93721681,3.779797737,9.507708959,1.95E-21,4.26E-18,LOC110052533,2,2_LOC110052533,LOC110052533,uncharacterized skeletal organic matrix protein 5-like, D_EE_D_D_EE_H
521,4.279062042,35.94409698,5.744601996,6.257021288,3.92E-10,7.09E-08,LOC110061589,2,2_LOC110061589,LOC110061589,L-cysteine desulfhydrase-like, D_EE_D_D_EE_H
456,6.150945463,35.97132941,4.372304934,8.227086159,1.92E-16,1.33E-13,LOC110056711,2,2_LOC110056711,LOC110056711,"uncharacterized LOC110056711, transcript variant X1", D_EE_D_D_EE_H
446,13.86692027,36.15924281,3.955325435,9.141913453,6.14E-20,7.50E-17,LOC110066436,2,2_LOC110066436,LOC110066436,uncharacterized LOC110066436, D_EE_D_D_EE_H
467,6.983002979,36.18609793,4.645151573,7.790079045,6.70E-15,3.13E-12,LOC110043637,2,2_LOC110043637,LOC110043637,gamma-tubulin complex component 2-like, D_EE_D_D_EE_H
443,14.50198738,36.41882482,3.906764693,9.321990876,1.14E-20,1.81E-17,LOC110065103,2,2_LOC110065103,LOC110065103,uncharacterized LOC110065103, D_EE_D_D_EE_H
447,13.36534141,36.41982063,4.057713696,8.975453509,2.82E-19,3.20E-16,LOC110039728,2,2_LOC110039728,LOC110039728,protein DD3-3-like, D_EE_D_D_EE_H
436,10.1639114,36.65740921,3.478270178,10.53897694,5.71E-26,3.03E-22,LOC110049889,2,2_LOC110049889,LOC110049889,uncharacterized LOC110049889, D_EE_D_D_EE_H
502,8.643826804,36.65873013,5.560750118,6.592407381,4.33E-11,9.97E-09,LOC110068152,2,2_LOC110068152,LOC110068152,hemicentin-2-like, D_EE_D_D_EE_H
455,12.92363649,36.74827956,4.409267478,8.334327582,7.79E-17,5.63E-14,LOC110045829,2,2_LOC110045829,LOC110045829,leucine-rich repeat-containing protein 27-like, D_EE_D_D_EE_H
529,6.221166298,36.75963169,5.99202554,6.134758847,8.53E-10,1.41E-07,LOC110064052,2,2_LOC110064052,LOC110064052,kelch-like protein diablo, D_EE_D_D_EE_H
478,9.396402799,36.8363309,5.035839022,7.314834875,2.58E-13,9.10E-11,LOC110040441,2,2_LOC110040441,LOC110040441,uncharacterized LOC110040441, D_EE_D_D_EE_H
486,6.561833955,36.85516202,5.18854198,7.103182776,1.22E-12,3.66E-10,LOC110066836,2,2_LOC110066836,LOC110066836,"uncharacterized LOC110066836, transcript variant X1", D_EE_D_D_EE_H
454,14.99790522,36.87805319,4.309232979,8.557915845,1.15E-17,8.70E-15,LOC110063175,2,2_LOC110063175,LOC110063175,voltage-dependent calcium channel subunit alpha-2/delta-2-like, D_EE_D_D_EE_H
465,8.27947898,37.05727199,4.74891335,7.803316098,6.03E-15,2.99E-12,LOC110064941,2,2_LOC110064941,LOC110064941,uncharacterized LOC110064941, D_EE_D_D_EE_H
462,11.55081215,37.18795449,4.688467853,7.931792573,2.16E-15,1.18E-12,LOC110063870,2,2_LOC110063870,LOC110063870,uncharacterized LOC110063870, D_EE_D_D_EE_H
489,5.139103845,37.19313521,5.317788925,6.994097685,2.67E-12,7.58E-10,LOC110068201,2,2_LOC110068201,LOC110068201,uncharacterized LOC110068201, D_EE_D_D_EE_H
445,10.26599665,37.38876916,4.073510453,9.178513125,4.37E-20,5.79E-17,LOC110059406,2,2_LOC110059406,LOC110059406,pre-mRNA-splicing factor cwc2-like, D_EE_D_D_EE_H
475,5.661814534,37.54142675,5.018536011,7.480553425,7.40E-14,2.80E-11,LOC110056850,2,2_LOC110056850,LOC110056850,uncharacterized LOC110056850, D_EE_D_D_EE_H
473,9.153247807,37.58636673,4.921975408,7.63643936,2.23E-14,8.87E-12,LOC110054364,2,2_LOC110054364,LOC110054364,coadhesin-like, D_EE_D_D_EE_H
444,11.86698384,37.91458905,4.120343628,9.201802683,3.52E-20,5.09E-17,LOC110043035,2,2_LOC110043035,LOC110043035,acetylserotonin O-methyltransferase-like, D_EE_D_D_EE_H
461,14.29591687,38.28883399,4.82096332,7.942154181,1.99E-15,1.13E-12,LOC110055348,2,2_LOC110055348,LOC110055348,"golgin subfamily A member 6-like protein 6, transcript variant X2", D_EE_D_D_EE_H
501,7.183966188,38.3811275,5.754110844,6.670209967,2.55E-11,5.97E-09,LOC110065687,2,2_LOC110065687,LOC110065687,collagen alpha-1(I) chain-like, D_EE_D_D_EE_H
482,12.21777091,38.40450342,5.321426829,7.216956026,5.32E-13,1.72E-10,LOC110050342,2,2_LOC110050342,LOC110050342,uncharacterized LOC110050342, D_EE_D_D_EE_H
448,11.18387365,39.09877476,4.421399095,8.843077478,9.31E-19,9.86E-16,LOC110060002,2,2_LOC110060002,LOC110060002,"BTB/POZ domain-containing protein 6-like, transcript variant X1", D_EE_D_D_EE_H
1145,NA,NA,NA,NA,NA,NA,NA,NA,4_KEG21_P09,None,None, C_PE_H_C_EE_H